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  Abstract. 
 
Overall this thesis describes the study of the ability of the 
tetracationic cyclophane CBPQT
4+ to form inclusion complexes with 
electron-rich moieties such as tetrathiafulvalene (TTF) and 
dioxynaphthalene. These complexes are strengthened by π-stacking and 
charge transfer interactions, which give rise to coloured complexes. The 
complexes are fully reversible and can be decomplexed by the addition of 
a stimulus that can be chemical, electrochemical, and thermal. In addition 
we have exploited the ability of ferrocene to form inclusion complexes 
with cyclodextrins in aqueous media. The host-guest interactions that 
occur between these molecules were investigated using a number of 
techniques such as UV-Vis, fluorescence, NMR spectroscopy and cyclic 
voltammetry. Isothermal titration calorimetery (ITC) was also be used to 
measure the Ka of the complexes.  
Chapter two describes the synthesis of naphthalene and ferrocene 
functionalised dihydroimidazophenanthridines (DIPs). These materials 
were synthesised in order to create DNA intercalating agents that could 
undergo further host-guest interactions with either CBPQT
4+ or   
β-cyclodextrin. These interactions were studied using ITC in a number of 
aqueous buffers with calf thymus DNA and the synthetic Dickerson 
dodecamer D-DNA. Additionally, the host-guest interactions for the 
naphthalene functionalised DIP with CBPQT
4+ were studied using UV-Vis, 
fluorescence and NMR spectroscopy. The cytotoxic nature of the 
functionalised DIPs were investigated using MDCK epithelial cell culture 
experiments. 
Chapter three describes the synthesis and analysis of silane and 
disulfides modified with chosen electron rich substrates for the production 
of functionalised surfaces where self-assembled monolayers were 
produced on either glass or gold surfaces. These functionalised surfaces 
were then utilised in cell adhesion experiments with MDCK cells where the modulation of adhesion was attempted by the formation of pseudo-
rotaxanes with either CBPQT
4+ or β-cyclodextrin and by changing the 
oxidation state of the functional group in the case of ferrocene. 
Chapter four describes the synthesis of functionalised diacetylenes 
for the formation of polydiacetylene liposomes in aqueous conditions. The 
liposomes successfully formed were analysed by DLS. UV-Vis 
spectroscopy and cyclic voltammetry were used to investigate the dual 
response chromophoric sensing applications of these materials. 
Chapter five describes the synthesis of functionalised surfactant 
compounds for the formation of mixed micelles in aqueous conditions 
with sodium dodecyl sulfate (SDS). The interactions between the 
surfactant and CBPQT
4+ were measured by ITC, NMR, UV-Vis, and 
fluorescence spectroscopy. 
Chapter six describes the modification of the protein BSA with a 
naphthalene functionalised chloroacetate. The modified protein was 
analysed by ITC, MALDI TOF, UV-Vis, and fluorescence spectroscopy in 
order to identify the degree of functionalisation that had occurred and 
whether complexation was possible with CBPQT
4+. 
Chapter seven describes the synthesis of a naphthalene, and two 
ferrocene functionalised biotin conjugates with a view to investigate the 
interactions with avidin proteins. The interactions were measured by ITC 
and UV-Vis spectroscopy. The effect of changing the chain length on 
binding to neutravidin and β-cyclodextrin was studied in the ferrocene 
biotin conjugates where the interactions were assessed using ITC, cyclic 
voltammetry, and NMR spectroscopy. The interactions between the 
naphthalene based conjugate and CBPQT
4+ was measured by UV-Vis 
and fluorescence spectroscopy. 
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DNA    Deoxyribose  nucleic  acid 
D-DNA  Dickerson dodecamer DNA with sequence. 
d(CGCGAATTCGCG)2 
DMAP    4-Dimethylaminopyridine. 
EDCI    1-(3-Dimethylaminopropyl)-3-ethyl  carbodiimide. 
ECM    Extracellular  Matrix 
FAB    Fast  Atom  Bombardment. 
MDCK      Madin Derby Canine Kidney Epithelial cells 
NOBA    Nitro  benzyl  alcohol. 
TTF    Tetrathiafulvalene 
CBPQT
4+    Tetracationic cyclophane  
cyclobis(paraquat-p-phenylene) 
MALDI    Matrix assisted laser desorption ionisation. 
EPR    Electron  Paramagnetic  Resonance 
SPR    Surface  Plasmon  Resonance 
NMR    Nuclear  Magnetic  Resonance 
ITC    Isothermal  Titration  Calorimetry 
DLS    Dynamic  Light  Scattering 
CV    Cyclic  Voltammetry 
DIP      Dihydrimidazophenanthridine 
IP    Imidazophenanthridine 
POM      Polyoxometallate  crystals SAM    Self-assembled  Monolayer 
Fc    Ferrocene 
CR    Colorimetric  Response 
SDS    Sodium  Dodecyl  sulfate 
Cp    Cyclopentadiene 
HABA    4’-Hydroxy  azobenzene-2-carboxylic  acid 
NA    Neutravidin 
Av    A v i d i n  
PBS    Phosphate  buffered  saline 
BSA    Bovine  Serum  Albumin 
PIPES    Piperazine-1,4-bis(ethanesulfonic  acid) 
MOPS    3-(N-morpholino) propane sulfonic acid 
ITO    Indium  Tin  Oxide 
FTIR    Fourier  Transform  Infrared  Spectroscopy 
PDI    Polydispersity  Index 
RGD       Tripeptide chain with Arginine, Glycine, Aspartic acid  
NBS    N-bromosuccinimide 
CMC    Critical  micelle  concentration i 
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1. Introduction. 
 
1.1 Supramolecular Chemistry. 
 
“Chemistry beyond the molecule” 
[1]. 
 
Supramolecular chemistry is the study of molecular assemblies 
made of two or more discrete molecular subunits that are held together 
via non-covalent binding interactions. It is defined as a highly 
interdisciplinary field that covers the chemical, physical, and biological 
features of complex molecular assemblies that are held together and 
organised by intermolecular bonding interactions.
[2] These assemblies are 
made of two or more discrete molecular subunits that can assemble to 
create a more complex system via reversible binding interactions, such 
as hydrogen bonding, hydrophobic effects, and van der Waals 
interactions. Examples of naturally occurring supramolecular structures 
include DNA, tobacco mosaic virus, and chlorophyll in plant leaves. 
In 1987 Charles J. Pedersen and Donald J. Cram, and Jean-Marie 
Lehn won the Nobel Prize for chemistry for their work within the area of 
supramolecular chemistry. Jean-Marie Lehn described supramolecular 
chemistry as: 
“the chemistry of the intermolecular bond covering the structures and 
functions of the entities formed by association of two or more chemical 
species.”
[3] 
He described these interactions as the basis for the highly specific 
recognition processes found in biology such as found in substrate binding 
to a receptor protein. Donald J Cram, Lehn’s fellow Nobel laureate, 
defined host-guest complexes as: 
  
 
2 
 
“Complexes are composed of two or more molecules or ions held 
together in unique structural relationships by electrostatic forces other 
than those of full covalent bonds.” “High structural organization is usually 
produced only through multiple binding sites.” “A host-guest relationship 
involves a complimentary stereo-electronic arrangement of binding sites 
in host and guest.”
[4] 
 
1.2 Intermolecular Interactions. 
 
Host-guest complexes involve reversible binding of a substrate to 
a receptor using non-covalent interactions such as hydrogen bonding, 
electrostatic interactions and, π-π stacking interactions. A diagrammatic 
illustration is shown in Figure 1.1. 
 
 
Figure 1.1.Schematic diagram of host – guest binding. 
 
In 1894 Fischer hypothesised the lock and key principle for the 
visualisation of substrate-enzyme interactions. The principle describes 
the complementary nature of the host-guest binding site, which is 
dependent on size, shape and position of host to guest in the complex. 
The binding site must be both sterically and electronically complementary 
to the substrate requiring to bind. A schematic of the Fischer lock and key 
concept is shown in Figure 1.2.
[5] 
[6]  
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Figure 1.2. Schematic diagram showing Fischer’s lock and key principle.
[5] 
[6] 
 
Examples include the complementary association of the two 
strands in DNA, where hydrogen bonding and -stacking occur between 
the nucleobases, adenine and thymine and guanine and cytosine 
respectively as shown in Figure 1.3. 
 
Figure 1.3. Hydrogen bonding found between the nucleoside base pairs of DNA. 
 
Non-covalent interactions are weaker forces than covalent 
interactions with a strength in the range of 2 kJmol
-1 to 250 kJmol
-1 
compared 350 kJmol
-1 for covalent bonding. Each interaction has different 
ranges in strength.  
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1.2.1 Electrostatic Interactions. 
 
Electrostatic interactions are high strength interactions based on 
the Coulombic attraction between opposite charges. They can be found in 
ionic bonding complexes, between dipoles, and through the attraction of 
lone pairs in highly electronegative atoms to electron rich atoms in 
another molecule. Hydrogen bonding is a specific type of electrostatic 
interaction found in supramolecular chemistry. 
[5] 
[6] 
[7] The different types 
of interaction are shown in Figure 1.4. 
 
Figure 1.4. Shows the different types of electrostatic interaction. 
 
1.2.2 Van der Waals Forces. 
 
van der Waals forces, are general weak interactions that are 
typically <5 kJmol
-1 in strength. An electron cloud can be polarised by its 
proximity to an adjacent nucleus causing a weak, temporary electrostatic 
interaction. van der Waals forces are not used for the design of 
supramolecular structures due to the unspecific and low strength of these 
interactions.
[5] 
[6] 
 
1.2.3 Ion-Dipole Interactions. 
 
Ion-dipole interactions are strong, and relatively directional, with 
interactions of between 50- 200 kJmol
-1.The strongest interactions occur 
when suitable alignment of the dipole and charge is present. They are 
Na+ Cl- O -CN 

O 

NH3
Interactions
Between ions
Charge- Dipole
Electrostatic Interactions
Lone Pair - Dipole
Interactions   
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found in the binding of metal cations to crown ethers, where the oxygen 
lone pairs are attracted to the positive charge of metal cation. An example 
of ion-dipole interactions can be seen in Figure 1.5. 
[5] 
[6] 
 
 
Figure 1.5. The binding of Na
+ within the cavity of [18]-Crown-6. 
 
1.2.4 Dipole-Dipole Interactions. 
 
Dipole-dipole interactions require the alignment of dipoles, which 
can result in an attractive force in the range of 5-50 kJmol
-1. Alignment 
can be of a single pair of poles or opposing alignments of dipoles. 
Opposing alignments of dipoles give the strongest interactions. Figure 1.6 
shows both single and opposing dipole interactions. 
[5] 
[6] 
 
 
Figure 1.6. Dipole-Dipole Interactions. a) Singular Dipole Interactions. 
b) Opposing Dipole Interactions. 
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1.2.5 Hydrophobic Interactions. 
 
Hydrophobic interactions are the specific driving force for non-
polar species to associate together in aqueous solutions. As the species 
associate together there is an increase in entropy as water molecules 
become more disordered. There is also an increase in enthalpy as the 
hydrogen bonding between water molecules becomes stronger. The 
schematic below in Figure 1.7 shows the expulsion of water from a 
hydrophobic centre, as a result of binding from a general hydrophobic 
species. 
[5] 
[6] 
 
 
Figure 1.7. Schematic Represation of the Hydrophobic Effect. 
 
1.2.6 Hydrogen Bonding Interactions. 
 
Hydrogen bonding is an important type of intermolecular 
interaction found between hydrogen atoms attached to a highly 
electronegative atom that can be N, O, P, and a halogen, and the non-
bonding electron pair on another electronegative atom, which can also be 
N, O, P, and a halogen. They are highly specific directional electrostatic 
forces, which are precise and can have a wide range of strengths, varying 
from 4–12 kJmol
-1 for weak bonds up to 60-120 kJmol
-1 for strong 
hydrogen bonds. Hydrogen bonding is utilised in biological systems 
including enzymes and DNA. They are found in receptors where 
coordination of neutral organic species such as amides and short chain 
alcohols to amino acids at the active site occur. The bonding in the donor  
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complex is highly polarised with the donor atom being δ- and the 
hydrogen atom is δ+, as shown in Figure 1.8. 
 
R
O
R


N
R
H
R


Donor
Atom
Acceptor 
Atom
 
Figure 1.8. The Donor-Acceptor Interactions found in Hydrogen Bonding. 
 
Hydrogen bonding can be spread over multiple atoms and have a 
number of different angles in relation to the position of the hydrogen to 
the acceptor atom. The more linear the hydrogen bond the stronger the 
bond: angles of 175-180˚ have strengths of between 60-120 kJmol
-1, 
angles of 130-180˚ tend to have strengths of 16-60 kJmol
-1 and the 
weakest interactions of <12 kJmol
-1 tend to occur when the angle of   
H-bonding is between 90-150˚. Bond distances can vary between   
1.2–3.2 Å for H-A and 2.2-4.0 Å for D-H, where the closer the atoms, the 
stronger the interaction. Hydrogen bonding angles are shown in   
Figure 1.9. 
[5] 
[6] 
 
HA D H D
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Figure 1.9. The Different Possible Angles for H-bonding. 
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1.2.7 π-π Stacking Interactions. 
 
π-π stacking interactions are the weak electrostatic interaction 
between aromatic rings. The strength of these interactions ranges from  
0-50 kJmol
-1. There are two types of  stacking interactions, they are 
face-to-face and edge-to-face. Face-to-face -stacking is the interaction 
between the electron clouds of the aromatic rings where the clouds are 
parallel to each other. Face-to-face  stacking is found between the 
nucleobases in DNA. Edge-to-face  stacking is where there is an 
interaction between an electron deficient hydrogen of one aromatic ring to 
the electron rich  cloud of another aromatic ring. Crystallisation of edge 
to face aromatic rings yields a herringbone distribution pattern. Edge-to-
face and face-to-face alignment structures are shown below in   
Figure 1.10.
[5] 
[6] 
 
3.5Å
H
a) b)  
Figure 1.10. π-π Stacking Interactions. a) Edge to Face π Stacking. 
b) Face to Face π Stacking. 
 
 
 
 
 
  
 
9 
 
1.2.8 Self Assembly and Other Factors for Complexation. 
 
1.2.8.1 Self Assembly. 
 
When two or more components aggregate spontaneously and 
reversibly together to give a non-covalently bound complex, using 
intermolecular forces to hold the complex together. Coordination of 
substrates can give appropriate alignment for covalent interactions to 
occur between individual substrates to form a macrocycle in situ of 
complexation.
[5] 
[6] An example of a self-assembled structure is the double 
helix found in DNA. The two strands are held together by a combination 
of hydrophobic interactions, hydrogen bonding and -stacking between 
the nitrogen base pairs attached to the phosphate backbone. An 
illustration of the conformation shape of DNA is shown in Figure 1.11.
[8] 
 
 
Figure 1.11. Illustration of DNA. 
[8]
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1.2.8.2 The Chelate Effect. 
 
The chelate effect is where the stability of a complex increases 
with the number of binding sites on a guest in comparison to the 
equivalent monodentate ligand bound to the same substrate. For 
example the chelation of ethylenediamine to Ni
2+ is 10
8 times stronger 
than the chelation of ammonia to Ni
2+, due to the enhanced stability of the 
complex. As shown in Figure 1.12.
[5] 
[6] 
 
 
Figure 1.12. Binding of Ni
2+ complexes. a) [Ni(NH3)6]
2+. b) [Ni(en)3]
2+. 
*en = ethylenediamine 
 
1.2.8.3 Pre-organisation. 
 
Pre-organisation is where the host is in a conformation that 
requires very little or no rearrangement to bind the substrate.   
Pre-organised structures exhibit slower binding kinetics compared to less 
pre-organised structures, however, binding tends to be stronger in   
pre-organised complexes, such that the spherand binds up to 10
10 times 
more strongly than the equivalent crown ether. This is exemplified in 
Figure 1.13.
[5] 
[6] 
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Figure 1.13. The Binding of a Metal Cation to a) a spherand b) a crown ether. 
 
 
1.3 Molecular Architectures. 
 
Rotaxanes and catenanes are interconnected structures, where 
the components are joined together by mechanical bonds, and cannot be 
separated without breaking covalent bonds. Rotaxanes are constructed 
from an axle with one or more rings threaded onto it. The ends of the axle 
have large bulky stopper groups which stop the ring from unthreading. 
The axle typically has two or more intermolecular binding sites at which 
interaction with the macrocycle can occur. Catenanes, consist of two or 
more interlocked macrocyclic rings. Catenanes also typically have two or 
more binding sites for interactions to occur. Figure 1.14 shows the basic 
form of these structures. Naming of these structures comes from the 
number of interlocked components, thus, the rotaxane and catenane of 
Figure 1.14 are [2]-rotaxane and [2]-catenane structures. It is possible to 
have more than two components in these structures and the names 
change accordingly. Pseudorotaxanes are similar to rotaxanes, where a 
macrocycle is threaded onto an axle. However, with pseudorotaxanes 
there are no stopper groups on the axle and the macrocycle can freely 
associate and dissociate from the thread.  
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Figure 1.14. Illustration of a) A [2]-Rotaxane b) A [2]-Catenane. 
 
These architectures have gained interest in recent years due to 
their potential uses as molecular machines and devices. Movement within 
these molecules can occur freely without cleavage of covalent bonds. 
The motions found within a rotaxane can occur in two ways, where the 
macrocycle moves in relation to the axle either by lateral shuttling from 
one site on the axle to another, or rotation around one site with no lateral 
movement observed.
[7] Movement within a catenane can be described by 
the motion of one ring relative to the other and can also be designated by 
lateral shuttling around the ring or pirouetting around a particular point on 
the ring. These motions are shown diagrammatically in Figure 1.15.  
 
 
Figure 1.15. Motions found in a) [2]-Rotaxanes b) [2]-Catenanes. 
 
The structure of these architectures can be modified in such a way 
that a variety of properties can be incorporated, such as fluorescence, 
electrochemical potential, and optical activity. The strength of non-
covalent interactions found within each construct can be tuned, and so 
the degree of movement can be controlled.
  Rotaxanes can be 
synthesised by a number of methods. One method is via the formation of 
a pseudorotaxane intermediate that is then stoppered at each end prior to 
the macrocycle dethreading. This method generally does not have a great 
yield as dethreading of the macrocycle can occur rapidly at equilibrium,  
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and the macrocycle is not always trapped on the axle at time of 
stoppering. Figure 1.16 shows a schematic of this principle.  
 
 
Figure 1.16. Formation of Pseudorotaxane then Capping of the ends. 
 
The second method, clipping, utilises the intermolecular 
interactions formed between the macrocycle and the axle. Two halves of 
a ring orientate themselves around the preformed axle at a binding site 
where they then join together to form the complete macrocycle. The ring 
cannot then dethread due to the bulky stoppers on the ends of the axle. 
This method is shown schematically in Figure 1.17. 
 
 
Figure 1.17. Formation by Clipping. 
 
Rotaxanes can also be formed by ring slippage reactions. The 
bulky stopper groups are first attached to the axle, and then the intact ring 
is slipped onto the axle in a high temperature reaction. The stability of the 
components at the high temperatures required makes this method of 
rotaxane formation not always appropriate. Figure 1.18 illustrates this 
process.  
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Figure 1.18. Formation by Ring Slippage. 
 
Catenanes are can be made in a similar way to rotaxanes. They 
can be formed by the clipping of two halves of one ring around a point on 
a second preformed macrocycle, where intermolecular interactions hold 
both halves of the ring in the correct orientation for joining together. 
Clipping together of both rings can also occur where all four halves of the 
rings are held together in the correct orientation for formation of the 
required catenane. This synthesis can be metal mediated or by simply 
using intermolecular interactions. Figure 1.19 shows the potential clipping 
methods. 
 
 
Figure 1.19. Clipping to form Catenanes a) One ring Preformed b) Clipping of both rings. 
 
Ring slippage in catenanes is rare, but can occur with metal-ligand 
complexes, where an intermediate in which the ligand metal centres 
change. The ligands loop back to their original metal centre, interlocking 
the two rings and the catenane is formed. This method is referred to as 
Mobius strip ring slippage and is illustrated in Figure 1.20. 
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Figure 1.20. 'Mobius Strip' Ring Slippage in Catenanes. 
 
 
1.4 Key Functional Supramolecular Groups used in this study. 
1.4.1 Cyclobis(paraquat-p-phenylene) (CBPQT
4+). 
 
N+ N+
N+ N+
   
benH
benH
.4X-
 
Figure 1.21. Structure of CBPQT
4+ with the α, β, and benzyl hydrogens labelled. 
 
The electron deficient cyclophane CBPQT
4+, shown above in 
Figure 1.21, has been shown to interact with a number of π-electron rich 
substrates such that inclusion complexes are formed within the cavity of 
the CBPQT
4+. The inclusion complexes are stabilised by a number of 
molecular recognition interactions including charge transfer, π-π stacking 
and hydrogen bonding interactions.
[9] As a direct result of the charge 
transfer interactions these complexes are highly coloured, where 
complexes with hydroquinone are red, dioxynaphthalene are purple and 
tetrathiafulvalene (TTF) are green. The inclusion complexes are fully 
reversible and the switching from complexed to uncomplexed can be 
induced by the addition of a stimulus. The stimulus used can vary from 
thermal to chemical or electrochemical.  
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Examples include the formation of a pseudorotaxane with a 
hydroquinone functionalised axle.
[10] It has been observed that this 
complex has a strong red colour from the interaction between the 
CBPQT
4+ the hydroquinone group. X-ray crystal structures showed that 
the hydroquinone group was found in the center of the cavity and 
interacted with the CBPQT
4+ through ‘T-type’ edge-face π-stacking 
interactions in addition to the charge transfer interactions. It was also 
found that for the rotaxane used, the thread folded back upon itself where 
the aromatic groups in the chain performed additional π-stacking 
interactions with CBPQT
4+ resulting a highly stable complex.
[10] The 
structure of the [2]-rotaxane is shown in Figure 1.22. The X-ray crystal 
structure produced is shown in Figure 1.23.
[10] 
 
O O O O O O O O O O O
N+
N+
N+
N+
O
 
Figure 1.22. Structure of [2]-Rotaxane. The CBPQT
4+ ring in blue, the axle in red. 
 
Figure 1.23. X-ray crystal structure of the [2]-Rotaxane 1. 
The axle in red folds around the CBPQT
4+ bead shown in blue.
[10] 
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Similarly, the inclusion complex formed between CBPQT
4+ and   
1,5-dioxynaphthalene systems have been thoroughly investigated. 
[9, 11] 
[12] 
It has been found by X-ray crystallography, that the naphthalene is 
threaded centrosymmetrically through the cavity of CBPQT
4+ and is 
positioned with interplanar separations of ~3.5Å between the π- donor 
and  π-acceptors. An example of this sort complex is shown in   
Figure 1.24, where the pseudorotaxane comprises of a   
1,5-naphthalenediyl axle threaded through the cavity of CBPQT
4+.  
The naphthalene group undergoes π-π interactions with the 
electron deficient bipyridyl groups of the CBPQT
4+. It can be observed 
that the thread has an anti geometry associated with the conformation of 
the ethyleneglycol chains. Hydrogen bonding interactions between the 
ethylene glycol oxygens and the Hα on the bipyridyl rings aid the 
stabilisation of the complex. The PF6
- counter ions can also form 
hydrogen bonding with the H2/6 protons on the naphthalene moiety, the 
bipyridinium Hβ  protons, and the ethylene glycol chains. However this 
does not always occur in the X-Ray structure and is dependent upon the 
additional functionality present.
[11]  
The changes in the 
1H NMR spectrum upon complexation, are 
particularly defined due to the prominent shifts of the naphthalene 
aromatic protons. In particular, the H4/8 protons that perform C-H—π 
interactions with the CBPQT
4+ can be found in the region of δ 2.1-2.9ppm, 
in the complexed form, while in the un-complexed form are found within 
the range of 6.8-7.9ppm.
[12] 
[13] 
[14] The complex can be reversed by the 
addition of a competitor compound such as TTF,
[12] by application of 
heat,
[15] and by reduction of CBPQT
4+ to its radical form, CBPQT
••2+. 
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A 
B 
Figure 1.24. A) Basic structure of the pseudorotaxane and B) The X-ray crystal structure. 
Hydrogen atoms, solvent molecules, and counterions are omitted for the sake of clarity. 
The DNP unit is colored red, the CBPQT
4+ ring blue, and the remainder gray.
[11] 
 
It has also been found that the reversible interactions between 
CBPQT
4+ and 1,5-dialkoxynaphthalene are optimal for use in the 
templated synthesis of CBPQT
4+ from 1,1-[1,4-phenylenebis-
(methylene)] bis(4,4-bipyridinium) bis(hexafluorophosphate) and 1,4-
bis(bromomethyl) benzene where the yields have been published as, up 
to 81%.
[9] The stability of the complex is higher than that of the complex 
between CBPQT
4+ and hydroquinone.
[9] The complex is fully reversible 
and the naphthalene template is easily removed by liquid/liquid 
extraction. The reaction scheme for this process is shown in   
Scheme 1.1 :
[9] 
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Scheme 1.1. Naphthalene templated synthesis of CBPQT
4+. 
 
The interactions between TTF and CBPQT
4+ have been found to 
be strong whereby TTF can competitively enter the cavity of CBPQT
4+, 
displacing groups such as 1,5-dioxynaphthalene to give a strong dark 
green colour from the charge transfer interactions in water. From the   
X-ray crystal structure it has been observed that the TTF inserts at an 
angle that has the long axis of the centrally located TTF at an angle of 
66° to the N
+---N
+ vector.
[16] This orientation maximises the π-stacking 
interactions between the two components and as a result it forms a tightly 
bound complex.
[9] The X-ray crystal structure is shown in Figure 1.25.
[16] It 
has been shown that TTF can be removed from the cavity of CBPQT
4+ by 
the oxidation to TTF
•+  and/ or TTF
2+. The complex reformed by the 
reduction back to the neutral TTF. The oxidation reduction process can 
be carried by both chemical and electrochemical means.
[15] 
[17] 
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Figure 1.25. X-ray structure of TTF in the cavity of CBPQT
4+. 
The TTF unit is coloured green, the CBPQT
4+ blue. Hydrogen atoms, solvent molecules, and 
counterions are omitted for the sake of clarity. 
[16] 
 
CBPQT
4+ can itself undergo redox processes where there are two 
sets of redox waves formed in the cyclic voltammogram that are fully 
reversible. Each redox wave represents a 2x 1e
- reduction of the 
paraquat moieties. The first reduction wave at E1 = -283 mV converts the 
cyclophane into the diradical species. The second reduction at   
E2 = -709mV forms the neutral compound. The cyclic voltammogram is 
shown in Figure 1.26. 
[18] 
 
 
Figure 1.26. CV of CBPQT
4+4PF6
-. 0.5mM solution in 0.1M TABPF6/MeCN at 25°C.  
Scan rate 50mV/s.
[18]  
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The reduced species of CBPQT produces an EPR spectrum that 
has a broad signal that indicates a fast electron exchange between 
paraquat subunits. The spectrum produced at room temperature is shown 
in Figure 1.27. 
[18] 
 
 
Figure 1.27. EPR spectrum for the CBPQT radical. 
[18] 
 
 
1.4.2 Tetrathiafulvalene as redox active guests for CBPQT
4+. 
 
Tetrathiafulvalene (TTF) is a redox active compound that can act 
as an electron donating or electron accepting substrate depending upon 
its oxidation state. TTF has been found to have three stable forms; 
TTF(0), TTF
+•, and TTF
2+. The TTF(0) has electron donating character, 
while the fully oxidised TTF
2+ state has electron acceptor character.
[19] 
The structure of each oxidation state is shown in Figure 1.28.  
 
S
S
S
S
S
S S
S S
S S
S
TTF(0) TTF+.
TTF2+
-e-
-e-
+e- +e-
 
Figure 1.28. The three forms of TTF. TTF(0), TTF
+•, and TTF
2+.  
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TTF(0) can form inclusion complexes with the electron accepting 
cyclophane CBPQT
4+, where a strong absorbance band is observed in 
the UV-Vis absorbance spectrum with λmax = 855 nm.
[19] 
[15] 
[17]. Upon 
oxidation to the radical cation, the complex dissociates, but will re-
associate upon reduction back to the neutral species. The TTF
2+ form is 
fully aromatic and fluorescent with an emission band at 488 nm. In this 
oxidation state the TTF can form inclusion complexes with an electron 
donating crown ether 1,5-dinaphtho-[38]-crown-10. Upon complexation, 
there is a quenching of the fluorescence and a charge transfer band is 
observed in the UV-Vis absorbance spectrum at λmax = 840 nm. 
Cyclic voltammetry has shown that TTF(0) undergoes two 
reversible one electron oxidation processes to form the TTF
2+ species. 
The complex with CBPQT
4+ displaces the first oxidation process by up to 
+70mV.
[19] This process is the transformation from TTF(0) to TTF
+•. The 
subsequent oxidation process from TTF
+• to TTF
2+ is unaffected by the 
presence of the cyclophane.
[19] Additionally the presence of   
1,5-dinaphtho-[38]-crown-10 affects the first reduction, where the position 
is shifted by -14 mV.
[19] This process is associated with the reduction from 
TTF
2+ to TTF
+•. By mixing the three components in the CV experiment the 
TTF-CBPQT
4+ is initially formed, and the oxidation process is shifted by 
+70 mV. Upon oxidation to the TTF
+•, the complex dissociates and all 
components are separate. Further oxidation to the TTF
2+ leads to the 
formation of the complex between 1,5-dinaphtho-[38]-crown-10 and 
TTF
2+. The reverse process exhibits a shift by -14 mV for the 
transformation from TTF
2+ to TTF
+•.
[19] Again, the components are non-
complexed until further reduction to the neutral species formed at which 
point the CBPQT
4+ re-complexes with the TTF. From this it can be 
observed that the radical cation form does not interact with either the 
CBPQT
4+ or the crown ether. The CV for the free TTF and the mix of 
CBPQT
4+, 1,5-dinaphtho-[38]-crown-10, and the TTF is shown in   
Figure 1.29. The complexation-decomplexation switching process by the 
oxidation / reduction of TTF with the two host molecules is shown in 
Scheme 1.2.  
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Figure 1.29. Cyclic voltammogram for TTF (black) in the presence of CBPQT
4+ and  
1,5-DN-[38]-C10 (red). 
[19] 
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Scheme 1.2. Complexation switching by redox oxidation reduction processes for TTF.
[19] 
 
 
1.4.3 Cyclodextrins. 
 
Cyclodextrins are water soluble, hollow, truncated cone shaped 
structures that contain 6-8 glucose units linked by α-1,4-glucoside bonds. 
These structures have hollow hydrophobic cavities that can vary in size 
from 0.45 to 0.95 nm.
[20] 
[21] 
[22]. The structure of these molecules is shown 
in Figure 1.30. Inclusion complexes are formed readily with these 
compounds and many other low molecular weight guest molecules that 
can vary in their physiochemical properties, where the molecules can 
contain polar groups such as amines or acids or can be completely non- 
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polar. Metallocenes can form inclusion complexes with cyclodextrins in 
their reduced state. Upon oxidation of the metallocene, complete 
decomplexation occurs.
[23]  
 
 
Figure 1.30. Structure of a cyclodextrin. n = number of glucose units that make up the 
structure. 
 
The interactions of cyclodextrins can be tuned by the modification 
of the pendant hydroxyl groups. By methylating, the solubility in organic 
solvents can be improved and the binding of metallocenes has been 
observed to be enhanced by this modification. Cyclodextrin has a great 
many applications from use within sensing devices,
[11] 
[24] to use as 
insulation for ‘molecular wires’.
[25] The sensing applications utilise the 
competitive binding of substrates within the cavity of the cyclodextrin. The 
attachment of fluorophores, such that partial incorporation into the cavity 
leads to a quenching in fluorescence, can be used in sensing devices. As 
substrates that can competitively form inclusion complexes with the 
cyclodextrin displace the fluorophore, quenching ceases and the 
fluorescence is activated. An example of this is the formation of dimer 
complexes with a series of bile acid steroids.
[24] The formation of 
pseudorotaxanes and rotaxanes with semiconducting polymer chains with 
either α- or β-cyclodextrin have been shown to reduce self-quenching of 
photoluminescence within the polymer chains and there is a retention of 
the semi-conducting and optical properties. 
[25] 
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1.4.4 Ferrocene as a redox active guest. 
 
Fe Fe
+
Oxidation
Reduction
Diamagnetic Paramagnetic  
Scheme 1.3. Conversion of Ferrocene to Ferrocenium. 
 
Ferrocene is comprised of iron
  in an oxidation state of 2+ 
sandwiched between two (η-C5H5) cyclopentadienyl rings (Cp) in a 
structure that is overall neutral in charge and diamagnetic. It can undergo 
reversible oxidation to the ferrocenium species which has an overall 
positive charge and is paramagnetic, as shown in Scheme 1.3. The redox 
activity of ferrocene can be modulated by the functional groups pendant 
to the Cp rings. The potential shift is dependent upon the ability of the 
substituent attached to either donate or accept electrons.
[26] The 
electrophilicity of the substituent is measured by the Hammett constant 
σp.  σp  is calculated by the following equation, where ρ stands for the 
reaction constant, K and Ko are the rate constants for the substituted and 
unsubstituted compounds. 
 
   
 
  
        Equation 1.1. The Hammett Equation
[27] 
 
Functionalised ferrocenes have found a wide scope of applications 
within catalysis, materials and coordination chemistry. The electronic 
properties of ferrocene are key for the range of applications available for 
its use.
[28] The incorporation of these structures into signalling / reporter 
molecules is of use as the spectroscopic and redox activity of ferrocene is 
altered with the binding of guest molecules. By undergoing redox  
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processes prior to guest binding, the affinity for the guest to the receptor 
can be altered. The two processes of redox activity and host-guest 
interactions are interrelated and each affects the other. The relationship 
between electron transfer and guest binding can be expressed by 
Equation 1.2.
[28-29] The equation is derived from the Nernst equation the 
Gibbs free energy equation. The derivation is given in Equation 1.3. From 
the equation it can be seen that ∆E° (E°-E°+) is proportional to the affinity 
of the receptor to guest molecules (ln (K+/K)). An example where this 
effect is observed is with the complexation of Sodium with N-
ferrocenylmethylaza-18-crown-6,
[28] where a shift in the oxidation potential 
is induced upon the complexation of sodium ions into the cavity of the 
crown ether. The transformation is shown in Figure 1.31. 
 
          
                       ⁄  
Equation 1.2.  
Derivised equation from Gibbs Free Energy 
and the Nernst Equation.
[28] 
[29] 
 
                           
For closed systems there is no change in ∆G 
       0            
                                           
          
                     ⁄  
Equation 1.3. Derivation of Gibbs Free Energy and the Nernst Equation to yield  
Equation 12.
[29] 
 
  
 
27 
 
Fe
O
O
O O
O
N
Fe+
O
O
O O
O
N
Fe
O
O
O O
O
N
Fe+
O
O
O O
O
N
Eo
+ e-
+ Na+ K+
Na+ Na+
+ Na+ K
Eo
+
+ e-
nF(Eo-Eo
+) = RTln(K+/K)
 
Figure 1.31. The complexation of Sodium with N-ferrocenylmethylaza-18-crown-6. 
 
Ferrocene and its derivatives can form inclusion complexes with 
cyclodextrins and cucurbiturils. The optimal interaction between ferrocene 
and cyclodextrin is formed with β-cyclodextrin, where a 1:1 complex is 
formed. Studies have shown that ferrocene and α-cyclodextrin form 
inclusion complexes where the ratio of cyclodextrin to ferrocene is 2:1.   
Ɣ-cyclodextrin, the largest of these compounds can accommodate up to 
two ferrocene groups within its cavity and has a ratio of ferroecene : 
cyclodextrin greater than 1:1
[20]. The structures of the inclusion complexes 
formed are illustrated in Figure 1.32. 
The complexes have been shown to be stable, such that there are 
examples where the complexes have been crystallised from water and 
are thermally stable up to the melting point of cyclodextrin ~200°C.
[30] The 
binding constant Ka has been reported to be in the range of 10
3-10
4 M
-1.
[31] 
The driving force for the inclusion complex is through hydrophobic 
interactions, and the interaction and formation of the complex occurs 
irrespective of the charge on the ferrocene derivative and is unaffected by 
the presence of buffer or salt in the solution.
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Figure 1.32. Illustration of the inclusion complexes of ferrocene and α, β and  
Ɣ- Cyclodextrins. 
 
It has been found that for ferrocene-cyclodextrin complexes to 
undergo redox processes, partial or full decomplexation from the cavity 
must occur prior to the oxidation process to form the ferrocenium 
species.
[20] The complexation/ decomplexation processes required for the 
oxidation of ferrocene with each cyclodextrin is shown in Figure 1.33.
[20] 
With  α-cyclodextrin, only partial decomplexation from the Fc(α-CD)2 is 
required for oxidation to occur. However it has been shown that full 
decomplexation may occur prior to oxidation. For both β, and Ɣ-
cyclodextrin, full decomplexation is required before oxidation of the iron 
can occur. 
 
[Fc(-CD)2] [Fc(-CD)]+ + -CD + e-
[Fc(-CD)2] Fc+ + 2(-CD) + e- (30%)
(70%)
Fc(-CD)                 Fc+   + -CD  + e-
Fc(-CD)                 Fc+   + -CD  + e-
 
Figure 1.33. Complexation/Decomplexation process required for the oxidation of ferrocene 
cyclodextrin inclusion complexes. 
 
The cyclic voltammogram of ferrocene changes upon 
complexation with cyclodextrin such that the half wave potential E½ 
becomes more positive and the intensity of the signal diminishes slightly.  
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This change is illustrated in Figure 1.34.
[20] Cyclic voltammetry will be 
discussed in greater detail in § 1.8.2. 
 
 
Figure 1.34. Cyclic voltammogram of ferrocene with the complex of ferrocene with  
β-cyclodextrin overlayed.
[20] 
 
1H NMR spectroscopy can be used to show that the inclusion 
complex has formed. Typically, addition of a large excess of   
β-cyclodextrin to a ferrocene derivative causes a broadening of shifts as 
the complex forms. This broadening is due to shielding and de-shielding 
effects on the ferrocene compound. These changes are exemplified by 
the shifts observed for the ferrocene derivative as shown in   
Figure 1.35.
[32] 
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Figure 1.35. 
1H NMR shifts observed for the ferrocene derivative with cyclodextrins.
[32] 
 
Where cyclodextrins are structurally like truncated cones, 
cucurbiturils are barrel shaped compounds that are made of 6-8 glycoluril 
units. The cavities are fully symmetrical and as a result molecules can 
enter the cavity from either end of the structure. The structure of these 
compounds are shown in Figure 1.36. 
 
 
 
Figure 1.36. Structure of a cucurbituril. n = number of glycoluril units that make up the 
structure. 
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These molecules are similar to cyclodextrins in relation to their 
cavity diameters, where the cucurbit-[7]-uril (CB7) is equivalent to β-
cyclodextrin. The inclusion complex formed between ferrocene and, in 
particular, CB7 has a higher binding constant in the range of 10
9-10
13 
than that of the complex between ferrocene and β-cyclodextrin.
[31] There 
are also examples where the binding constant reaches levels comparable 
to avidin-biotin binding.
[33] The driving forces for the formation of inclusion 
complexes with ferrocene are hydrophobic and ion-dipole interactions. 
The binding is affected by the charge on the ferrocene where cationic 
derivatives exhibit stronger binding interactions, and anionic derivatives 
tend not to form complexes due to charge repulsion interactions.
[31] 
[34] 
The effect of buffer or salts in solution also diminishes the interactions 
with ferrocene and its derivatives where ion-dipole interactions will occur 
with the salts over the ferrocene derivative used. The effect of 
complexation on the 
1H NMR spectrum differs from the shifts exhibited by 
cyclodextrin with ferrocene, whereby the cyclopentadiene protons move 
upfield towards 3.5 ppm from 4.25 ppm. The spectra recorded for the 
ferrocene derivative with CB7 is shown Figure 1.37.
[31] 
 
 
 
Figure 1.37. 
1H NMR spectra of ferrocene derivative (A) in the absence, and in the presence 
of (B) 0.5 equiv and (C) 1.1 equiv of CB7. 
[31]
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Investigation of the effects of the inclusion complex between CB7 
and ferrocene on the redox activity of ferrocene derivatives has shown 
that the complex behaves in a similar way to cyclodextrin complexes, 
where there is a positive shift in the half potential and the current flow is 
reduced. However, the degree of change exhibited upon the E½ varies 
with the substitution on the ferrocene derivative. As with cyclodextrin, the 
ferrocene form of the redox couple is stabilised by the inclusion complex 
over the ferrocenium species. 
 
1.5 Molecular Machines. 
 
Molecular devices are molecular assemblies that can carry out a 
function of some sort using non-covalent interactions in host-guest 
complexes. Molecular machines are molecular assemblies that with the 
addition of a stimulus cause a net nuclear displacement of one molecule 
relative to another in the complex. This displacement can, in turn, affect 
the external environment in a way that can be utilised. An example of this 
is the ON/OFF of fluorescence by a molecular switch in the presence of a 
quenching agent. Molecular machines can be made from singular- or 
multi-component structures interacting using intermolecular interactions. 
Singular component structures can contain multiple moieties that can 
interact with each other joined together covalently, whereas multi-
component structures have at least two distinct complexes joined either 
by a physical barrier to avoid separation, or simply by intermolecular 
interactions allowing the separate components to move freely relative to 
one another. 
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1.6 Sensors and Biosensors. 
 
Sensors are devices that can detect changes in the environment 
from the presence of a material or chemical, to changes in temperature. 
Upon recognition of this stimulus, the sensor undergoes feedback where 
the change is translated into a readable output.  
Stoddart and co-workers have created a chromophoric receptor for 
TTF.
[12] By taking advantage of the molecular recognition properties found 
in the complex between the electron rich aromatic group of   
1,5-dioxynaphthalene groups with the electron deficient aryl rings in the 
cyclophane, CBPQT
4+. The tetracationic macrobicyclic structure shown in 
Figure 1.38 was proven to change its conformation upon addition of 
TTF.
[12] The tethered bicylic compound in its native conformation has the 
naphthalene moiety sandwiched between the two bipyridyl groups. The 
conformation is stabilised by π-π stacking, hydrogen bonding between 
polyether linkage and the α- and β-bipyridinium hydrogen atoms. CH—π 
interactions between the C4/8 hydrogen atoms on the naphthalene with 
the p-xylyl aromatic ring also aids in the stabilisation of this complex.
[12] 
 
 
Figure 1.38. Structure of tetracationic macrobicyclic molecule in its native conformation. 
[12] 
 
The 
1H NMR spectrum for this complex shows the protons on the 
naphthalene at the H4/8 position resonate at 2.14 and 2.67 ppm, indicating 
the inclusion complex is formed. Heating above 36°C causes a rotation 
about the CH2C6H2R2CH2 axis and the naphthalene group exits the cavity 
of the CBPQT
4+.
[12] This decomplexation event can also be induced by the  
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addition of 1 eq of TTF. The complex undergoes a colour change from 
purple to green, where the absorption maximium changes from λ = 537 
nm to λ = 846 nm upon this addition.
[12] It is also noted that the 
naphthalene protons are now all in the typical aromatic region with shifts 
at 6.57, 7.25, and 7.53 ppm. The loss of peaks at δ = 2.14 and   
2.67 ppm show that the naphthalene is no longer found within the cavity 
of the CBPQT
4+, while the resonance for TTF is a singlet at δ = 5.68 ppm, 
suggesting that it is now within the cavity of CBPQT
4+.
[12] The change in 
conformation of the complex is shown in Figure 1.39.
[12] 
 
 
Figure 1.39. Chromophoric switching of the macrobicyclic molecule with the addition of 
TTF. 
[12] 
 
Biosensors are a specific type of sensoring device that use living 
organisms
[35] or biological molecules to detect the presence of 
chemicals.
[36] Biosensors can be thought as containing two components; a 
bioreceptor and a transducer.
[36] The bioreceptor binds biomolecules and 
chemicals and the transducer translates the change resulting from 
binding into an output signal that is readable.  
 
Figure 1.40. Schematic Illustration of a biosensor.  
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As will be shown throughout later chapters, sensors can take 
multiple forms and can utilise multiple functionalities for the sensing of 
particular stimuli. The interaction between the bioreceptor and the analyte 
can be measured using various analytical techniques
[37] such as UV-Vis 
spectroscopy for chromaphoric changes,
[38] and fluorescence 
spectroscopy to measure changes in the fluorescence emission 
spectrum.
[39] Electrical signals such as a change in electrical current can 
also be measured easily.
[35] Changes in the redox activity observed by 
cyclic voltammetry
[40] among other techniques such as square wave 
voltammetry may be adopted for measuring the changes upon 
complexation. 
 
1.7 Cells and their adhesion properties. 
 
Cell adhesion to surfaces or the extracellular matrix (ECM) is key 
to cell growth and development. Cells adhere to the ECM through the 
formation of integrin mediated adhesion complexes. These complexes 
can have a large variation in the subcellular distribution, size and form. 
However, there are two common features found in the adhesion 
complexes; firstly, cell adhesion is mediated through integrin proteins, 
and secondly, the integrin links to the actin cytoskeleton at the cell 
interior
[41]. Integrins are a family of heterodimer membrane spanning 
proteins that link the extracellular matrix to the inside of the cell. The 
different types of integrin are denoted by the α- and β- subunits that make 
up the heterodimer.
[42] 
[43] The integrin proteins connect to the ECM 
through binding interactions with proteins such as fibronectin or 
vitronectin. A simplified cartoon of cell adhesion through the formation of 
focal adhesions is shown in Figure 1.41. 
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Figure 1.41. Cartoon of cell adhesion to the ECM via focal adhesions. 
 
The ECM contains a large variety of proteins that interact with cells 
either by physical or chemical signalling. These interactions can control a 
great many processes with relation to cell development. In particular, the 
ECM can control gene expression, differentiation, protein expression and 
proliferation. The ECM can also direct cell adhesion, migration, 
orientation and cell guidance through these physical and chemical 
signalling processes. Within the cell, the cytoskeleton controls detection, 
transduction and regulation of the cellular interactions with the 
extracellular matrix, and so controls the fundamental functions of the 
cell.
[44] In cell culture, surfaces that can mimic the ECM either 
topographically or by the underlying chemical properties are highly sought 
after. By utilising the interactions between the ECM and cells, 
researchers can manipulate cells on surfaces by tuning the interactions 
that are exhibited between the surface and the cells. Nanotopologies 
have been found to modulate cell adhesion, proliferation, gene 
expression and cytoskeleton development.
[45] 
[46] 
[47] 
By changing the surface chemistry, cell adhesion and growth can 
be modulated. Cell adhesion to surfaces can be mediated by the prior 
adsorption of a layer of proteins to the surface such as fibronectin and a 
number of immunoglobulins.
[48] The chemistry of the surface affects the 
adsorption of proteins and so the adhesion of cells. The underlying 
chemistry of the surface can dictate the protein interactions that can then 
lead to the changes in the phenotype of cells. For example, changing the 
physiochemical properties of a surface can induce the differentiation of 
stem cells into specific cell types from blood, bone, cartilage, and skin.
[49]  
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Changes in surface chemistry can affect the signalling pathways used by 
the cells which in turn can lead to changes in gene expression within the 
cell.
[50] 
The surface chemistry of self assembled monloyers (SAMs) can 
be modulated by the functional groups attached. Thus, by incorporating 
different functionality the properties of the SAMs can be modulated. Non-
polar groups produce hydrophobic surfaces that are not wettable. The 
water droplet contact angle on these surfaces typically measures θ > 80°. 
These surfaces will adsorb protein readily onto their surface, which leads 
to cell adhesion. Groups that are charged at physiological pH such as 
carboxylic acids and amino groups have moderate wettability and their 
water contact angles measure in the range of θ  = 48 - 62°. Polar 
substituents such as hydroxyl and polyethylene glycol chains are very 
hydrophilic and the water contact angles measure θ < 35°. These 
surfaces tend to repel non-specific protein adsorption and are deemed to 
be biologically inert.
[51] 
[52]  
Protein adsorption to a surface generally correlates to the 
hydrophobicity of the surface, whereby the degree protein adsorption 
increases with increasing hydrophobicity. Surfaces can be made where 
the deposition protein is repelled. These surfaces also repel cell adhesion 
and are described as ‘biologically inert’. Typically surfaces presenting 
oligomer chains of ethylene glycol are biologically inert. Pre-adsorption of 
proteins such as BSA can have a similar effect, where additional 
adsorption cannot occur. However, gradual denaturation of the adsorbed 
protein over time occurs and the protein may undergo exchange with 
other proteins present in solution. Another limiting factor to pre-adsorption 
of protein to surfaces is that additional functionality cannot be presented 
on the surface.
[52] 
SAMs have been used extensively for the modification of surfaces 
for a number of applications ranging from the use in sensing technologies 
to tunable surfaces for cell culture work.
[53]  [54]  [55]  [56] Surfaces for 
modification with SAMs cover a wide range of materials, from metallic  
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coated glass ( typically gold films) for the immobilisation of functionalised 
thiols and disulfides, functionalised carboxylic acids on alumina, to oxides 
and silicates for adhesion of derivatised silane SAMs. The examples 
described herein will focus in particular on work carried out for cell culture 
experiments and their applications.  
The gold surfaces that thiolate SAMs can adsorb onto can be of 
varying thicknesses, from the transparent 5-20 nm range to greater than 
100 nm opaque, reflective surfaces.
[52] All thicknesses have been found to 
be electrically conductive and are stable for several months to air and 
solvent.
[52]  [57] They have been found to be stable up to temperatures of 
145° C before desorption of the monolayer will occur. Desorption may be 
induced by the application of UV light in the presence of oxygen.
[57] 
Further modulation of surface chemistry can be controlled by the 
formation of mixed solutions of two or more thiols. Microcontact printing 
(μCP) is a method for the formation of patterned SAMs where a specific 
thiol can be placed onto a gold surface with high precision. By using 
these different methods for deposition of the thiols onto the surface it is 
possible to produce multifunctional surfaces with a high degree of 
precision. Furthermore, it has been shown that the surface chemistry of 
gold-thiol SAMs can be tuned to respond to stimuli such that the activity 
towards non-specific protein adsorption and cell adhesion can be 
switched on and off.
[53] 
[54]  [55]  [56] The attachment of the tripeptide with 
sequence RGD can be used to mimic the integrin binding proteins found 
in the ECM. This sequence is found in several integrin binding proteins 
such as fibronectin. The peptide has been shown to be sufficient to 
induce focal adhesions to the surface by the cells.
[54] [55]  
This form of dynamic surfaces is exemplified by the formation of 
mixed surface where a C18 thiol [HS(CH2)17CH3] was microcontact printed 
onto gold/titanium coated glass slides. The SAMs produced areas for 
non-specific protein adsorption. A second thiol containing a chain of three 
ethylene glycols [HS(CH2)11(EG)3] was used to coat the remaining gold, in 
order to create areas that were resistant to protein adsorption.
[53] Bovine  
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capillary endothelial (BCE) cells were grown on this surface where they 
were confined to areas that were purely C18 thiol monolayers. After an 
application of -1.2 V electrical potential for 30 s through the underlying 
gold surface, the C11EG3 thiols desorbed from the surface of the gold, 
allowing the BCE cells to spread and grow across the entire surface. 
Monitoring by surface plasmon resonance (SPR) showed that after the 
electrical treatment, the layer of proteins adsorbed onto the surface 
increased, indicating that the C11EG3 thiols were no longer present.
[53] 
Cyclic voltammetry studies showed that the C11EG3 thiol monolayers had 
desorbed off the gold with the application of the electrical potential. 
Quantitative fluorescence experiments with rhodamine labelled 
fibronectin showed that the proteins that had adsorbed to the surface 
prior to application of the -1.2 V potential were retained and were 
unaffected by this electrical potential.
[53] Close inspection showed that the 
BCE cells appeared to be unaffected by the electrical pulse such that 
they underwent normal growth and cytokinesis.
[53] 
 
 
Figure 1.42. The growth and migration of BCE cells on a surface after the application of an 
electrical potential where the time in minutes after the voltage pulse is indicated.
[53] 
 
The efficacies of a number of drugs affecting motility of cells were 
tested using the migration of the cells after the pulse of voltage had been 
applied. The drugs used were fumagillin, an inhibitor of motility in  
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capilliary cells; cycloheximide, a general protein synthesis inhibitor; and 
nocodazole, which depolymerises microtubules. The motility of the BCE 
cells was inhibited by these drugs, where the rate of spreading over the 
surface was reduced by the both the fumagillin and the cycloheximide, 
and completely halted with the nocodazole. The results are shown in 
Figure 1.43.
[53] 
 
 
Figure 1.43. Summary of the influence of drugs on the motility of BCE cells after the 
application of a voltage pulse of -1.2V for 30s. 
 
Additional complexity has been incorporated into gold surfaces 
patterned with hexadecane thiol, presenting CH3, using microcontact 
printing to form islands on the gold where non-specific protein absorption 
and so cell adhesion could occur. The bare gold was then treated with a 
mixed thiol solution of 1% hydroquinone thiol (HQ) and penta(ethylene 
glycol) thiol (EG5OH) to give a protein-inert SAM on the remaining gold.
[54] 
Swiss 3T3 fibroblast cells were grown onto the surface where the growth 
and adhesion of these cells were confined to the areas coated with the 
hexadecane thiol SAMs. Application of a 500 mV electrical potential for 
10 seconds in the presence of serum-free growth media containing a 
peptide functionalised cyclopentadiene-RGD-Cp, converted the inert 
hydroquinone to a selectively labile surface for integrin binding, thus 
allowing the fibroblast cells to be released from the areas of the 
hexadecane thiol.
[54] The hydroquinone was electrically oxidised to the  
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quinone moiety that was then reacted by Diels-Alder cycloaddition with 
the RGD-cycopentadiene to give the labelled thiol SAMs.  
The Swiss 3T3 fibroblasts then quickly migrated across the surface 
such that after 22 hours of incubation with fresh media the cells had 
evenly distributed across the surface. After a period of two days the cells 
had reached confluence across the entire surface, indicating that normal 
growth and motility had occurred on this surface.
[54] Blank experiments 
showed that both the electrical potential and the addition of the RGD-Cp 
were required for the activation of the surfaces for cell growth and 
motility. The conversion of the SAMs from the hydroquinone moiety to the 
RGD functionalisation is shown in Figure 1.44. The results of the cell 
growth and migration after electrical activation and the Diels-Alder 
reaction is shown in Figure 1.45. 
 
 
Figure 1.44. Redox process to form the benzoquinone from the hydroquinone followed by 
Diels alder reaction to create biologically active SAMs for Swiss 3T3 fibroblast cell 
migration.
[54] 
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Figure 1.45. Production and activation of surfaces for the migration and growth of cells 
with an electroactive substrate.
[54] 
 
Further experiments to show the use of this system as an assay 
for testing the effectiveness of drugs that affect mobility of cells were 
carried out. By treating the culture with either 15 µM cytochalasin D or  
5 µM nocodozole, drugs that disrupt the remodelling of the cytoskeleton 
and so inhibit cell migration. After the application of the electrical potential 
with the RGD-Cp and either drug present in the media, it was found that 
even after 7 hours both drugs had retarded the movement of the cells 
almost completely. It was found that after refreshing the media, the cells 
were then able to spread across the surface again, showing that the 
drugs were not cytotoxic at the level used.
[54] The results are shown in 
Figure 1.46. 
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Figure 1.46. The effects of anti-motility drugs on the migration of Swiss 3T3 fibroblasts 
after the application of an electrical potential.
[54] 
 
Following on from this work, functionalised surfaces were prepared 
by microcontact printing of hexadecane thiol onto gold/ titanium glass 
slides. The remaining gold surface was then treated with a mixed solution 
of 0.02% diethylisopropylsilyl hydroquinone-terminated alkanethiol   
(E*-RGD) with tri(ethylene glycol) terminated alkane thiol. The structure of 
E*-RGD is shown in Figure 1.47.
[55] 
 
 
Figure 1.47. Structure of E*-RGD. 
[55] 
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The patterned surface was then treated with fibronectin.
[55] The 
fibronectin adsorbed only on the regions of the hexadecanethiolate 
SAMs. The triethylene glycol terminated SAMs repel all non-specific 
adsorption of protein to the surface and the RGD peptide also repelled 
further deposition of the protein. Swiss 3T3 fibroblast cells were 
incubated onto the surface for two hours, where the cells adhered 
uniformly across the entire surface with no preference for the areas of 
fibronectin or the RGD peptide.
[55] Application of 550 mV electrical 
potential for 5 minutes across the gold surface led to the oxidation of the 
O-silyl hydroquinone in the E*-RGD thiol to the benzoquinone, releasing 
the RGD peptide and the peptide-bound cells. The fibronectin bound cells 
were retained on the surface.
[55] The SAMs around these areas had 
become non-adsorbant and so the cells could not freely migrate across 
the surface. The cell culture was then treated with serum-free medium 
that contained RGD-Cp. The structure of RGD-Cp is shown in   
Figure 1.48.
[55]  
 
 
Figure 1.48. Structure of RGD-Cp. 
[55] 
 
The RGD-Cp reacted with the benzoquinone moiety in a Diels-
Alder reaction. After 1 hour of incubation, the medium was replaced with 
serum containing medium. The cells were incubated for 14 hours, after 
which time the cells had spread across the surface uniformly such that by 
24 hours the patterning was no longer evident.
[55] The release and 
remigration across the patterned substrate is shown in Figure 1.49. It was 
observed that the fibroblast cells were unaffected by the conditions 
applied where the cells on the hexadecanethiol SAMs were not only  
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retained by the surface, but they were also able to grow and spread 
across the surface in a normal fashion after the reaction with RGD-Cp.
[55] 
 
 
Figure 1.49. Release of cells then remigration across surface after addition of RGD-Cp.
[55] 
 
Additional experiments where the RGD-Cp was either left out 
completely or substituted with RGE-Cp showed no migration of the 
fibroblast cells across the surface, showing that the cells were bound to 
the surface via the specific interactions with fibronectin and the fibronectin 
mimic RGD only.
[55] 
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1.8 Analytical Techniques used in this research programme. 
1.8.1.  Isothermal titration calorimetry. 
 
ITC is a direct accurate method of measuring individual 
thermodynamic parameters.
[58] It allows for a greater understanding of the 
favourable and un-favourable processes that occur during binding 
interactions. ITC is used primarily for the direct measurement of enthalpy 
upon binding of biomolecules and their ligands in aqueous media.
[58] 
[59] 
[60] 
[61] The binding of molecules will cause a change in heat, where the 
system will either release or absorb heat from the surroundings 
depending uponthe nature of the association.
[60] 
[61] The degree of change 
is directly proportional to the amount of binding. By quantifying this 
change in heat, calculation of additional thermodynamic parameters for 
the interaction such as: association constant Ka, binding stoichiometry N, 
and change in enthalpy ∆H can be performed. Additional information can 
be calculated by investigating the dependence of ∆H with temperature 
and by applying thermodynamic functions such as those shown in 
Equation 1.4 and Equation 1.5.
[62] 
[61] 
 
∆       ln     ∆     ∆   Equation 1.4. Free Energy Equation. 
∆     
∆    ∆    
       
  Equation 1.5 Calculation for heat capacity 
 
The experimental set-up of the Microcal VT isothermal calorimeter 
used in this research programme consists of two cells encased within a 
thermally insulating shield.
[60] The cells are the reference and sample cells 
and both are equipped with heating elements and thermocouples. The 
thermally insulating shield guards against temperature fluctuations that 
are unrelated to the interactions. A diagram of the set-up of a calorimeter 
is shown in Figure 1.50.  
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Figure 1.50. Schematic of ITC instrument showing the layout the sample and reference 
cells, insulating shield and injection syringe.
[60] 
 
The reference cell is maintained at a required temperature 
throughout the experiment, where it is subjected to a fixed amount of 
power.
[60] 
[61] The injection syringe is incorporated into the sample cell for 
the experiment, where the cell contains the macromolecule and the ligand 
is within the syringe.
[62] 
[61] Using the calorimeter’s software, the ligand is 
titrated into the cell in set volumes over the course of a period of time. As 
the ligand binds to the macromolecule, the temperature of the sample is 
corrected where the power variance to either heat or cool the cell back to 
the starting temperature is measured.
[58, 62] 
[61] As the macromolecule is 
saturated with the ligand the change in heat diminishes until dilution 
effects are all that is observed.
[62] 
[61] The change in power applied is 
referred to as the cell feedback signal. For exothermic binding 
interactions, the feedback signal is negative as power is removed from 
the thermocouple in order to cool the sample.
[58] 
[62] 
[61] Correspondingly, 
endothermic interactions produce positive a spectrum, where additional  
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heating of the thermocouple is required to regain the initial   
temperature.
[62] 
[61] 
The cell feedback signal is plotted against time and the area under 
each peak is integrated to generate the value of heat associated with 
each injection. 
[58] 
[62] 
[60] 
[61] The final binding curve is then obtained from a 
plot of the association heats from each injection against the molar ratio of 
the ligand and macromolecule in the cell.
[62] 
[61]. Using the required set-of-
sites binding model, the curve can be analysed to gain the Ka, N and ∆H 
of binding.
[58] The set-of-sites binding model uses a set complex 
equations to best fit a line through the curve from which the 
thermodynamic data is then calculated the single set of sites uses the 
assumption that there are n identical degenerate binding sites on the 
macromolecule.
[61] The standard graph produced is shown in   
Figure 1.51.
[61] 
 
 
Figure 1.51. Typical binding curve produced by an ITC experiment. 
[61]  
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1.8.2 Cyclic Voltammetry. 
 
For a reversible electrochemical reaction the ratio between the 
concentrations of the oxidised (C°ox) and reduced species (C°red) can be 
related to the standard electrical potential E°, required for the 
electrochemical process.
[63] 
[64] When the electrical potential E, is changed 
the ratio between oxidised and reduced species also changes to satisfy 
the Nernst equation shown in Equation 1.6. 
 
    ° 
  
  
ln
 °   
 °  
 
Equation 1.6. Nernst Equation. 
 
E° = Standard reduction potential for the redox couple, R = molar gas constant 
T = absolute temperature, n = number of electrons transferred, F = Faraday constant 
C°red = concentration of reduced species, C°ox = concentration of oxidised species. 
  
As E becomes more positive there is a reduction in the ratio 
between C°red  and C°ox,  where the reduced species is oxidised. 
Correspondingly, as E becomes more negative the oxidised species is 
reduced and the ratio is enlarged.
[63] The change in electrical current I is 
an important variable when measuring a cyclic voltammogram. The 
Butler-Volmer equation links the variables for electrical potential, current 
and species concentration together and from it the effects of a parameter 
on the system can be observed.
[63] 
[64] Equation 1.7 shows the Butler-
Volmer equation. 
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   °   °              °         1       
Equation 1.7.  
Butler-Volmer Equation 
  
       °  
  
 
E° = Standard reduction potential for the redox couple, R = molar gas constant 
T = absolute temperature, n = number of electrons transferred, F = Faraday constant 
C°red = concentration of reduced species, C°ox = concentration of oxidised species 
k° = heterogeneous rate constant, α = transfer coefficient i = current 
 
Additionally the current I, is also dependent upon the flux of the 
material to the electrode.
[65] When there is an increase in the 
concentration of either oxidised or reduced species diffusion away from 
electrode into the bulk solution occurs. As the other species is diminished 
in concentration, the diffusion of more of that species towards the 
electrode from the bulk solution also occurs.
[65] It has been found that the 
flux of the material is proportional to the concentration gradient and is 
described by Fick’s law as shown in Equation 1.8. 
 
Φ    A D   
∂C  
∂x
   Equation 1.8. Fick’s Law. 
Φ = flux of material, A = area of electrode, Do = diffusion coefficient of Ox, 
x = distance from electrode 
 
Cyclic voltammetry is a solution based electroanalytical technique 
for use in mechanistic studies of redox systems.
[63] 
[64] 
[65] 
[66] The oxidation 
reduction potential can cycle through a range of electronic potentials to 
find the redox couple of the compound to be studied. Repetition through a 
triangular excitation signal for the cyclic voltammogram triggers the 
potential at the working electrode to sweep back and forth between the 
two switching potentials.
[64] 
[66] The current at the working electrode is 
monitored during the sweeping process. A diagram of the triangular 
excitation signal is shown in Figure 1.52. 
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Figure 1.52. Triangular sweeping of the electrical potential. 
 
As the sweep proceeds, the potential becomes positive.
[64] 
[66] Once 
the potential is sufficiently positive, oxidation of the redox couple is 
performed.
[64] 
[66] The anodic current rapidly increases as the reduced form 
is oxidised until the concentration of oxidisable material is diminished and 
the current reaches a peak and then slowly is itself diminished.
[64] 
[66] Once 
the potential is switched there is a gradual increase in cathodic current 
until the potential reaches a level at which the oxidised species is 
electrochemically reduced back to its initial form.
[63] The reverse peak in 
current occurs as the concentration of the oxidised species diminishes in 
the same mechanism as observed for the oxidation wave. The CV wave 
for the reversible redox wave for Fe
2+ to Fe
3+ is shown in Figure 1.53.
[64] 
From the peaks Eox and Ered the halfwave potential E½, can be calculated. 
In the ideal case Eox = Ered = E½.
[63] However this typically does not occur, 
and peaks are slightly shifted. As result E½ is taken as the point halfway 
between the two peaks and can be described by Equation 1.9.
[64] This can 
be simplified down to Equation 1.10, by virtue that the diffusion 
coefficients Dred  ~ Dox leading to the potential being very close to the 
value of the standard reduction potential E°. 
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Equation 1.9.
 ½    
          
2
  
Equation 1.10
 
 
Figure 1.53. CV wave for the reversible redox process for Fe
2+ to Fe
3+.
[66] 
 
A cyclic voltammetry experiment can be performed in a variety of 
solvents from water to acetonitrile.
[64] The solvent used is required to not 
be electrochemically active in the range of electrical potential used. The 
range of electrical potential used is dictated by the solvent, electrolyte 
and electrodes used.
[64] An electrolyte is required to ensure conductivity 
through the solution. CV utilises a three electrode set-up.
[64] These 
electrodes are the working electrode, the counter electrode and a 
reference electrode.
[64] The working electrode and counter electrode are 
typically made from glassy carbon, platinum, or gold. The counter 
electrode is separated from the working electrode using a glass frit.
[64] It 
conducts the electrical potential without affecting the bulk solution.  
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The reference electrode can be a large variety of materials in 
aqueous solutions, where typically saturated calomel electrodes (SCE) or 
silver / silver chloride electrodes are used. The reference electrode has 
well defined redox activity and is highly stable.
[64] For non-aqueous 
conditions a quasi-reference electrode is used such as ferrocene or 
cobaltocene.
[64] This is due to the incompatibility of the aqueous 
electrodes with the solvent used. The solutions require degassing to 
remove dissolved oxygen, to avoid the redox processes of oxygen 
impeding the experiment. The setup of an aqueous cyclic voltammetry 
experiment is shown in Figure 1.54. 
 
 
Figure 1.54. Schematic diagram of a cyclic voltammetry experimental setup. 
 
1.8.3 Dynamic Light Scattering. 
 
DLS measures the Brownian motion exhibited by particles in 
solution.
[67] The Brownian motion exhibited by a particle is directly 
correlated to the size of the particle and the viscosity of the solution it is 
suspended in.
[67] The hydrodynamic diameter of a particle is calculated 
using the Stokes-Einstein equation which is presented as Equation 1.11 
overleaf. d (H) signifies the hydrodynamic diameter, k is the Boltzmann 
constant (1.38 x10
-23 JK
-1). D is the translational diffusion coefficient, T is 
the absolute temperature, and η signifies the viscosity of the solution.
[67]  
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3   
  Equation 1.11. Stokes-Einstein equation. 
 
Particles in dispersion move in the constant and random manner of 
Brownian motion.
[67] By directing a beam of light with a known wavelength 
into a sample, the light is scattered upon impact with the particles in the 
solution. The degree of scattering observed relates to the size of the 
particle hit with the light. By measuring the rate at which scattered light 
fluctuates as a function of time the size distribution of the particle can be 
measured. The detector can be positioned at various angles from the 
direction of the incident light path.
[67] Typically the position of the detector 
lies either at 90° or 173° to the laser beam. A schematic diagram of the 
DLS set up is shown in Figure 1.55. For monodisperse samples, the 
function G (τ), a correlation function of scattered light intensity, has an 
exponential decay pattern that follows the formula shown in   
Equation 1.12.
[67] 
 
          1         2Γ     Equation 1.12
A = baseline of correlation function. B = intercept of correlation function 
Γ        Equation 1.13
D = The translational diffusion coefficient 
 
    4  
 °    sin  
2      Equation 1.14
n = refractive index of dispersant. λo = wavelength of laser. θ = scattering angle 
  
For polydisperse samples, the function G (τ) is modified slightly as 
shown in Equation 1.15. Where the g1  (τ) relates to the sum of all 
exponential decays in the correlation function.
[67] 
 
           1             Equation 1.15
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The correlation data using a number of complex algorithms 
produces the mean size of the particles (ZAv) and an estimate of the 
distribution width referred to as the polydispersity index (PDI).
[67] 
 
 
Figure 1.55. Schematic diagram of a typical DLS experimental setup.
[67] 
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1.8.4.  UV-Vis and Fluorescence spectroscopy. 
 
UV-Vis and fluorescence spectroscopy are two complementary 
spectroscopic techniques.  
 
 
Figure 1.56. Schematic diagram of a UV-Vis experiment. 
 
UV-Vis measures the absorbance of light by a solution. Electrons 
from the ground state are elevated to an excited state upon absorption of 
the light.
[68] 
[69] Absorbance of light follows the Beer-Lambert Law, where 
[c] corresponds to the concentration of the solution, ε is the molar 
extinction coefficient, l is the pathlength and A is the absorbance at λx as 
shown below in Equation 1.16. From the absorbance spectrum the λmax  
can be observed which in turn be used to measure the fluorescence 
emission spectrum.
[70] 
[69] The concentration of a sample can vary from 
typically 10
-3-10
-4  M depending upon the chromophore intensity of the 
sample. The measurement occurs by reading the wavelengths of light 
that pass directly through the sample. The light that does not pass 
through the sample is absorbed.
[69] 
[68] Figure 1.56 shows a schematic of a 
UV-Vis experiment. 
 
                Equation 1.16. Beer-Lambert Law. 
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Fluorescence spectroscopy utilises the irradiation of a compound 
in solution at λmax where electrons from the ground state are elevated to 
an excitation state.
[71] The compound then loses energy as the electron 
returns to the ground state.
[72] The release of the energy through 
fluorescence can be measured. The emission spectrum is measured by 
irradiating the sample with the λmax for the absorbance in the UV-Vis 
spectrum
[68] 
[70] where the emission over the course of a range of 
wavelengths is measured. The concentration of samples used for 
fluorescence tend to not exceed 10
-5 M as Raleigh scattering becomes a 
prominent effect at higher concentrations.
[72] The set-up for a fluorescence 
experiment is shown in Figure 1.57. The light emitted from the sample 
after irradiation is measured at 90° to the beam of light. The light emitted 
follows the equation below, where hv signifies the amount of light emitted 
at a specific wavelength.
[72] 
 
             Equation 1.17
 
 
Figure 1.57. Schematic of a fluorescence experiment 
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2. Functionalised Dihydro-imidazo-phenanthridine 
Intercalating Agents. 
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2.1.  Dihydro-imidazo-phenanthridines and  
           Imidazo-phenanthridines. 
 
2.1.1. Synthesis of Dihydro-imidazo-phenanthridines and Imidazo-
phenanthridines. 
 
Modifications of phenanthridine and its derivatives have been 
carried out in an attempt to tune the cytotoxic and intercalative properties. 
It is hoped that by tuning the properties, these compounds can be used 
as molecular probes, and potential chemotherapeutic drugs. Key 
modifications include the addition of hydroimidazole and imidazole 
functionality to the phenanthridine core to form dihydro-imidazo-
phenanthridines, DIP
[73] and imidazo-phenanthridines, IP.
[74] The general 
structures are for these compounds are shown below in Figure 2.1.  
 
 
Figure 2.1. General structures of derivatised phenanthridine derivatives.  
a) Dihydro-imidazo-phenanthridine. b) Imidazo-phenanthridine. 
 
The addition of the imidazole functionality to the phenanthridine 
core blocks the metabolic pathway which rapidly deactivates these 
compounds by forming a neutral dihydrogenated species.
[73] 
[75] 
Benzo[c]phenanthridine alkaloids (BCPA) are naturally occurring 
biologically highly active intercalators with a phenanthridine core that 
undergo rapid reduction by NADH in vivo to give these inactive forms.
[76] 
The general structure of the reduced benzo[c]phenanthridine alkaloids 
are shown in Figure 2.2 (a).
[75] This addition also gives a degree of 
resistance to the formation of a pseudobase by the α-addition of  
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hydroxide to the structure as shown in Figure 2.2 (b) and (c), and so 
increases the stability of these structures in vivo.
[73] 
 
 
Figure 2.2. a) Generalised structure of a reduced BCPA b) Pseudobase of a BCPA  
c) Pseudobase of a DIP. 
 
The DIP and IP moieties are made from a common starting 
material of 5-(2-bromoethyl) phenanthridinium salt. The dihydroimdazo 
phenanthridines are formed in a one-pot-three-step reaction. The 5-(2-
bromoethyl) phenanthridinium salt is reacted with a primary amine in the 
presence of base in a biphasic solvent mixture of ethyl acetate and water 
for two hours. After an aqueous wash, NBS is added to the reaction 
mixture and allowed to react for two hours in the dark, to give the required 
DIP as a precipitate in high yield.  
The imidazo phenanthridines (IP) are produced by the reaction of 
5-(2-bromoethyl) phenanthridinium salt with liquid ammonia at -78°C for 1 
hour. Base and MnO2 are added and the reaction is then refluxed in 
toluene for three hours, at which point an alkylating agent R-X is added 
and the reaction mixture is refluxed overnight. The product is then 
recovered by filtration in high yield. The oxidation steps are thought to 
occur prior to the re-aromatisation of the central ring in the IPs as 
attempts to convert the DIP structures into their equivalent IPs with a 
number of agents failed to give the required transformation. It is thought 
that the high stability of the compounds after the re-aromatisation of the 
core stops the further oxidation to the IP functionality to form. The 
reaction mechanism for the formation of DIP and IP are shown in   
Scheme 2.1 and Scheme 2.2.   
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Scheme 2.1. Formation DIP from 5-(2-bromoethyl) phenanthridinium salt.
[74] 
 
 
Scheme 2.2. Formation IP from 5-(2-bromoethyl) phenanthridinium salt.
[74] 
 
Both DIP and IP can support a large degree of functionality at the 
N1 position.
[77] The numbering of the general DIP structure with N1 and 
N2 labelled is shown below in Figure 2.3. Examples of the range of 
amines that have successfully been added to the DIP core are shown in 
Table 2.1.
[73] [74] 
[77] 
[78] 
[79]  
 
 
Figure 2.3 Numbered general DIP structure with the N1 and N2 postions labelled in blue.  
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R-* (*= NH2) 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
11 
 
12 
 
13 
 
14   
15 
 
16 
 
17 
 
18   
19 
 
20 
 
21 
 
22 
 
23 
 
24 
25 
 
26 
 
27   
28 
* Indicates additional NH2 to which a DIP can form. 
Indicates groups also tethered to the IP core
[74] 
Table 2.1 Functionalised amines used to synthesise DIP compounds. 
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2.1.2 Intercalative and Cytotoxic Properties of DIP and IP 
compounds. 
 
As phenanthridine and the benzo[c]phenanthridine alkaloids have 
been previously shown to be cytotoxic to certain cancer cell lines, a 
variety of the compounds shown in Table 2.1 were tested against human 
ovarian tumour cell line A2780, whereby the cell line was treated with the 
required DIP at varying concentrations for 24 hours then allowed to 
recover for three days, prior to treatment with MTT stain.
[79] From data 
collected the IC50 – the concentration at which 50% of the A2780 cells 
died upon culture with that particular DIP over 24 hours. 
[79] 
The cytotoxicity of these compounds is thought to be due to DNA 
binding, namely, intercalation of DNA. To investigate the relationship 
between binding and cytotoxicity, isothermal titration calorimetry (ITC) 
was carried out with the DIP compounds that had sufficient solubility. As 
the size of the functionality at the nitrogen increased, the hydrophobicity 
increased, whereas the aqueous solubility of the DIP compounds 
decreased to a point that calorimetry could not be carried out on all 
samples.
[79] For the samples that ITC was carried out on, the majority 
gave the expected results where the thermodynamic and binding data 
could be measured. The IC50 data and Ka values for key ligands are 
shown in Table 2.2. A typical ITC spectrum recorded for these 
compounds is shown in Figure 2.4. 
 
Ligand  Ka (10
4 M
-1) IC50 (µM) 
EtBr  12.9 0.30 
DIP-H  2.6 1.56 
DIP-Me  4.6 2.60 
DIP-Bn  4.3 2.32 
DIP-Bn-p-OMe  2.9 1.53 
Table 2.2. IC50 and Ka values for key phenathridine based ligands. Salmon Testes in PBS.
[79]  
 
64 
 
 
Figure 2.4. An example of ITC data for binding of a DIP ligand to salmon testes DNA. 
[78] 
 
Segment A of Figure 2.4 shows the raw data collected for both 
ligand–DNA binding. Segment B shows the ligand dilution control. Part C 
shows the integrated data fit to a single set of sites binding model. 
[78] 
Table 2.3 shows the ITC data parameters recorded for key functionalised 
DIP and IP ligands in a) PBS
[78] and b) PIPES buffer
[74]. 
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Ligand  N Ka (10
4M
-1) 
∆H 
(kcalmol) 
Ethidium Bromide
a  0.32 11.7 -7.3 
DIP-H
a  0.3 2.6  -3.6 
DIP-Me
a  0.19 1.7 -5.9 
DIP-Bn
a  0.15 1.1 -4.7 
IP-Bn
b  Not Reported 6.1 
Not 
Reported 
DIP-Bn-p-OMe
a  0.26 1.1 -4.4 
IP-Bn-p-OMe
b  0.09 11.8 -9.9 
DIP-CH(CO2Me)(C7H7)
a* Not Defined  Not Defined  Exothermic 
Table 2.3. ITC data parameters recorded for key ligands with Salmon Testes DNA. 
aPBS 
bPIPES buffer
[78] 
[74]. *The data recorded did not fit a one-set-of-sites binding model, with a 
more complex mode of binding. 
 
The binding constant Ka for IP ligands was greater than that of the 
corresponding DIP ligands. This is thought to be due to increased 
planarity and the fully aromatic nature of the IP core where π-stacking 
between base pairs is stronger than the interaction between the less 
aromatic DIP and the base pairs. From the ITC data it can be shown that 
the binding properties can be modulated by the changing R groups. 
Nevertheless it can also be noted that the R group used does not block 
the binding to DNA by intercalation. 
 
2.1.3. Microtubule Formation with Polyoxometallate (POM) Crystals. 
 
It has been found that the solutions of DIP compounds can interact 
with polyoxometallate Keggin net crystals such that, the crystals partially 
dissolve in the aqueous media.
[80] 
[81] 
[82] Upon solvation of the outer 
edges of the crystal the dissolved POMs come in contact with the DIP 
molecules in solution and salt exchange occurs, whereby the resulting 
complex comes out of solution forming a semi-permeable membrane-like  
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structure around the inner crystal structure.
[80] 
[81] 
[82] The semi-permeable 
complex allows water to enter but not leave. As the osmotic pressure 
reaches its maximum, the membrane-like structure bursts and the 
contents flow out at the site of rupture.
[80] 
[81] 
[82] As this occurs the POM 
interacts with the positively charged DIP / IP molecules and precipitation 
of the complex occurs forming a tube.
[80] 
[81] 
[82] The flow of liquid 
continues along the hollow tube and exits the end precipitating out as it 
comes in contact with more substrate, until all the POM or DIP / IP has 
been used up. The images shown in Figure 2.5 show an example of the 
growth of a microtubule with time.  
The diameter of the microtubes formed are typically in the range of 
1-100 µm and it has been found that the diameter can be modulated by a 
number of factors including: the concentration of DIP used;
[80] 
[81] 
[82] the 
functionality on the DIP derivatrive;
[80] 
[81] 
[82] and the particular POM 
crystals used.
[80] By increasing the concentration of DIP used the tubes 
become narrower, and dilution causes a widening of the tube diameter.
[80] 
[81] 
[82] This control of size is exemplified in Figure 2.6. 
 
 
Figure 2.5. Time-lapse images of a single tube emerging from a crystal. 
[81] 
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Figure 2.6. Size control of a growing tube by altering the available concentration of cations 
at points (a), (b), (c), and (d). The estimated concentrations at each point are shown in the 
lower section.
[82] 
 
The direction of the microtube growth can also be modulated by 
the application of an electrical potential over the sample, where the 
application of a minimum 9 V potential across the sample causes 
localised heating and the flow of bulk solvent through convection and the 
tubes flow towards the cathode electrode. This has led to a number of 
motifs being formed by the micotubes with careful manipulation of 
electrical potentials across the sample. Figure 2.7 shows the different 
motifs that have been made by this method of manipulation.
[82]  
Puncturing the growing tube will cause a halt in the direction the 
tube was flowing in and a new tube will sprout from the site of rupture 
allowing control of movement manually. Figure 2.8 shows an example of 
this manipulation of tube growth. When tubes from different crystals 
collide the two tubes will merge and form one wider tube. Figure 2.9 
shows an example of this where the two tubes run parallel and then 
merge to form a larger tube.
[82] 
It has been found that these tubes are hollow and it has been 
shown that the tubes can retain any liquids that are very carefully injected 
into them. An example of liquids that have been injected into the tubes 
successfully include the fluorescein isothiocyanate dye. It was found that 
it was possible to inject 10 mM solutions into the POM microtubule with  
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no damage to the microtubule. The flow of the flourescein dye could be 
monitored by fluorescence. Figure 2.10 shows the images taken of the 
flourescein stained POM microtubes.
[81] 
 
 
Figure 2.7. Motifs formed by controlling the tube growth direction.
[82] 
 
 
Figure 2.8. Manual breakage of tube to causes branching then manipulation growth. 
[81] 
 
 
Figure 2.9. Two microtubes merging to form a larger tube. 
[81] 
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Figure 2.10. POM microtube injected with fluorescein isothiocyanate dye.
[81] 
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2.2. Aims and Objectives. 
 
The aims of this project were to synthesise two DNA intercalating 
agents that could undergo additional host-guest interactions. The addition 
to the functionalised intercalator could then give an indirect modulation of 
the DNA, with the ability to introduce groups to the structure that would 
normally not associate. 
Prof L Cronin’s group had recently formed dihydro-imidazo-
phenanthridines in a three-step-one-pot reaction with potent intercalative 
properties that could tolerate a great deal of functionalisation at the N1 
position.
[77] In collaboration with the Cronin group we then had a basis for 
the synthesis of the intercalating agents. 
The 1,5-dioxynaphthalene subunit’s ability to form stable and 
reversible deep pink complexes with CBPQT
4+, was seen as the preferred 
substrate for attachment to the DIP compound. The motivation for this 
was the pseudorotaxane formed when the naphthalene is threaded into 
the CBPQT
4+ host cavity can be reversed by the treatment with a number 
of stimuli that can be thermal, electrochemical and chemical, with the 
change in complexation state easily observed by a simple colour change. 
Ferrocene was chosen as the alternative to naphthalene, where 
pseudorotaxane formation with cyclodextrins would give us a neutral 
additional host-guest interaction that could also be reversible by 
electrochemical means. The target DIP compounds for synthesis are 
shown in Figure 2.11. 
 
 
Figure 2.11. Final DIP products.  
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2.3 Results and Discussion. 
2.3.1 Synthesis of the naphthalene amine 5a. 
 
 
Scheme 2.3. Alkylation of 1,5-Dihydroxynaphthalene. 
 
The first reaction in the synthesis of the possible naphthalene 
amines, involved the reaction between 1,5-naphthalene diol with 2, 2-
(chloroethoxy)ethanol in acetonitrile with potassium carbonate, as shown 
in Scheme 2.3. The reaction took one week under reflux to complete and 
gave the dialkylated product in moderate yield. The yield of this reaction 
varied and was dependent on concentration, where the higher the 
concentration typically the better the yield. The reaction could be 
performed on quite a large scale and optimal results were gained on a  
20 g scale. This diol (2) was the starting material for all the naphthalene 
based systems described in later chapters. 
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Scheme 2.4. EDCI couplings to the alkylated naphthalene. 
 
EDCI coupling reactions with Fmoc-GABA and 6-amino caproic 
acid were carried out with diol 2 as shown in Scheme 2.4. The EDCI 
coupling of 6-amino caproic acid with the alkylated naphthalene in DMF 
failed to react, even at high temperatures. The EDCI coupling reaction 
with Fmoc protected 4-aminobutyric acid succeded in producing the 
required product; however, we could not remove the EDCI reaction by-
product impurities from the required protected amine even after repeated 
column chromatography. Changing the coupling agent from EDCI to 
EEDQ had very little effect, such that the quinoline impurities from the 
reaction continued to contaminate the Fmoc amine, even after repeated 
column chromatography. The Fmoc protection was chosen as the DIP 
formation conditions would also deprotect the amine in situ. 
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Scheme 2.5. Methods for amine synthesis via nitrile formation. 
 
Attempts to form the naphthalene functionalised amine 14 via 
nitrile formation were carried out as shown in Scheme 2.5. The reaction 
with bromopropionitrile in dry DMF to gain the nitrile product, 13 that 
would then be reduced to the amine in a subsequent step failed react, 
and the starting material was recovered by column chromatography. The 
successful addition of propionitrile was achieved by the reaction with 
acrylonitrile in the presence of base Triton B in DCM.
[83] The addition 
gave both the mono and di-propionitrile products, where separation by 
column chromatography to recover the required compound in a 36% 
yield. Subsequent lithium aluminium hydride reduction failed to yield the 
required amine and instead gave the retro-Michael reaction product of the 
starting material 2 quantitatively. It may have been possible to reduce the 
nitrile with Raney nickel, but due to the pyrophoric nature of the reaction 
this was viewed purely as a last resort if all other attempts to synthesise 
an amino-PEG-naphthalene compound failed. The proposed mechanism 
for the Retro-Michael reaction is shown in Scheme 2.6. 
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Scheme 2.6. Retro-Michael reaction for the cleavage of the acrylonitrile. 
 
 
Scheme 2.7. Tosylation reaction scheme. 
 
The treatment of the alkylated diol 2 with tosyl chloride gave a 
mixture of the monotosylate, (3a), ditosylate (3b) products, and the 
starting material in equal proportions. The products were easily separated 
by column chromatography and the unreacted starting material could also 
be recovered by this manner. Conversion to the azide (4) was successful, 
where the product was separated from any impurities present by column 
chromatography, which also removed the last traces of DMF from 
compound. The full reaction scheme is presented in Scheme 2.7. 
Initial reduction of the naphthalene azide 4 with palladium on 
carbon failed to give either starting material or product. However,  
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reduction using triphenylphosphine in the Staudinger reaction succeeded 
in forming the desired product 5a. However, the column chromatography 
failed to yield the pure product as observed by proton NMR. Thin layer 
chromatography showed only one spot, which indicated the presence of 
an impurity at the same Rf value. The impure product still gained the 
required DIP functionalisation in high yield which indicated that the 
impurities did not impede the formation of the DIP reaction, or its 
purification by precipitation. Closer investigation of the crude mixture from 
the column chromatography was that the elution solvent of acetone – 
dichloromethane mixtures with 2% triethylamine was producing the 
acetone imine form of the amine, and the impurities in the 
1H NMR 
spectra were as a result of a mixture of the amine and imine forms. The 
imine produced was fully reversible in the presence of weak acidic 
conditions, such that chloroform was able to convert it to the amine 
cleanly with the only bi-product being acetone. Thus, subsequently to 
avoid the formation of the imine, the solvent used in the chromatography 
step was changed from acetone-DCM mixtures to methanol-DCM 
mixtures with good success.  
 
 
2.3.2 Synthesis of the ferrocene amino derivative 25a. 
 
 
Scheme 2.8. EDCI couplings to ferrocene carboxylic acid. 
 
EDCI coupling reactions of amines and carboxylic acids generally 
afford the required amide in good yields. It was for this reason that we 
decided upon forming the ferrocene modified amine 25a from the 
ferrocene carboxylic acid and 2,2’-(ethylenedioxy)diethylamine.  
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Unfortunately, the standard conditions with DMAP in DCM failed to react 
in any way. Changing solvent and heating to reflux still had no effect on 
the reaction. When the non-protected amine failed to react, the aim was 
then to produce the protected monoamine that would then by deprotected 
prior to DIP formation. Use of the equivalent Boc-protected amine in the 
presence of pentafluorophenol in the EDCI couplings also failed to react 
and the unreacted starting material was recovered by column 
chromatography. The reaction Scheme 2.8 shows the route attempted for 
this synthesis.  
 
 
Scheme2.9. Amine formation via acid chloride formation. 
 
The formation of the reactive acid chloride (26) by treatment of the 
ferrocene carboxylic acid with oxalyl chloride followed by the subsequent 
addition to 2, 2’-(ethylenedioxy)diethylamine in DCM gave us the required 
amine (25a) plus the unwanted diferrocenyl compound (25b) to varying 
degrees. The slow addition of the acid chloride to a mixture of the 
diamine and triethylamine, where the diamine was in excess and at a 
higher concentration compared to the slowly added acid chloride pushed 
the ratio of the products made towards the required amine, as shown in 
Scheme 2.9. By learning the lessons from the naphthalene amine we 
decided to avoid the acetone when dealing with the amine in order to 
prevent any chance of imine formation. It was also observed that this 
compound also oxidised in the air over a period of time as the orange oil 
became black with time as the amine degraded.  
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The product was also passed onto Dr C Richmond from Prof L 
Cronin’s group for the subsequent formation of the ferrocene DIP 30 as a 
dark red / brown solid. 
 
 
 
Scheme 2.10 Ferrocene acetonitrile reduction. 
 
As an alternative, where the ferrocene would be attached almost 
directly to the DIP, we investigated the synthesis of the amine from the 
ferrocene acetonitrile by lithium aluminium hydride reduction. The 
reaction performed gave only degradation products, where all the starting 
material was consumed, but no amine product formed. This attempted 
conversion is shown in Scheme 2.10. 
As the ferrocene DIP (30) was not sufficiently soluble in aqueous 
media, it was expected that the equivalent DIP from the ferrocene amino 
derivative (37)  would be even less soluble and so this compound 
synthesis was not pursued further. 
 
 
 
 
 
2.3.3 Analysis of the functionalised Dihydro-Imidazo-
Phenanthridines. 
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Figure 2.12. Functionalised DIPs 23 and 30. 
 
The dihydro-imidazo-phenanthridines (DIPs) were synthesised by 
Dr C. Richmond of Prof L Cronins’ group from their respective amines. 
Appendix 1 contains the experimental conditions used to synthesise 
these compounds from their amines. These compounds were produced 
as bromide salts form and were poorly soluble in aqueous media, in 
particular the ferrocene DIP compound 30. Salt exchange reactions were 
attempted on the 23 with a view to increase the solubility in water. The 
exchange reactions that were carried out had no beneficial effect on the 
solubility, to the point that the DIP compound became more insoluble in 
water after salt exchange had been performed. All analysis from then on 
was carried out with the original bromide salts. 
 
 
 
 
 
 
 
2.3.3.1 UV-Vis Spectroscopy of Naphthalene DIP (23) and CBPQT
4+ 
(61). 
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Scheme 2.11. Nap-DIP complex with CBPQT
4+ then displacement with TTF. 
 
A UV-Vis experiment in aqueous 1 mM solutions with the 23 and 
CBPQT
4+ 4Cl
- (61) was carried out where the complex formed gave the 
standard pink solution that is found with naphthalene-CBPQT
4+ systems 
indicating that complexation had occurred
[13] 
[12]. 1-5 equivalents of TTF 
(51) were added to displace the naphthalene from the cavity of the 
CBPQT
4+; this displacement was observed by a colour change from pink 
to green. Additional equivalents of TTF intensified the green band 
observed as more TTF dissolved and full complexation with CBPQT
4+ 
occurred. The spectroscopic data gained from this experiment are shown 
in Figure 2.13.   
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Figure 2.13. UV-Vis data from the complex of 23 and 61 at room temperature with baseline 
correction. Concentration 10
-3 M in water. 
 
From Figure 2.13 we can observe that the binding interactions 
between the CBPQT
4+ and naphthalene are quite weak when compared 
to the binding interactions between TTF and CBPQT
4+. This is typical of 
these systems, where the stronger charge transfer interactions between 
TTF and the cyclophane compared to that of the naphthalene moiety, 
cause the TTF to competitively displace the naphthalene from the cavity 
of the cyclophane.
[12] 
[84] 
 
2.3.3.2 
1H NMR spectroscopic studies. 
 
1H NMR spectra were recorded in D2O for the naphthalene 
functionalised DIP (23), and for its complex with CBPQT
4+. As the 
complex formed the typical colour change to dark purple was 
observed
[13]. The 
1H NMR spectrum recorded for the complex was 
extremely broad and most of the detail became obscured. In an attempt 
to regain some of the details that had been obscured, the solution of the 
complex was diluted by half, but to no avail. The appearance of two broad 
signals in the region of ~2.45ppm and 2.25ppm are typical of the shift 
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exhibited by the H4/8 protons on the naphthalene group upon inclusion 
into the core of the CBPQT
4+[14]. The loss of definition and the distinct 
dark purple colour change upon addition of the CBPQT
4+ also indicates 
that the pseudo rotaxane had formed. Figure 2.14 shows the spectra 
recorded at room temperature for the individual compounds 23 and 61 
plus the pseudorotaxane complex. 
 
Figure 2.14. 
1H NMR spectra recorded for A)23 B)61 C) 1:1 Complex of 23/61 in D2O. 
A
B
H4/8 
C 
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2.3.4 DNA Interactions with the DIP compounds. 
 
2.3.4.1 ITC experiments with calf thymus DNA. 
 
In order to measure the binding constants for the interaction of the 
23 with DNA a number of ITC experiments were carried out using calf 
thymus DNA (CT-DNA). Later the interactions with 23 and a synthetic 
duplex D-DNA were carried out. The aqueous solubility of the ferrocene 
DIP was not sufficient to allow calorimetric experiments to be carried out. 
Initially the isothermal titration calorimetry (ITC) experiments were 
carried out in water. The data collected showed good binding interactions 
between the 23 compound and CT-DNA. However, the data recorded 
indicated that 23 did not interact with the CBPQT
4+, which was 
contradicted by the fact that the solution for these compounds when 
mixed turned pink, indicating interaction. An added complication was that 
it appeared that the CBPQT
4+ interacted with the CT-DNA, which 
contradicted previous experiments that showed no binding. Figure 2.15 
shows the data recorded for the experiments for water. The 
thermodynamic data recorded for this experiment are shown below in 
Table 2.4. 
 
  N  Ka (M
-1)  ∆H (cal mol
-1) ∆S (cal mol
-1K
-1)
23 into CT  1.47 ± 0.02
3.76 x10
5 ± 
6.75 x10
4 
-6259 ± 140.5 4.52 
CBPQT into 
23/CT 
0.31 ± 0.01
7.34 x10
6 
± 3.58 
x10
6 
5026 ± 185.8  48.27 
CBPQT into 
CT 
0.36 ± 0.01
3.49 x10
8 
± 6.58 
x10
8 
-5088 ± 174.2 22.02 
Table 2.4. Thermodynamic data recorded for ITC titrations in water.  
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A  B 
C  D 
Figure 2.15. ITC data for experiment with water as the solvent. A) is the raw data recorded. 
B) is analysed DIP injected into CT-DNA. C) is CBPQT injected into DIP/CT-DNA. D) is 
CBPQT injected into CT-DNA. 
 
It was then proposed that the exotherms were not binding 
interactions and were heats of neutralisation, where the different pH of 
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the solutions mixed and gave the temperatures that appeared to binding 
interactions rather than the thermal neutralisation artefacts that they 
potentially were. The pH of each solution was measured in order to 
confirm or negate the probability that the thermal signals observed were 
purely neutralisations. As can be seen from Table 2.5, the pH differences 
were such that the results could not be explained purely by acid base 
neutralisation. 
 
Component  pH of solution 
CT-DNA 5.70-6.20 
Naphthalene DIP 23 6.20 
CBPQT
4+ 4Cl
- 61 5.10 
Table 2.5. pH of the aqueous solutions used. 
 
In order to avoid the neutralisation interactions, experiments were 
then carried out in phosphate buffered saline (PBS) at pH 7.0. The 
changing of solvent to PBS added its own set of complications, namely 
that compound 23 was poorly soluble in this media, so that suspensions 
of the DIP had to be used and actual concentrations used for the 
experiments could not be accurately measured. This set of experiments 
showed the standard binding interactions for naphthalene and CBPQT
4+. 
The solubility of the compound 23 in PBS was very low and there 
appeared to be very little binding interaction with CT-DNA. This lack of 
binding may have been due to the lack of solubility of the DIP in the PBS. 
The titration of CBPQT
4+ into CT-DNA showed only dilution effects, 
indicating that there was no binding to CT-DNA occurring. Addition of 
CBPQT
4+ to the 23 / CT-DNA mixture showed a diminished binding 
interaction which would indicate a partial blocking of the naphthalene 
group to threading into the CBPQT
4+ cavity when compared to the 
titration data recorded for the experiment without the CT-DNA present. 
The data recorded are shown in Figure 2.16 with the thermodynamic data 
recorded shown in Table 2.6.  
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A  B 
C  D 
Figure 2.16. The ITC data for 23 with CT-DNA in PBS. A 23 into CT-DNA. B CBPQT into 
23/CT-DNA. C CBPQT into CT-DNA. D 23 into CBPQT/CT-DNA. 
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  23 into CT  61 into CT 
N  0.34 ± 0.37  0.07 ± 0.12 
Ka (M
-1)  2.83 x10
4± 1.82 x10
4 7.03 x10
4 ± 4.06 x10
4 
∆H (cal mol
-1)  -932.2 ± 1144  -6617 ± 1.22 x10
4 
∆S (cal mol
-1K
-1)  17.24 -0.02 
  61 into 23/CT  23 into 61/CT 
N  0.22 ± 0.01  0.14 ± 0.01 
Ka (M
-1)  1.39 x10
5± 1.20 x10
4 1.42 x10
5 ± 1.80 x10
4 
∆H (cal mol
-1)  -1.08 x10
4 ± 628.9  -7939 ± 959.9 
∆S (cal mol
-1K
-1)  -12.72 -3.05 
Table 2.6. Thermodynamic data recorded for ITC titration experiments in PBS 
 
An added complication of the 23 was that the solutions tended to 
precipitate over a period of a few hours such that the solutions could not 
be prepared in advance and had to be made fresh directly before use. 
This issue was especially prevalent in the PBS solutions. In an attempt to 
improve the solubility of compound 23 in solution the ITC experiments 
were run in phosphate buffer at pH = 7.0 with no salt added. The 
observed results from these experiments were extremely complicated 
and no interaction with CT-DNA occurred for the first 17 injections and 
then interaction for the remaining 12. Subsequent addition of CBPQT
4+ to 
this mixture also gave a complicated response where there appeared to 
be up to three different interactions occurring. The data collected could 
not be fitted to any data sets.  
The effect of the buffer used was then probed further by the use 3-
(N-morpholino) propanesulfonic acid (MOPS) at pH = 7.3. The data 
recorded for this were highly complicated to the point that graphs could 
not be fitted to any data set. The interactions observed between Nap-DIP 
and CT-DNA was extended and suggested multiple interactions occurring 
stepwise that could not be fully elucidated. The interaction of CBPQT
4+ 
with the mixtures followed a similar path to the interactions seen in the 
experiments in phosphate, which would indicate that the naphthalene was  
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in more than one environment. At this point the experiments with 
unbuffered water were repeated with no change in the results for the 
aqueous experiments. This indicated that the results for the MOPS and 
phosphate were not due to the experimental method and were due to 
complications with the substrates used. The concentrations used for the 
three sets of experiments are shown below in Table 2.7. The raw data 
results for phosphate, MOPS, and water are shown in Figure 2.17. 
 
Solvent 
Concentration of: 
23  Calf Thymus 61
 
Phosphate 1.15mM  50μM 1.09mM 
MOPs 1.08mM  50μM 1.00mM 
Water 0.91mM 50μM 1.09mM 
Table 2.7. Solvent vs concentration of component. 
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Figure 2.17. The raw ITC data recorded for Phosphate, MOPS, and Water. 
 
A final set of experiments with CT-DNA in 20 mM piperazine-1,4-
bis(2-ethanesulfonic acid) (PIPES) buffer were carried out in an attempt 
to elucidate the binding interactions. The results showed very little 
interaction between the 23 and the CT-DNA. By titrating the pseudo-
rotaxane of the CBPQT and 23 into CT-DNA, a binding curve was 
observed that incorporated the dissociation of the pseudorotaxane and 
binding to the CT-DNA. Titration of the complex into the PIPES buffer 
gave a good dissociation curve that was almost a perfect reflection of the 
titration of CBPQT into 23 /CT-DNA mix. The raw data can be seen in 
Figure 2.18. 
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Figure 2.18. Raw ITC data for experiments ran in PIPES buffer. 
 
2.3.4.2 ITC experiments with a synthetic dodecamer DNA. 
 
Experiments with the synthetic ‘Dickerson’ dodecamer DNA in 20 
mM phosphate buffer were carried out. Ths DNA sequence is known to 
form hairpin conformations and so perform the same interactions with the 
DIP as natural DNA.
[85] The synthetic dodecamer DNA (D-DNA) was 
annealed repeatedly prior to use by rapid heating to 80°C, allowing the 
material then to cool slowly. Once cool the DNA was reheated to 85 °C 
then allowed to cool. The process was repeated three times per sample 
of the D-DNA. From the absorption at λ= 260 nm, where the extinction 
coefficient εc was taken as 12828 per base pair,
[77] the concentration of 
the D-DNA of the solutions could be measured, where the number of 
base pairs per molecule was 12. Equation 2.1 shows the formula used to 
calculate the concentration of D-DNA in a solution. 
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12   12828
 
Equation 2.18. Formula for calculating the 
concentration of the D-DNA from the absorption at 
260nm. 
 
Table 2.8 shows the details of each ITC experiment carried out. 
Figure 2.19 shows the raw results of the experiments. Figure 2.20 
contains the analysed data from the ITC. The interaction between 23 and 
the D-DNA was weak, however the curve could be fitted to a single set of 
sites binding model. The result of CBPQT into the D-DNA gave a very 
weak binding curve that would indicate that there is a very slight 
interaction. The pre-formed complex gave a complex strong binding 
interaction that could not be fitted to a single set of sites, but a sequential 
set of sites binding model. It may be that the pseudorotaxane was aiding 
in the solvation of the 23 leading to a greater interaction with the D-DNA. 
There may have also been an additional interaction with any 
uncomplexed naphthalene DIP 23 with the D-DNA, leading to the 
additional binding site. Other possibilities include the unwinding of the 
DNA allowing additional binding to occur after initial insertion. The 
thermodynamic data gathered from the analysed ITC data is given in 
Table 2.9. 
 
Experiment No.  Contents of Cell  Contents of Syringe 
1 Phosphate  buffer  CBPQT
4+ 0.93 mM 
2 D-DNA  30  µM  CBPQT
4+ 0.93 mM 
3 D-DNA  30  µM Nap DIP 1.01 mM 
4  D-DNA / Nap DIP  CBPQT
4+ 0.93 mM 
5  Phosphate buffer  Nap DIP/CBPQT
4+ 1 mM 
6 D-DNA  30  µM  Nap DIP/CBPQT
4+ 1 mM 
Table 2.8. Experimental details of the 23 and CBPQT
4+ with D-DNA. 
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Figure 2.19. Raw ITC data of 23 and CBPQT
4+ with D-DNA. 
 
Ligand  N  Ka (M
-1)  ∆H (cal/ mol)  ∆S (cal K
-1 mol
-1) 
23 
2.02 ± 
0.323 
1.88 x10
4± 
4125 
-1948 ± 416.1 13.03 
CBPQT 
1.76 ± 
0.1018 
9.51 x10
5± 
7.50 x10
5  863.7 ± 77.53 30.25 
23 / 
CBPQT 
N/A 
1.0 x10
5± 
1.42 x10
4  -1015 ± 271.3 19.48 
N/A 
4.40 x10
4 ± 
2503 
-3.52 x10
4 ± 
467 
-96.90 
Table 2.9. Thermodynamic data recorded for the interaction between 23, CBPQT
4+ and D-
DNA. 
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Figure 2.20. Analysed ITC experiments with D-DNA. A) 23 into D-DNA. B) CBPQT
4+ into D-
DNA. C) 23 /CBPQT
4+ into D-DNA. 
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2.3.5 Cell Culture Studies. 
2.3.5.1 Cell Injection studies. 
 
The principle for the cell injection studies was that we wished to 
form complexes with our substrates within living cells, where the two 
components were injected separately and the complexation would be 
monitored by both fluorescence and by observing a visible colour 
change.
[86] The cells used for these experiments were Madin-Darby 
canine kidney epithelial cells (MDCK). 
The primary substrate that we wished to investigate was the 
naphthalene trimethylammonium bromide compound 9 shown in   
Figure 2.21 The reasoning for using this substrate was that this molecule 
has a strong fluorescence excitation at λ= 295 nm
[87] 
[88] 
[14] that can be 
quenched by CBPQT
4+.
[87] 
[88] 
[14] In addition to the changes in 
fluorescence, the complex is also strongly coloured. A further aspect was 
that it was hoped to be fairly non-toxic to the cells.
[89] 
[90] The fluorescence 
spectra of the naphthalene trimethylammonium bromide and its complex 
with CBPQT
4+4Cl
- are shown in Figure 2.22. This compound will be 
described in greater detail in §5.3.1 
 
 
Figure 2.21 Naphthalene trimethylammonium bromide (9). 
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Figure 2.22 Fluorescence of Naphthalene trimethylammonium bromide with CBPQT
4+ (61) 
Ex = 295nm at room temperature. 10
-5 M in water 
 
It was at this point that it was noted that the naphthalene 
trimethylammonium bromide did not fluoresce at the required wavelength 
for the microscope. It was found that the operational wavelengths of the 
microscope were excitation λ = 365 nm and emission from 420 nm. At 
this point we then looked at the DIP compounds as these substrates 
contain the phenanthridine moiety that is highly fluorescent and its 
derivatives fluoresce under the conditions used with the microscope. The 
fluorescence measurements for 23 with CBPQT
4+.4Cl
- are shown in 
Figure 2.23. 
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Figure 2.23. Fluorescence of 23 with and without CBPQT
4+ at room temperature. Excitation 
wavelengths of 295 nm and 365 nm. Concentration 10
-5 M in water. 
 
The fluorescence of the ferrocene DIP 30 with cyclodextrin was 
also measured to compare intensities with the spectra of 23. As can be 
observed in Figure 2.24 compound 30 had a stronger signal intensity 
relative to that of the naphthalene compound at excitation λ of 365 nm. 
The complex with β-cyclodextrin (63) also gave a more significant drop in 
intensity compared to the changes given with 23 and CBPQT
4+ (61). 
 
 
Figure 2.24. Fluorescence of 30 with 63 compared to 23. Ex 365 nm. 10
-5 M in water at 25°C. 
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Although the compound 30 had improved fluorescence 
characteristics; the improved solubility of the naphthalene substrate, with 
its ability to form coloured complexes with CBPQT
4+ was chosen for use 
in the initial cell injection work. It was thought that time permitting, once 
the procedure and monitoring of the fluorescence was optimised, we 
would then move onto work with substrate 30  and its complex with   
β-cyclodextrin. 
The MDCK cells were seeded onto glass coverslips with a 
diameter of 3 cm at a cell density of ~5000 cells/ml. The cells were grown 
for three days to reach the required level of confluence. Solutions of 23 
were made up at a concentration of 10
-3 M, 10
-4 M, and 10
-5 M in 100 mM 
PIPES buffer with 0.1 mM MgCl2 at pH 6.5. Microlitre volumes of the 
solutions were added to a capillary sealed at one end and centrifuged in 
order to remove any particulates that may have been in solution. Up to 
5.0 µl of the spun solutions were then transferred into the micro-syringe 
for injection into the cells. An illustration of the syringe is shown in 
Figure 2.25. 
 
 
Figure 2.25 Illustration of the microsyringe within its holder. 
 
The syringe was positioned at a set level above the cells called the 
search plane. Once the required cell is in the correct position underneath 
the needle, the needle is inserted into the cell and a small amount of the 
solution is injected into the cell. After injection the syringe moves back to 
its position on the search plane. Injection of the solution is controlled by 
an application of air pressure to the needle capillary which causes the  
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fluid to leave the needle. The amount of pressure applied can be 
modulated and the injection time can be varied in which the length of time 
the pressure is applied for. This in turn will allow control over the volumes 
of liquid released per injection. This is illustrated in Figure 2.26 and 
Figure 2.27. 
 
Figure 2.26. Illustration of Syringe at search plane over a cell. 
 
Figure 2.27. Illustration of the movement of the needle from the search plane to cell 
injection then return to search plane. 
 
Upon injection of the 10
-3 M solution of 23 into the MDCK cells it 
was found that the DIP was, as expected cytotoxic and cells rapidly died 
when the DIP was injected directly into the nucleus. This would indicate 
that the DIP’s cytotoxicity is by the interaction with DNA, most likely by 
the same intercalation pathway exhibited by other phenanthridine based 
compounds.
[76]  
Further optimisation in order to investigate the minimum 
concentration required to kill and to observe the changes by the addition 
of CBPQT
4+ to the 23 to the cells was planned. However, the microscope 
developed a fault that meant that it could not be used and so this work 
could not be carried out.  
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From the initial work we observed that the DIP, when it entered the 
cell, killed the cell fairly rapidly. From this work we decided to investigate 
how cytotoxic these compounds were when present in the growth 
medium, and whether the DIPs could pass the cell membrane, and so kill 
the cells. 
 
2.3.2.5.2 Cell toxicity studies. 
 
As there is precedent for these compounds to be cytotoxic to cell 
culture, as exemplified with the cell injection studies, several live/dead 
and cell viability experiments were carried out using the MDCK cell line 
and the DIP compounds. Varying volumes of 0.5mM solutions of the 23 
(Nap DIP) and 30 (Fc DIP) in 1:1 ratios of water: DMEM were added to 
cells seeded into a 24 well plate (~5000 cells/ml) and allowed to grow for 
one week ahead of treatment with the DIP compounds. The cells were 
incubated with the DIPs for 24 hours. The volumes and resulting 
concentrations of DIP in each set of wells is shown in Table 2.10 Each 
concentration was run in a minimum of triplicate per experiment.  
 
DIP Volume Added  Effective Concentration of DIP 
0 ml  0 M 
2 µl  0.99 µM 
20 µl  9.8 µM 
200 µl  83 µM 
1 ml  0.5 mM 
Table 2.10. Concentrations of DIP treatment from volumes of 0.5 mM DIP to 1 ml wells. 
 
The medium containing the DIPs was removed and the cells were 
carefully washed with PBS (2x1 mL). Live / Dead stain was added to the 
wells with incubation for 30 minutes. The cells were then fixed and stored  
 
99 
 
in PBS, prior to investigation under the microscope. The Live/ Dead stain 
contained propidium iodide and Hoechst 33342. The propidium iodide, is 
an intercalating agent that fluoresces red when bound to DNA and cannot 
penetrate the cell membrane of living cells, but will freely enter the cells 
where the membrane is damaged and the cell is dead. Hoechst 33342 is 
a groove binding fluorescent agent that can penetrate the cell membrane 
and will stain the nucleus of these cells blue. The structures of these 
molecules are shown in Figure 2.28. 
 
 
Figure 2.28. Live/Dead Stain Components: Hoechst 33342 and propidium iodide. 
 
From these experiments we found that there had been no 
significant cell death and indeed there did not appear to be any insertion 
of the DIP compounds by the lack of fluorescence before the application 
of the Live/ Dead stain. Later experiments were carried out after 2 days of 
incubation from seeding. The concentrations used for this set of 
experiments were 0 M, 9.8 µM, and 83 µM, with each set of 
concentrations applied to 4 wells each. Again there appeared to be no 
cell death after 24 hours as there showed no red staining observed until a 
sample was treated with methanol for 5 minutes and re-stained with Live / 
Dead, whereby the red stain was observed predominately, showing that 
there was no issue with the staining and the cells were still alive after 24 
hours of exposure to the DIPs. Representative images of each set of 
samples are shown in Figure 2.29.  
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0M 30 after 24hrs  
 
0M 23 after 24hrs  
 
9.8µM 30 after 24hrs.  
 
9.8µM 23 after 24hrs.  
 
83µM 30 after 24hrs. 
 
83µM 23 after 24hrs  
 
9.8µM 30 after 2min MeOH added. 
(x20 magnification) 
 
9.8µM 23 after 2min MeOH added 
(x20 magnification) 
Figure 2.29. Live Dead stained cells after treatment with 23 and 30. Blue the nuclei of 
stained Live cells stained with Hoechst 33342 and red are the nuclei of dead cells stained 
with propidium iodide. 10x optical zoom magnification. 
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Although the DIPs were clearly not cytotoxic by the Live/Dead 
staining, the effects on growth of the cells were investigated using MTT 
staining experiments. Alongside the MTT experiments, further Live/Dead 
experiments were carried out in parallel. Results of the Live Dead stain 
for each set of substrates are shown below in Figure 2.30. 
 
 
Nap DIP (23) after 24hrs. 
 
Nap DIP (23)/ CBPQT (61) after 24hrs. 
 
FcDIP (30) after 24hrs. 
 
FcDIP (30) / β-CD (63) after 24hrs. 
 
CBPQT (61) after 24hrs. 
 
Blank after 24hrs. 
Figure 2.30. Live Dead stained cells after treatment with DIP substrates. Blue the nuclei of 
stained Live cells stained with Hoechst 33342 and red are the nuclei of dead cells stained 
with Propidium Iodide. 10x magnification. 
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The MTT agent used was thiazoyl blue tetrazolium bromide. This 
compound is metabolised by the mitochondria of living viable cells. Upon 
metabolism, the purple formazan salt is formed, and the culture goes 
from yellow to blue / purple, where the intensity of the colour can be 
correlated to the viability of the cell culture. Structures of the thiazoyl blue 
tetrazolium bromide and its metabolite are shown below in Figure 2.31. 
 
 
Figure 2.31. MTT staining agent and its metabolite. 
 
The cells were cultured for 3 days to grow to a suitable level of 
confluence after seeding at a general cell density of 5000 cells/ml. After 
this time, 200 µl of a 0.5 mM solution (0.083 mM overall) of the required 
treatment material was added. Table 2.11 shows the treatment material 
and the label used to denote it. 
 
Treatment Material  Treatment Label 
Naphthalene DIP 23  N 
23 / CBPQT
4+.4Cl
- (200µl of 1:1 complex)  NB 
CBPQT
4+.4Cl
-  B 
Ferrocene DIP 30  F 
30 / β-Cyclodextrin (200µl of 1:1 complex)  FC 
Blank (Reverse Osmosis distilled water 200µl)  X 
Table 2.11. MTT treatment materials with the letters denoting treatment label. 
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The solutions were added to the 1 ml fresh growth media present 
in the well. The cells were then incubated with the solutions for 24 hours. 
The media was then removed and the cells washed with PBS   
(2x 1 ml). The MTT (300 µl/ well) solution was then added and the cells 
were incubated for 1.5 hours in the dark. After this time the MTT was 
removed and warmed DMSO (150 µl) was added to the cells and left to 
react for ten minutes. The cell–DMSO mixtures were then transferred into 
a 96 well plate. The plate was then read by a DYNATECH MR700   
λ= 550 nm to yield the results. XAV denotes the average reading for a 
particular treatment material. 
 
Viability is calculated using 
   
       
  100 
 
Each set of solutions per experiment was carried out 4 times in a 
24 well plate. The array positions for the 24 well plate is shown below in  
Figure 2.32 Experiments with the 96 well plate were carried out where the 
location of each treatment solution was placed in an array as shown in 
Figure 2.33. 
 
 
Figure 2.32. Layout of the DIP treatments for MTT in 24 well plate. 
 
A B 
Figure 2.33. Layout of the DIP treatments for MTT in 96 well plates A and B.  
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Average %age viabilities for Treatments C=83µM after 24 hours 
# N B  NB  F  FC 
1  71  73  67 75.5 75 
2  78 81 68 76 75 
3  98.7 102 67.5 90.2  92 
4*  56.6 59.2 44.0 62.4 56.7 
5**  97.0 97.5 93.5 97.4 96.9 
6*  56.2 56.4 51.4 87.5 84.6 
7A
$  119 105  67  87  81 
7B
$  133 116 110 115  73 
*Loss of cells during staining procedure. **High seeding experiment. 
$96 well plate experiment 
Table 2.12. Average Percentage viabilities for several runs. 
 
The MTT experiments were exceedingly difficult to gain 
reproducible results. The cells were easily removed from the surface of 
the culture wells such that removal of any liquids during the staining 
process could result in loss of cells. This is exemplified with run 6, where 
the viabilities appear particularly low. Upon removal of the MTT staining 
agent fragments of purple/blue came out with the stain and so resulted in 
lower readings from the plate reader. During run 4 it was observed that 
there had been a significant loss of cells after the PBS rinse. The 
homogenicity of the cell suspension at cell seeding was fairly difficult to 
control and measure, but by thorough mixing prior to addition to each 
well, this issue was reduced. By allowing several days worth of growth 
and then inspection of each well prior to staining this potential for 
variation was reduced.  
By inspection of the results generally, slight trends can be 
observed. It appears that 23 and CBPQT
4+ separately have comparable 
effect, whereas the complex of the two shows consistently a drop in 
viability when compared to the two individual compounds alone. 
Compound  30 and its complex with β-cyclodextrin shows very little  
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variation as results for these substrates are almost identical with the 
viabilities always within 10% of each other with the exception of 
experiment 7B. Further experimental repeats would be needed for 
precise statistical analysis of the results. 
Whether the DIP compounds have any effect on the growth of the 
MDCK cell line is inconclusive due to the great variation in results found 
per run. By looking at the results along with the Live/Dead studies, it can 
be concluded that these molecules are not causing cell death. This in 
turn, when compared to the initial cell injection work, would indicate that 
the DIP compounds do not penetrate the cell membrane. 
 
 
2.3.6 Mictrotubule Formation from Anionic Polyoxometallate 
crystals and Cationic DIPs. 
 
As previously described in §2.1.3 it has been found that 
microtubule growth can be initiated by mixing solutions of DIP 
compounds with anionic polyoxometallate (POM) clusters, where the DIP 
exchanges with the cation counter ions in the POMs that then causes a 
precipitation out of the aqueous medium that the DIP was initially 
dissolved in. Microtubule formation is dependent of the concentration of 
the DIP and correspondingly the solubility of the POM crystal used. 
Courtesy of Mr A G Boulay of the Cronin group, several 
experiments with polyoxometallate Keggin net crystals (POM) with a 
general molecular formula of (C4H10NO)40-[W72Mn12O268Si7].48H2O and 
the DIP compounds with their respective guest molecules were 
undertaken to investigate the possibility of microtube formation that could 
undergo additional host-guest interaction, where the effects of forming the 
host-guest complex would be measured. The general structure of the  
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POM and the structures of the components used in these experiments 
are shown below in Table 2.13. 
 
 
Keggin Net POM 
 
Naphthalene DIP  
 
Ferrocene DIP 
 
CBPQT
4+ 
 
β-Cyclodextrin 
Table 2.13. Structure of POM crystal, DIPs and guest molecules used in experiments. 
 
The concentration of components used was 5 mM in distilled 
water. A POM crystal was placed on a microscope slide and drops of the 
5 mM solution were added to the slide. Table 2.14 shows the experiments 
carried out with the POM crystals. 
 
 
64 
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Compound / Complex 
Tube 
Formation 
Comments 
23  No 
DIP precipitated POM 
dissolved 
CBPQT
4+ 4Cl
-  Yes  Tubes successfully formed 
23 / CBPQT
4+ 4Cl
-  Yes Pink  solution 
CBPQT
4+ 4Cl
- then 23  Yes then No 
DIP precipitated POM 
dissolved 
30  No 
DIP precipitated POM 
dissolved 
β-Cyclodextrin No  POM  dissolved 
30 / β-Cyclodextrin No 
DIP precipitated POM 
dissolved 
Table 2.14. Experiments with POM and substrates for microtube formation. 
 
It was necessary that both the ferrocene and naphthalene DIPs 
were heated and vigorously stirred in order to gain a solution of the 
required concentration prior to addition to the slide. Compound 30, upon 
addition to the microscope slide with the crystal present, instantly 
precipitated out of solution, whereby the remaining DIP did not have 
either the concentration or ionic strength required for tube formation and 
the POM dissolved into the aqueous media. Similarly, solutions of   
β-cyclodextrin also had no effect on the POM and no tubes formed with 
this mixture. The ferrocene DIP (30)/  β-cyclodextrin complex was 
marginally more soluble than that of compound 30 by itself; however, the 
gain in solubility was not enough to keep the mixture in solution upon 
addition to the microscope slide and again no microtubes formed with this 
mixture. 
The complex between compound 23 and CBPQT
4+4Cl
- had an 
improved solubility in comparison to 23 by itself to the point that 
microtubule formation occurred with this mixture upon addition to the 
POM crystals. It was found that the CBPQT
4+  4Cl
- could also form 
microtubes with the POM crystals by itself as it freely exchanged with the  
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morpholinium counter ion of the POM crystal. Images showing 
microtubule formation by the POM and the complex 23 /CBPQT
4+ are 
shown in Figure 2.34. 
 
 
a) x10 objective 
 
 
b) x10 objective 
 
 
c) x4 objective 
Figure 2.34. Microtubule growth of Naphthalene DIP/ CBPQT
4+4Cl
- with POM Keggin net 
crystal over time. 
 
In an attempt to form the complex between 23 and CBPQT
4+ and 
microtube growth in situ, the tube growth was initiated with the addition of 
CBPQT
4+ 4Cl
- to a POM crystal. Compound 23 was then added to the 
mixture in an effort to form the complex whilst growing the microtubule. 
However, precipitation of the DIP occurred at a faster rate than the 
complexation with CBPQT
4+ causing a significant dilution of the local 
concentration of CBPQT
4+, halting the growth of the microtubule. The 
POM then gradually dissolved into the aqueous media. Figure 2.35 
shows the initial growth of the microtube and then the subsequent halting 
and the destruction of the POM crystal as it was dissolved by the distilled 
water. 
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POM crystal  With CBPQT
4+  23 added  Crystal 
dissolving 
 
    
X20 objective  X10 objective  X10 objective  X10 objective 
Figure 2.35. Growth of CBPQT
4+ POM microtube which is halted by addition of 23. 
 
From these experiments we can see that microtubule formation by 
our DIP substrates cannot occur due to the lack of solubility in aqueous 
solutions. Compound 30 failed to achieve the level of solubility required 
for the growth of microtubes either by itself or upon formation of an 
inclusion complex with β-cyclodextrin. Compound 23 also failed to stay in 
solution for a sustained amount of time such that, precipitation from the 
solution occurred rapidly and microtubule growth failed to occur. By 
forming the pseudorotaxane with CBPQT
4+ the solubility of the complex 
was far greater than the uncomplexed DIP such that microtubes formed 
with the POM Keggin net crystals. However, the complex had to be 
formed prior to addition to the POM crystal. Through the investigation of 
the microtube formation it was found that CBPQT
4+ could form microtubes 
with the POM crystals without the DIP present. 
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2.4 Conclusions and Future Work. 
2.4.1 Conclusions. 
 
To summarise we have successfully synthesised two derivatised 
dihydro-imidazo-phenanthridine compounds that can undergo host-guest 
interactions with either the cyclophane CBPQT
4+ or β-cyclodextrin 
respectively. The ferrocene functionalised DIP was fairly insoluble in 
aqueous media, to the degree many of the analysis techniques employed 
for these compounds could not be carried out.  
The 23 has been shown to interact with CBPQT
4+ to form coloured 
solutions that can be monitored by UV-Vis and fluorescence 
measurements. The ITC studies have shown that 23 undergoes a highly 
complicated interaction with DNA that is buffer dependent, such that the 
binding model and binding constant Ka cannot be determined 
consistently. 
We have shown that these compounds although they are cytotoxic 
if they can enter the nucleus of the cell, cannot penetrate the cell 
membrane, and so do not kill the cell culture when present in the growth 
medium for up to 24 hours. From the Live Dead staining we can see that 
the DIPs and their complexes appear to have little effect on the cells. The 
MTT studies are inconclusive as to whether there is any significant effect 
on cell viability and further investigation is required. 
It has been shown that although both DIP compounds failed to 
form microtubes with POM Keggin net crystals, by forming the 
pseudorotaxane complex with 23 and CBPQT, microtubes can be 
successfully formed in aqueous media. 
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2.4.2 Future Work. 
 
If there had been more time available, further investigations would 
have been carried out on the cell culture experiments, such that the cell 
injection would have been further optimised so as to investigate the effect 
of low concentrations of both DIP molecules on the cells.  
The MTT experiments would have been subject to further repeats 
in order to identify outliers from the experiments and gain an improved 
statistical value for each substrate. By increasing the number of results 
we can then observe any trends that are actually there rather than 
potential artefacts of the experiments. 
The effects of changing from aqueous loading of the DIP 
substrates to DMSO loading into the cell experiments would have been 
carried out in order to observe the changes in toxicity of these 
compounds. If time had permitted changing the cell type from the MDCK 
cells may have been an interesting pathway to investigate the changes in 
toxicity with changing cell type. 
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3 
Functionalised Self Assembled Monolayers for Cell 
Adhesion Studies 
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3.1 Introduction. 
 
As previously described in § 1.7 self assembled monolayers 
(SAMs) have been used widely in cell culture experiments due their ability 
to model the extra-cellular matrix interactions. The chemical properties 
presented by the SAMs can be tuned by a number of stimuli, ranging 
from electrochemical conversions of functional groups, to the covalent 
modification of the pendant functionality as described in § 1.7. Host-guest 
interactions can also utilised in the control of cell adhesion and growth 
properties.  
Mrksich and co workers
[91] have produced a system where cell 
adhesion is tuned by the presence of a connector protein
[91]. SAMs made 
of a mix of a 1% amine functionalised thiol and a triethylene glycol thiol 
were reacted with 1 mM benzenesulfonamide-N-hydroxysuccinimide 
solution to form the required functionalised substrate. The 
benzenesulfonamide moiety could bind selectively carbonic anhydrase 
proteins with micromolar affinity. Human carbonic anhydrase IV (hCAIV) 
was functionalised with a peptide presenting the peptide chain RGD (CA-
RGD) in order to facilitate the binding of integrin proteins found on the 
surface of cells.
[91] This is illustrated in Figure 3.1. 
 
 
Figure 3.1. Illustration of the selective adhesion to the surface with CA-RGD present. 
 
The CA-RGD adaptor protein produced from hCAIV at the gene 
expression level where the peptide sequence GGSGGGGSGGRGDS 
was coded for at the end of the reverse complementary sequence of  
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hCAIV. The vector formed was inserted into Escherichia coli (strain 
Origami B DE3) cells for the production of CA-RGD. 
[91] 
SPR experiments showed that the CA-RGD connector protein 
bound to the surface via interactions with the benzenesulfonamide moiety 
only and was repelled by the triethylene glycol groups. The SPR results 
for the 1% benzenesulfonamide and 100% triethylene glycol SAMs are 
shown in Figure 3.2. 
 
 
Figure 3.2. SPR sensorgrams that show that CA-RGD binds to 1% benzene sulfonamide,  
but fails to bind to 100% triethylene glycol SAMs.
[91] 
 
When Chinese hamster ovary (CHO) cells were introduced to the 
SAMs without the CA-RGD present in the growth medium, no cell 
adhesion occurred. After the addition of the CA-RGD to the growth 
medium in concentration up to 10 µM, adhesion of the cells to the surface 
proceeded successfully such that when compared to cells on surfaces 
with RGD covalently bound there was no discernible difference. Addition 
of CA-RGD in concentrations above 10 µM led to an inhibition of the cell 
adhesion due to the division of the binding interactions into binary 
complexes where the CA-RGD bound either to the SAMs or the cells 
only. The formation of SAMs with the GRGDSC peptide attached 
covalently showed that the CHO cells adhered normally through integrin 
binding to the peptide and the appearance of the cells were identical to 
those grown on the benzensulfonamide functionalised surface when the 
connector protein was present. An illustration of the effect CA-RGD  
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concentration on cell adhesion is shown in Figure 3.3. The cell adhesion 
mediated by CA-RGD with the bezenesulfonamide SAMs and onto SAMs 
presenting the peptide GRGDSC is shown in Figure 3.4. 
 
 
Figure 3.3. Illustration of the effect of CA-RGD concentration on cell adhesion to the 
surface. 
 
 
Figure 3.4. CHO cell adhesion mediated by CA-RGD on 1% benzenesulfonamide (C) and 1% 
Ac-GRGDSC (D). Cells failed to adhere to benzenesulfonamide monolayers (B).
[91] 
 
Although thiol SAMs on gold have been studied extensively due to 
their useful properties and ease of synthesis, silane SAMs on glass have 
also been studied. Silanes on glass behave in a similar manner as thiols 
on gold however, it has been found that the silane SAMs when compared  
 
116 
 
to the equivalent thiols on gold have a significantly higher thermal 
stability. For example 1H,1H,2H,2H-perfluorodecanethiol has been found 
to desorb from gold at temperatures exceeding 145-165°C, whereas the 
silane equivalent on silicon or glass is thermally stable up to 350°C.
[57] 
SAMs on glass have the added benefit that they are completely 
transparent, while gold surfaces are semi-transparent to opaque. The 
applications of silanes on glass and silicon wafers has been 
predominately found within the field of electrical engineering. However, 
there are examples where silanes have been used to form thin films on 
glass for the modulation of cell adhesion properties and the creation of  
anti-bacterial surfaces for potential implant coatings. This is exemplified 
by work carried out by Mohorcic and co-workers.
[92] 
Slides of indium tin oxide (ITO) glass functionalised with   
polymyxin B (PMB), a known anti-microbial agent were created in order to 
investigate the effectiveness of immobilised PMB on the viability of gram 
negative  E coli. PMB is an anti-microbial polycationic lipopeptide that 
permeablises the inner membrane of bacteria. This permeablisation 
induces an uptake of water which then leads to cell apoptosis.
[93] 
The silane, 3-glycidyloxypropyl trimethoxysilane (GPTMS), as a 
50% solution in isopropyl alcohol (IPA) was partially hydrolysed using   
0.1 M hydrochloric acid, where the ratio of silane to water was 1:3, for  
15 minutes. The mixture was diluted with IPA to gain a concentration of 
GPTMS of 0.3 M. The slides were dip coated and then fixed for   
30 minutes at 120 °C.
[92] The structure of the silane GPTMS is shown in 
Figure 3.5.
[92] An illustration of the functionalised surface is shown in   
Figure 3.6.
[92] 
 
O
Si
O
O O O
 
Figure 3.5. Structure of GPTMS. 
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Figure 3.6. Illustration of the fuctionalised ITO glass surface. 
 
The silanised glass was then treated with the PMB in the presence 
of an epoxide opening catalyst, either WCl6 or H3P(W3O10)4•H2O (PWA) to 
form the functionalised surface. The silanisation and modification of the 
surface was monitored by FTIR.
[92] Once functionalised the slides were 
immersed in distilled water for 20 hours, and then cleaned by 
ultrasonication in fresh distilled water in order to remove the excess PMB 
and catalyst from the surface. Optimal conditions were found to be 2.5 
mg / mL concentration of PMB in the presence 0.6 mg / mL of the WCl6 
catalyst for a period of 1-3 hours. The effectiveness of the functionalised 
surfaces against E coli as a function of reaction time with either catalyst 
with PMB is shown in Figure 3.7.
[92] By varying the pH, and the 
concentration the anti-bacterial properties could be tuned. The surfaces 
formed by the optimal conditions reduced the E coli cell count by up to 5 
orders of magnitude per millilitre of cell suspension.
[92] 
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Figure 3.7. E coli viability on the functionalised surfaces vs the time treated with WCl6/PWA 
with PMB. 
 
To ascertain that the activity came from the PMB tethered to the 
surface and not as a result of cleavage from the surface, experiments 
where the functionalised slides were placed within dialysis tubing in the 
presence of E coli. The sealed tubing was then immersed into media 
containing E coli. The premise was that if there was significant cell death 
outside and within the dialysis tubing, then the PMB was no longer 
attached to the surface. Positive and negative tests were run for 
comparison results. The bacteria were incubated in the dialysis tubing 
experiments for 18 hours, after which time the viability of the cells was 
measured. The results of these experiments are shown in Figure 3.8.
[92] It 
was found that cell death only occurred within the dialysis tubing for the 
functionalised surfaces showing that the PMB was retained on the 
surface.
[92] 
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Figure 3.8. Bactericidal activity of the surface vs Controls of PMB and PMB-free 
experiments. 
 
As these examples show the multitude of applications and types of 
modification available for surfaces modified by SAMs is wide ranging, 
allowing for further development of the area. 
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3.2 Aims and Objectives. 
 
The aims were to produce functionalised surfaces for investigation 
of the effects of host-guest interactions on cell adhesion and growth. The 
functional groups that were chosen to investigate were naphthalene, 
tetrathiafulvalene (TTF), and ferrocene. As these groups can undergo 
host-guest intreractions it was hoped that the formation of their 
complexes with either CBPQT
4+ or β-cyclodextrin could modulate the 
adhesive properties of the surface and so control cell cuture adhesion 
and growth. By incorporating each functional group the investigation into 
the effects of charged and neutral host-guest complexes on cell growth 
and adhesion could be performed. 
For the formation of tunable SAMs, there was a variety of choices 
for the substrates that could be used to form these SAMs onto. Of the 
options available two substrates were chosen to investigate; glass with 
the immobilisation of silanes, and gold surfaces for the attachment of 
disulfides and thiols. 
 
3.2.1 Modified  Silanes. 
 
The synthesis of self-assembled monolayers onto glass surfaces 
was thought to be a straightforward method of controlling the adhesion 
and growth of cell tissue culture, whereby the formation of a SAM onto 
transparent surfaces that could utilise intermolecular interactions to 
modulate cell adhesion and growth. One aim of this project was therefore 
to produce derivatised silanes that could form pseudorotaxanes with a 
guest substrate on the surface of a glass coverslip, such that a switching 
of adhesive properties of the surface could be controlled to either become 
non-adhesive or very adhesive to cells. The silanes could be modified by 
two methods, either prior or post formation of the monolayer. The silane 
target molecules for cell culture experiments are shown Figure 3.9.   
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Figure 3.9. Silane Target Molecules. 
 
3.2.2 Modified  Disulfides. 
 
The synthesis of self-assembled monolayers onto gold surfaces 
via disulfide bonds was thought to be a good alternative to the surfaces 
formed onto glass as a method of controlling the adhesion and growth of 
cell tissue culture. A second aim of this project was therefore, to produce 
derivatised disulfides that could form pseudo-rotaxanes with a guest 
substrate on the surface of a gold slide, such that a switching of adhesive 
properties of the surface could be controlled to either become non-
adhesive or very adhesive to cells. The target molecules to be used in the 
formation of SAMs on gold surfaces are shown below in Figure 3.10. 
 
 
 
 
Figure 3.10. Target Molecules for Functionalised Disulfide Synthesis. 
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3.3 Results and Discussion. 
 
3.3.1  Synthesis of functionalised silanes. 
 
3.3.1.1 Ferrocene  silane  synthesis. 
 
 
Scheme 3.1. Attempted formation of Ferrocene based silane. 
 
From the ferrocene amino compound 25a which was synthesised 
under the same conditions as described in § 2.3.2, a direct coupling of 
the amine with isocyanatopropyl triethoxy silane in dry pyridine was 
attempted. However, the reaction failed to yield the required product and 
the starting materials were consumed. As we could form the required 
ferrocene disulfide as described in § 3.3.2, further investigation into the 
possible identity of the compound produced from this reaction was not 
carried out.  
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3.3.1.2   Naphthalene silane synthesis. 
 
 
Scheme 3.2. Synthesis of the naphthalene silane 18 from the diol 2. 
 
The naphthalene silane 18 was synthesised in a two step 
synthesis from the starting naphthalene diol 2.  The synthesis of this 
material as described in § 2.2.1. The naphthalene diol 2, was methylated 
with methyl iodide. This reaction gave the mono-methylated 17a and 
dimethylated naphthalene 17b compounds with in varying ratio that was 
not controllable to any real degree. The dimethylated compound was, 
although not useful for this project, a key material for other syntheses 
within Prof G Cooke’s group. The two products were easily separated by 
column chromatography and any unreacted starting material could be 
recovered. The monomethylated naphthalene alcohol (17a) was then 
reacted with isocyanatopropyl triethoxy silane in dry pyridine. The 
pyridine was dried over calcium hydride overnight under an atmosphere 
of nitrogen and collected by vacuum distillation directly before use. The 
silane product (18) was produced in 78% yield.  
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3.3.2 Monolayer  formation  of 18 on glass surfaces. 
 
 
Figure 3.11. Naphthalene Silane SAM on glass. 
 
Prior to treatment with compound 18 the glass slide coverslips 
were first cleaned in a fresh solution of Caro’s acid solution. After the acid 
clean, treatment of the coverslips with 5M sodium hydroxide was 
performed to increase the number of hydroxyl groups on the surface of 
the now clean glass. Once complete, the coverslips were rinsed with 
copius amounts of water to remove any excess base residues, and then 
stored at 80°C until use in the formation of SAMs with compound 18. The 
protocol used can be found in Appendix 4. 
The glass coverslips were treated with a solution of 1% silane in 
1% acetic acid in ethanol for 30 minutes. The treated coverslips were 
then rinsed with ethanol followed by water to remove any excess silane. 
Water contact angle measurements were recorded for both the treated 
and untreated clean glass coverslips. The results indicated that the SAMs 
had successfully formed on the glass with a drop in contact angle 
observed as shown in Figure 3.12. The decrease in contact angle 
indicated a small increase in hydrophilicity and wettability of the surface. 
This would indicate an influence of the diethylene glycol on the chemical 
properties of the surface.
[51] 
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Figure 3.12. The Average Contact Angles measured in triplicate for cleaned glass 
coverslips and cleaned coverslips treated with the naphthalene silane 18. 
 
Cells from Madin Darby Canine Kidney (MDCK) cell culture were 
then seeded onto the treated coverslips and incubated for 1 week to allow 
for adhesion and growth onto the surfaces. After this time the cells were 
fixed with 4% formaldehyde in PBS and stained with Coomassie Blue. 
Protocols for these procedures can be found in Appendix 3.  
Repetition where the glass was left in the solution overnight and 
then treated with CBPQT
4+ solution for one hour prior to seeding, gave 
inconclusive results due to the seeding density used. The cells 
successfully reached confluency and were found to be extremely densely 
packed on the surface of the glass. It should be noted that upon 
treatment of CBPQT
4+ the concentration of naphthalene was too low to 
observe the change in colour. This may have been due to the lack of 
space between the naphthalene groups and so the pseudorotaxane may 
not have formed. Images of the cells for both with and without CBPQT
4+ 
added are shown in Figure 3.13. 
From the images it can be observed that the cells adhered to both 
surfaces, and grew to confluency rapidly, showing that the surfaces did 
not impede this process in any way.  
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Without CBPQT
4+ present  With CBPQT
4+ present 
   
   
Figure 3.13. Phase contrast images of MDCK cells grown on Naphthalene silane 
functionalised glass slides with and without CBPQT
4+ present. X10 optical zoom. 
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3.3.3  Synthesis and analysis of thiotic acid functionalised electron 
rich moieties. 
 
3.3.3.1 Synthesis  of  ferrocene disulfide. 
 
 
Scheme 3.3. EDCI coupling of ferrocene amine 25a with thiotic acid. 
 
The ferrocene disulfide compound (32) was synthesised by 
reacting the ferrocene amino compound (25a),
[94] with thiotic acid in the 
presence of EDCI. The reaction gave a good yield and column 
chromatography gave the clean product as a sticky orange oil. The 
reaction conditions tolerated large scale reactions so the material could 
be made in bulk and then stored at 0°C until use.  
 
3.3.3.2  Synthesis of tetrathiafulvalene disulfide. 
 
Two synthetic pathways were attempted to create the TTF 
functionalised disulfides. The TTF derivative was chosen for its inherent 
redox activity and its strong association with CBPQT
4+. The first pathway 
utilised a zincate intermediate, as shown in Scheme 3.4,  whereas the 
second pathway used the formation of a lithiated form of TTF to 
synthesise the required disulfide as shown in Scheme 3.5. 
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Synthesis 1 – Via Zincate intermediate. 
 
 
Scheme 3.4. TTF alcohol synthesis from the starting zincate compound. 
 
The zincate salt 46,
[95] was reacted with bromopropionitrile to gain 
the 4,5-bis(2-cyanoethylthio)-1,3-dithiole-2-thione  47.
[95] The product of 
this reaction was recovered by precipitation from toluene with diethyl 
ether. Any product that failed to precipitate out was then recovered by 
column chromatography followed by precipitation from toluene with 
diethyl ether. Compound 47 was then reacted with mercuric acetate to 
form the 4,5-bis(2-cyanoethylthio)-1,3-dithiol-2-one  48  in an 82% yield. 
The impurities were removed by filtration followed by a base extraction to 
remove any acetic acid present. Compound 48 was then taken on without 
any further purification required.  
The formation of the tetra(2-cyanoethanethio)tetrathiafulvalene 49 
by the reaction of compound 48 with triethyl phosphite in methanol gave 
the product in a 21% yield, where the product was recovered by 
precipitation and column chromatography of the liquor to remove the  
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phosphite by-product.
[95] The in situ deprotection of the thiol groups and 
subsequent reaction with 2-(2-chloroethoxy)ethanol failed to yield either 
starting material, product 50 or deprotection product, where complete 
decomposition of the TTF compound 49 occurred. Due to lack of starting 
materials and the problematic synthesis to create the zincate salt that had 
been the initial starting material, it was decided that this pathway would 
be abandoned. 
 
Synthesis 2 – Via Lithiation route. 
. 
 
Scheme 3.5. Reaction scheme for the synthesis of TTF disulfide 49 starting from TTF. 
 
The TTF disulfide 49 was made in a four step synthesis, starting 
from TTF as shown in Scheme 3.5. Tetrathiafulvalene (TTF) was first 
lithiated and then reacted with CO2
[96] in a one pot synthesis to gain the 
TTF carboxylic acid 55. The TTF acid was reacted with cyanuric 
fluoride
[97] in DCM. The reaction gave a dark red solid that was water 
stable. The acid fluoride 56 was then reacted with 2,2’-(ethylenedioxy) 
diethylamine, where there was an assumed 100% yield from the acid 
fluoride formation step. The resulting TTF amine 57 was contaminated 
with the 2,2’-(ethylenedioxy)diethylamine that had been used in excess in  
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order to drive the reaction to form the TTF mono amine rather than the 
TTF dimerised product, as was observed in the synthesis of the 
equivalent ferrocene amine 25a and 25b. The TTF-amine 57 was found 
to co-elute off the silica column with its contaminant such that repeated 
chromatographies led to loss of product with no gain in purity.  
The impure TTF amine 57 was reacted with thiotic acid via an 
EDCI coupling that gained the required disulfide compound 58 as an 
orange oil. Column chromatography successfully removed all impurities 
from the compound. It was found, however, that the TTF readily oxidised 
in solution. Ascorbic acid addition to the oxidised compound returned the 
TTF disulfide 49, indicating that the oxidation was partially reversible. 
Over the four steps the yield overall was 2%; this poor yield may be due 
to the fairly harsh conditions used and that the TTF oxidised readily at the 
last stage of the synthesis. The repeated column chromatography in the 
penultimate step, where the amine co-eluted with the product also had a 
detrimental effect on the yield as the product was lost with each 
chromatograph without any decrease in the amounts of impurity present. 
Due to the lack of stability of the final product, and poor overall yield it 
was decided that it was impractical to repeat the synthesis in order to 
gain more material. 
 
3.3.4  Immobilisation of naphthalene disulfide 16 onto gold. 
 
 
Figure 3.14. Structure of the Naphthalene disulfide 16. 
 
The naphthalene disulfide 16 had been made previously within 
Prof G Cooke’s group
[98] shown in Figure 3.14. Studies of this compound 
in chloroform with gold surfaces showed that successful immobilisation  
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was possible. In collaboration with Dr M Kadodwala’s group, studies were 
carried out on silicon wafers coated with 5 nm Ti overlaid with 20 nm gold 
were connected to a circuit, where the resistance over the gold surface 
was measured with time as the slide was brought into contact with a   
10 mL solution of disulfides at a total concentration of 1 mM in 
chloroform. As the SAMs formed on the gold, the resistance increased 
until the saturation of the surface reached a maximum and the resistance 
measurements reached a plateau. 100% butyl disulfide; 1:1 butyl 
disulfide: naphthalene disulfide; and 100% naphthalene disulfide 
solutions were typically used for these experiments. The butyl disulfide 
was used as a reference and a spacer group for the naphthalene 
disulfide, where interaction with CBPQT
4+ was not expected to occur. An 
experiment with CBPQT
4+4PF6
- on a clean wafer was also carried out as 
a reference for subsequent experiments and showed the non-specific 
adsorption of material onto gold. The changes in resistance for each 
substrate are shown in Figure 3.15, Figure 3.16, Figure 3.17, and   
Figure 3.18. 
 
 
Figure 3.15. Resistivity measured for the formation of the butyl disulfide SAM onto the gold 
surface at room temperature. 
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Figure 3.16. Resistivity measured for the 1:1 butyl - naphthalene disulfide SAM onto the 
gold surface at room temperature. 
 
 
 
Figure 3.17. Resistivity measured for the formation of the naphthalene disulfide SAM onto 
the gold surface at room temperature. 
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Figure 3.18. Resistivity measured at room temperature for the addition of CBPQT onto the 
gold surface. 
 
After removal from the disulfide solutions, the wafer was rinsed 
with chloroform, and then immersed in a solution of 1 mM CBPQT
4+ 4PF6
- 
in acetonitrile and measurements were carried out. Initial experiments 
showed a dramatic decrease in resistance and the formation of a blue 
solution indicating the formation of the CBPQT
2+• di-radical species. The 
formation of the di-radical species was attributed to the reduction of 
CBPQT
4+ by the copper wire and / or the zinc solder used to connect the 
wafer to the circuit coming in contact with the solution. It was thought that 
the di-radical species then caused the disulfide to be removed from the 
surface of the gold leading to a drop in resistance.  
EPR spectroscopy experiments were carried out using solutions of 
CBPQT
4+ treated with either zinc powder or copper wire. The results are 
shown in Figure 3.19. The EPR spectroscopy confirmed the formation of 
a radical species, which from literature precedent indicated the formation 
of the diradical species.
[18] From the EPR spectra shown in Figure 3.19 it 
can be observed that the addition of copper produced a strong signal, 
and so reduced the CBPQT
4+ more readily when compared to the 
equivalent conditions with zinc. This would indicate that the formation of 
the diradical was due to reaction of the CBPQT
4+ with the copper rather 
than the zinc.  
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Figure 3.19. EPR of CBPQT
2(+.) diradical formed by the addition of either zinc or copper. 
 
To confirm that the diradical species was the cause of the removal 
of the SAMs from the gold, experiments were carried out where the 
immobilised SAMs were immersed in acetonitrile, and then CBPQT
4+  
4 PF6
- solutions were very carefully added to the slide ensuring that the 
solution did not come in contact with either the zinc solder or the copper 
wire and the resistance measurements were recorded. Figure 3.20 shows 
the data recorded for the addition of CBPQT
4+ 4PF6
- to butyl disulfide 
SAMs and naphthalene disulfide SAMs.  
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Figure 3.20. The addition of CBPQT
4+ to the butyl and naphthalene SAMs in acetonitrile at 
room temperature. 
 
After addition of the CBPQT
4+ 4PF6
- a slight rise followed by a 
small drop in resistance was observed for the butyl SAMs whereby the 
resistance then levelled out. For the naphthalene SAMs after addition of 
the CBPQT
4+ 4PF6
- there was a drop in the resistance observed. The 
resistance then was partially regained, where it equilibrated over time. 
Addition of copper to a solution of CBPQT
4+ 4PF6
-, formed the di-radical, 
and subsequent treatment of a SAM immobilised surface gave the 
expected drop in resistance as the disulfide was removed from the 
surface. By the corresponding addition of zinc to the CBPQT
4+ 4PF6
- 
solution followed by a filtration and application to a SAM immobilised gold 
surface, it was observed that the removal of the disulfide from the surface 
of the gold. Figure 3.21 shows the data recorded for both the butyl and 
the naphthalene disulfide SAMs upon exposure to the pre-formed 
CBPQT
2+• species. Reduction was via the addition of copper to the 
solution of CBPQT
4+ in acetonitrile. 
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Figure 3.21. Resistivity for SAMs treated with CBPQT
2+ at room temperature A) butyl 
disulfide SAM. B) naphthalene disulfide SAM. 
 
 
Due to the overall reduction in resistance for the addition of 
CBPQT
4+ 4PF6
- to the SAMs on the wafer there was a degree of 
uncertainty as to if there had been successful formation of the 
pseudorotaxane or if there had been a small degree of dissociation of the 
disulfides from the gold as a result of the addition of the CBPQT
4+. As 
part of the cell culture experiments was to selectively separate the 
pseudo rotaxane formed by the reduction of CBPQT
4+, this set of 
experiments showed that by adding a reducing agent in this case copper 
or zinc, the CBPQT
2+• was formed and removal of the disulfides occurred 
non-selectively, where both the naphthalene and the butyl disulfides 
desorbed from the gold surface. Due to the successful synthetic route  
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applied that could tolerate gram scale synthesis, the ferrocene disulfide 
gold SAMs were chosen as the preferred vehicle to further investigate 
this methodology. 
 
3.3.5  Cell Engineering experiments. 
 
Glass microscope slides were spatter coated with Ti/Au with a 
layer thickness of 2µm Ti and 26µm Au. The slides were cut to fit a 24 
well plate with the approximate dimensions of 1cm
2. These cut slides 
were cleaned by rinsing with acetone x2, methanol x2, IPA x2, and 
ethanol x2 prior to treatment with the disulfide. A number of solutions 
were made where the amount of ferrocene disulfide (32) was varied 
relative to the amount of butyl disulfide spacer. The solutions were kept at 
1mM total disulfide concentration. All solutions were in ethanol and in 
order increase the probability of SAM formation these solutions were 
made directly before immobilisation onto the gold surface. The slides 
treated with the disulfide mixtures for 1.5 hours and then rinsed 
thoroughly with ethanol and water. These slides were then stored below 
0°C until use in cell culture experiments. Table 3.1 shows the amounts of 
ferrocene disulfide and butyl disulfide used in each solution mixture. 
 
Conc
n Butyl 
disulfide 
Conc
n Ferrocene 
Disulfide 
Ratio / Percentage 
1 mM  0 mM  100% Butyl disulfide 
0.91 mM  0.01 mM  10:1 butyl : ferrocene 
0.83 mM  0.17 mM  5:1 butyl :ferrocene 
0.75 mM  0.25 mM  3:1 butyl :ferrocene 
0.5 mM  0.5 mM  1:1 butyl :ferrocene 
0.25 mM  0.75 mM  1:3 butyl :ferrocene 
0 mM  1 mM  100% Ferrocene disulfide 
Table 3.1. Concentrations of ferrocene and butyl disulfide.  
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The treated slides were washed with ethanol and then HEPES 
prior to cell seeding. MDCK Cells were seeded onto the slides at a typical 
density of around 5000 cells per mL. The culture was then incubated in 
DMEM supplemented media for one week, where the media was 
changed every 2-3 days. The cells were grown for one week, after which 
time they were treated with either Live/Dead stain or fixed and stained 
with Coomassie Blue. Figure 3.22 shows the images gained from the 
Coomassie Blue staining of the cell culture experiment. 
As can be seen from the images, the MDCK cells became densely 
spread across all slides. What can be noted is that the cells grew more 
densely on the 100% ferrocene SAMs with β-cyclodextrin added 
compared to the density of cells on just 100% ferrocene SAM. There did 
not appear to be much change observed with the differing percentages of 
disulfide. From then on it was decided that for ease of solution formation 
and comparison that the ratios to investigate were 100% butyl disulfide, 
1:1 butyl disulfide: ferrocene disulfide, and 100% ferrocene disulfide. 
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Disulfide Mixture  Disulfide SAM only  With β-cyclodextrin 
A 
100% Butyl Disulfide 
   
B 
90% Butyl Disulfide 
10% Ferrocene 
Disulfide     
C 
75% Butyl Disulfide 
25% Ferrocene 
Disulfide     
D 
50% Butyl Disulfide 
50% Ferrocene 
Disulfide     
E 
25% Butyl Disulfide 
75% Ferrocene 
Disulfide     
F 
100% Ferrocene 
Disulfide 
   
Figure 3.22. Coomassie Blue staining of MDCK cells on the disulfide SAMs with and 
without β-cyclodextrin added. X10 optical zoom. 
 
To investigate the effects of oxidation of the ferrocene to 
ferricenium on cell growth we treated a set of SAMs of each mixture with 
iron trichloride. At the same time another set of SAMs on gold were 
treated with β-cyclodextrin in order to probe the changes in growth and 
adhesion with the addition of a guest species to the ferrocene group on 
the SAM. The iron trichloride and β-cyclodextrin were dissolved in distilled 
water to form 1 mM solutions. Treatment of the iron trichloride was left for  
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no more than 5 minutes before removal of the solution. The slides were 
washed with water x2 and ethanol to remove any iron trichloride residue. 
The β-cyclodextrin solutions were left for 15 minutes before rinsing with 
water x2 and ethanol x1.  
Prior to the cell culture experiments it was found that the culture 
media that had been used previously contained ascorbic acid, a known 
anti-oxidant that would reduce the ferricenium species back to the 
ferrocene before the cells could settle and so voiding an investigation of 
the role oxidation of the ferrocene on controlling adhesion. After a 
detailed search it was found that F10 HAM media did not contain ascorbic 
acid and could be used to suit our purposes. The slides were then rinsed 
with ethanol and HEPES prior to seeding. The cell culture was split by 
normal means, whereby the trypsin activity was quenched with DMEM 
media for centrifugation. The media was removed and the cells were 
taken up in the F10 HAM, and spun down. This procedure was performed 
in order to remove any traces of the DMEM. The cells were seeded onto 
the slides in the ascorbic acid free media at a cell density of ~5000 cells 
per mL.  
Alongside the gold slide experiment, a 24 well plate (containing 
cleaned glass coverslips) was also seeded and the cells grown in F10 
HAM, in order to discount any changes observed that were due to the 
change in media. The cell cultures were allowed to grow over the course 
of 1 week; at which point they were fixed with 4% formaldehyde solution, 
permeablised, and stained for actin and tubulin. The cells were also 
stained with DAPI to highlight the nucleus of the cells. For all the surfaces 
the MDCK cells successfully grew and spread across the surfaces. It can 
be seen that there is very little change in the appearance of the MDCK 
cells showing that there is very little perturbation of the culture from the 
SAMs on the gold surface. The images presented in Figure 3.23 show 
that there is very little difference in growth and adhesion between the 
SAMs indicating that there is no preference for each surface and that the 
cells will readily grow on all surfaces.   
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Disulfide 
Mixture 
SAMs Only 
SAMs after FeCl3 
treatment 
SAMs with 
β-cyclodextrin 
100% 
Butyl 
disulfide 
 
50% Butyl 
disulfide 
50% 
Ferrocene 
disulfide   
100% 
Ferrocene 
disulfide 
   
Figure 3.23. MDCK images stained for Actin (red), Tubulin (green) and with DAPI (blue).  
40x optical zoom. 
 
Appendix 5 shows the individual black and white images of each 
stain for the images in Figure 3.23 above. 
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3.4 Conclusions and Future Work.  
 
3.4.1 Conclusions. 
 
Several monomers have been successfully synthesised for 
applications to form SAMs onto either glass or gold surfaces. 
Experiments with the naphthalene silane derivative with and 
without the presence of CBPQT
4+ have shown that MDCK cell growth and 
adhesion are unaffected by these moieties, where the cells successfully 
grew to confluence rapidly. 
Experiments with the ferrocene disulfide on gold and its interaction 
with β-cyclodextrin also showed to have very little effect on the growth 
and adhesion of these cells in culture where the cells grew and spread 
across the surfaces with no specific preference for one surface over 
another. The formation of the ferrocenium species also had very little 
effect on the cells. 
Work with the naphthalene disulfide onto gold wafers with the 
addition of CBPQT
4+ showed that the disulfides will quickly adsorb onto 
the surface of the gold. Addition of the CBPQT
2+• radical was shown to 
remove the disulfide and thiol functionalities of the surface of the gold. 
The TTF disulfide was synthesised, however, it was found to be 
sensitive to solvent and rapidly oxidised, which may account for the very 
low overall yield. 
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3.4.2 Future  Work.   
 
Had there been greater quantities of the TTF disulfide available, 
and with further time, investigation into the effects of this moiety on cell 
adhesion could be performed. The addition of ascorbic acid to solutions 
of the TTF would potentially reduce the degree of oxidation and so allow 
the SAMs to form.  
Investigation of the adsorptions onto gold by SPR would be a key 
extension to this work, where the adsorption of protein onto surfaces 
could be measured. 
Investigations into the SAMs on gold with other cell types may be 
an interesting extension to this work, where the sensitivity to the surfaces 
may vary.  
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4. 
Pseudorotaxane modification of diacetylene 
liposomes. 
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4.1. Introduction. 
 
The name liposome is derived from the Greek ‘lipo’ meaning fat and 
‘soma’ meaning body. Liposomes can be singular or multilaminar vesicles 
that may be formed using either artificial lipid molecules or biological 
phospholipids. Liposomes have multiple applications including drug 
transport molecules and sensing devices. The general structure of a 
liposome is shown in Figure 4.1. 
 
 
Figure 4.1.Illustration of a liposome. 
 
Diacetylenes are an important class of artificial lipids that can form 
liposomes upon polymerisation in solutions. Structurally ordered 
diacetylene monomers in either vesicle forms, or thin films can be 
polymerised by the application of 254nm UV light in solution.
[99] [100]  
Ɣ-radiation can also be used to polymerise solid powders of 
diacetylenes.
[39] Upon irradiation the diacetylenes undergo a 1,4-addition 
to form ene-yne polymer chains.
[99] [100] [39] [101] The polymerisation will only 
proceed when the diacetylenes are in a structured lattice with the 
required geometry to undergo the 1,4-addition. Propagation of the 
polymerisation is thought to be from a dicarbene species.
[101] This 
polymerisation mechanism can be seen in Figure 4.2.  
The resulting blue materials can undergo a colour change to red 
upon addition of a stimulus. The colour change is caused by the 
perturbation of the conformation of the polymer such that there is an  
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increase in rotational freedom leading to the decrease in coplanarity and 
so the length of effective conjugation is reduced and the backbone is de-
symmetrised.  
 
 
Figure 4.2. 1,4-addition ene-yne polymerisation of diacetylene chains. 
 
In addition to a distinct colour change from blue to red, it has been 
observed that there is an activation of fluorescence upon the change from 
blue to red. The mechanism for fluorescence switching is not fully 
understood, however, it is thought to occur by the radiative decay of the 
lowest excited state Bu. In the blue phase this excited state has an Ag 
symmetry that has the dipole forbidden transition for the decay from the 
singlet excited state and so no fluorescence is possible. In the red phase 
this excited state is no longer symmetrical and the decay is an allowed 
transition, thus producing a fluorescent emission spectrum.
[39] 
This transformation makes this type of substrate valuable in the 
synthesis of chemo and biosensors. Functionalisation of the diacetylene 
prior to polymerisation allows for the incorporation moieties that can 
interact with a great deal of substrates leading to a large scope for the 
potential application of sensing materials.
[39] The polydiacetylene 
structures can be sensitised to a great number of types of stimuli that can 
range from thermal,
[102] chemical,
[103] electrochemical,
[104] and 
biological.
[39] 
[99] However, the observed colour change is typically 
irreversible, where once the colour change has occurred the 
polydiacetylene materials will not revert back even once the initial  
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stimulus has been removed. Figure 4.3 shows a schematic of the 
possible interactions available for use in PDA sensing applications.  
 
 
Figure 4.3. A schematic representation of the possible interactions that can be 
incorporated into colorimetric polydiacetylene sensors.
[39] 
 
Polydiacetylene liposomes and thin films make good sensing 
substrates due to the signal amplification and easy readout of a positive 
signal. Work carried out by Charych and co-workers have shown that it is 
possible to create thin films or liposomes that are selectively sensitive 
down concentrations of 10 
-10 M.
[105]  
Several polydiacetylene systems have been synthesised. The 
incorporation of a sialic acid functionalised diacetylenes in a mole ratio of  
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5% sialic acid diacetylene to 95% pentacosadiynoic acid produced a 
liposomal suspension that was sensitive to the influenza virus. The 
influenza virus binds to the α-glycolipid of the sialic acid. Upon viral 
binding to the sialic acid, the colour of the sensor changes from blue to 
red. The transformation can be measured by observing UV-Vis 
absorption, where the λmax of the blue phase = ~630 nm; binding converts 
the liposome or film to the red phase and a change in λmax to ~550 nm 
occurs.
[105] The structure of the sialic acid diacetylene is shown in   
Figure 4.4. 
 
 
Figure 4.4. Structure of sialic acid diacetylene 
 
Correspondingly, it was found that the non-covalent incorporation 
of gangliosides in the presence of a promoter diacetylene with 
pentacosadiynoic acid could produce sensors that were selective for 
specific neurotoxins.
[105] Two gangliosides were incorporated into the 
PDA matrix, GT1b and GM1. GT1b which is a ganglioside found in the 
neuromuscular junction, which is the target for the botulinum toxin 
responsible for botulism. GM1 ganglioside is found on the nerve cells in 
the intestines and is affected by the cholera toxin.
[105] The gangliosides 
GT1b and GM1 are shown in Figure 4.5. 
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Figure 4.5. Structure of gangliosides GT1b, and GM1. 
 
It was found that the matrices formed with the gangliosides 
inserted required a promoter diacetylene present in order to induce a 
colour change upon binding of the required toxin.
[105] The promoter 
molecules could be either the sialic acid diacetylene or a lactose derived 
diacetylene.
[105] Optimal ratios of ganglioside, promoter and 
pentacosadiynoic acid were defined as 5% ganglioside : 2-5% promoter 
diacetylene to 90-93% pentacosadiynoic acid. Above these ratios the 
resulting matrix became unstable.
[105] In particular the lactose diacetylene 
was found to form unstable polymer arrays when in concentration above 
2%, whereas the sialic acid formed stable arrays at up to 5% 
concentration.
[105] The promoter compounds were found to not participate 
in the binding event with the toxins, but were required for a colour change 
upon binding to occur. It was thought their function was to lower the 
activation energy for the transformation from blue to red.
[105] It was also 
suggested that the interaction between the ganglioside and the toxin 
interfered with the promoter diacetylenes headgroup via steric 
interactions inducing the colour change observed.
[105]  
The introduction of other toxins and agents, including the pertussis 
toxin, diphtheria toxin and BSA in addition to changing the pH and salt 
conditions gave a baseline colorimetric response of 5% and showed that 
the films were selective for their required toxins.
[105] It was found that the  
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sensing materials underwent chromaphoric changes rapidly, such that 
within one second of the addition of the substrate, 75% of the colorimetric 
response (CR) had occurred.
[105] This is exemplified by the addition of the 
cholera toxin to the films functionalised with GM1, as shown in Figure 4.6. 
The formula to calculate the CR is given by Equation 4.1. 
 
Figure 4.6. A) UV-Vis spectra for cholera toxin addition over time. B) Graph of the 
colorimetric response plotted % vs time. 
[105]* 
 
      
   
                
1 
AB0 /AR0 signifies the intensity at  
λ = 550 / 630 nm prior to addition of 
stimuli 
 
      
   
                
2 
AB1 /AR1 signifies the intensity at  
λ = 550 / 630 nm after the addition of 
stimuli 
 
               
  
      100% 
3 
Colorimetric Response calculation 
as a percentage change relative to B0 
 
Equation 4.1. Formulae for calculating the colorimetric response of polydiacetylene sensor. 
 
Although most polydiacetylenes have irreversible colorimetric 
switching, there have been examples where the colour change can be 
made to be reversible. Zou and co-workers have successfully produced 
A  B  
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reversible thermochromatic PDA films.
[106] They incorporated 
functionalised azobenzene dyes into the diacetylene moiety. Nitro, cyano 
and methyl groups at the 4 position of the azobenzene group have been 
used.
[106] The structures of the functionalised diacetylenes are shown in 
Figure 4.7.  
Thin films of the 1% solutions of azobenzene diacetylenes were 
cast onto silicon wafers prior to irradiation with UV-light. It is thought that 
the dye molecules increase the π-π stacking interactions between the 
side chains of the polydiacetylene in such a way that stabilises the 
liposome conformation to increased temperature. 
 
O
O
O
N
N R
R = Me, NO2, CN
Figure 4.7. Structure of the derivatised Azobenzene diacetylenes. 
 
It was found that the films underwent three transitions upon 
heating.
[106] Generally, from room temperature to above 50 °C the films 
changed colour from blue to purple.
[106] From > 50 °C up to 75 °C the 
films changed to red from purple.
[106] This transformation was fully 
reversible and the films went blue upon cooling back to room 
temperature. Heating to 150 °C produced films that were partially 
reversible, where cooling produced a purple colour that did not revert 
back to blue. Increasing the temperature to up to 170 °C caused the films 
to become irreversibly red.
[106] By increasing the temperature further to 
above 170 °C, the films turned yellow; an effect that was attributed to 
melting effects, that once cool reverted back to red.
[106] This 
transformation is shown schematically in Figure 4.8. The critical 
temperatures for each functionalised azobenzene polydiacetylene film 
were measured. It was found that the films made from the cyano  
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functionalised azobenzene diacetylene were the most stable of the films 
produced. The data recorded is shown in Table 4.1. 
 
Blue Purple Red Yellow Red Red >50oC> 1 0 5 oC >75oC> 1 5 0 oC >170oC
Reversible
Partially
Reversible
Irreversible
<105oC
<150oC
<170oC
 
Figure 4.8. Schematic of reversibility of the functionalised polydiacetylene films. 
 
Azobenzene TM °C TD °C TL °C  TH °C 
Nitro 182  291  60  160 
Cyano 188  289  57  162 
Methyl 173  286  50  154 
TM = Melting Temp. TD = Decomposition Temperature. 
TL = Reversibility Temperature. TH = Irreversiblity Temperature 
Table 4.1. Critical Temperatures for the azobenzene polydiacetylene films. 
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4.2. Aims and Objectives. 
 
Naphthalene and ferrocene functionalised diacetylenes were 
targeted as initial aims for the formation of polydiacetylene liposomes, 
The ferrocene functionalised diacetylene was formed on the premise of 
achieving a redox active liposome that could interact with both   
β-cyclodextrin and β-cyclodextrin polymers. The naphthalene 
functionalised diacetylene was produced on the basis that addition of 
CBPQT
4+ might not only give a colorimetric response, but also the binding 
might be measured by the change in fluorescence. The target 
diacetylenes are shown below in Figure 4.9. 
 
 
Figure 4.9.Functionalised diacetylene target molecules. 
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4.3. Results and Discussion. 
 
4.3.1 Synthesis of functional diacetylene monomers. 
 
Scheme 4.1.Synthesis of functionalised ferrocene diacetylene via the PDA acid chloride. 
 
The synthesis of the functionalised diacetylenes was initially 
attempted via the formation of the 10,12-pentacosadiynoic acid chloride 
followed by the treatment with the required amine, as shown in   
Scheme 4.1. When it was found that this route failed to yield the required 
ferrocene functionalised product 33, coupling reactions using EDCI were 
carried out successfully. The coupling of the amine 25a with   
10,12-pentacosadiynoic acid (PDA) gave the required functionalised 
diacetylene 33. This compound was fairly light sensitive and all work up 
conditions were carried out in the dark. 
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Scheme 4.2. Synthetic scheme for the synthesis of the ferrocene diacetylene monomer 33. 
 
The ferrocene amine 25a was synthesised from the carboxylic acid 
starting material via the acid chloride intermediate as previously 
described in §2.3.2. The EDCI coupling between the freshly prepared 
ferrocene amine 25a with 10,12-pentacosadiynoic acid gave the required 
diacetylene as a glassy orange solid in a 34% yield, as shown in   
Scheme 4.2. 
 
 
Scheme 4.3. Synthetic scheme for the synthesis of the naphthalene diacetylene 7. 
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The naphthalene diacetylene 7 was formed by an EDCI coupling 
reaction from the freshly prepared naphthalene amine 5a in a 60% yield 
as a pale blue light sensitive solid as indicated in Scheme 4.3. The 
synthesis of the naphthalene amine from the 1,5-dihydroxynaphthalene is 
described in § 2.3.1. 
 
4.3.2 Liposome Formation and Analysis. 
 
The liposomes were formed by following the protocol described by 
Ahn and co-workers.
[107] First the diacetylenes were dissolved in 
chloroform and the solvent was evaporated using nitrogen gas. The thin 
layers of diacetylenes formed was then suspended in water and heated to 
70-80C for 15 minutes. This heating was then followed by sonication at 
70-80C for 15 minutes and the mixture was then immediately filtered 
through 0.8m filters. The filtrate was then stored at 4C for 18 hours 
prior to irradiating with UV light. All work was carried out in the dark and 
the samples were wrapped in tinfoil to avoid exposure to the lights from 
the overhead lighting. The samples were irradiated with 254 nm UV light 
for 15 minutes. A colour change from clear to blue indicated that 
liposomes had been created. The reaction set up is illustrated in   
Figure 4.10.
[107] 
 
 
Figure 4.10. Illustration of general liposome formation procedure.
[107] 
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A number of ferrocene liposomes were attempted, where variable 
amounts of FcDA were mixed with pentacosadiynoic acid (PCDA). 
However, the successful formation of the liposomes varied to a large 
degree. The only consistent formulation was that of the 100% ferrocene 
diacetylene and the 100% PCDA liposome. The 10% FcDA liposomes 
failed to form in all bar one instance. The 20, 40, 60, and 80% FcDA 
liposomes formed liposomes to different degrees that were not 
consistently reproducible. The intensity of the blue solutions produced 
was fairly low. It should be noted that at the point of filtration there was a 
large amount of undissolved material left, thus reducing the amount of 
liposomes that could be polymerised. The UV-Vis of PCDA 
polydiacetylene and the 100% ferrocene polydiacetylene (FcDA) are 
shown in Figure 4.11. 
 
 
Figure 4.11. UV-Vis of polydiacetylene liposomes. 
 
UV-Vis experiments were carried out on samples of the 100% 
PCDA and 100% ferrocene polydiacetylene liposomes with poly   
-cyclodextrin,
[108] then adamantanol, and with -cyclodextrin. To 2 mL 
samples of 100% FcDA liposome varying quantities of β-cyclodextrin 
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polymer were added; 10
-2 M, 2x10
-2 M, and 3x10
-2 M, where the FW = 
3000 g/mol. The structure of the polymer is shown in Figure 4.12.
[108]  
 
 
Figure 4.12. Structure of the β-cyclodextrin polymer. 
[108] 
 
The colour of each sample changed from blue to shades of 
purple/pink with increasing amounts of -cyclodextrin polymer. The 
spectra are shown in Figure 4.13. The colorimetric response (CR) of the 
liposomes to the -cyclodextrin polymer were calculated where the Ablue 
was measured at λ = 646 nm and Ared was measured at λ = 548 nm. It 
was found that the CR for these liposomes was 51% after the addition of 
3 equivalents of the polymer. The CR was measured using Equation 4.2. 
 
         
  
       100 
Equation 4.2. Formulae for 
calculating the colorimetric 
response. 
 
      
      
                     
x = before (0) / after stimuli (1) 
 
To each of these samples varying quantities of adamantanol were 
added; 10
-2 M, 2x10
-2 M, and 3x10
-2 M. The adamantanol failed to fully  
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dissolve and had little or no effect on the colour of the samples. The 
addition of -cyclodextrin to 2 mL samples of 100% FcDA liposome 
caused the liposomes to turn pink and partially precipitate out of solution. 
The cloudy pink suspension that resulted failed to settle and remained 
cloudy even after filtering to the point that the UV-Vis spectrum could not 
be recorded.  
 
 
Figure 4.13. UV-Vis of FcDA liposome with β-cyclodextrin polymer. 
 
The corresponding experiments were carried out on 2.5 mL 
samples of the PCDA liposomes. As the -CD polymer was added the 
solutions also turned purple / pink. Figure 4.14 shows the spectra 
recorded for the addition of -cyclodextrin polymer to the PCDA 
liposomes. Similarly, addition of adamantanol also had no effect on the 
PCDA liposomes. The addition of -cyclodextrin to 2.5 mL samples of 
100% PCDA liposomes had no effect, with the -cyclodextrin failing to 
completely dissolve. The intensity of the colour change relative to that of 
the FcDA liposomes and -CD polymer is reduced with a slight max blue 
shift of 10 nm and 7 nm as shown in Figure 4.15. The colorimetric 
response using ABlue λ = 641 nm and Ared λ = 531 nm was found to be 
after three equivalents of -CD polymer to be 54.8%. From the results it  
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can be seen that there are some subtle differences between the FcDA 
and the PCDA liposomes. 
 
 
Figure 4.14. UV-Vis of PCDA liposome with β-cyclodextrin polymer. 
 
 
Figure 4.15. UV-Vis of the liposomes with 3x10
-2 M of β-cyclodextrin polymer added. 
 
Dynamic light scattering (DLS) was used to measure the size of 
the liposomes formed. Of the liposomes formed the results from the DLS  
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showed that with increasing amounts of the ferrocene the size of the 
liposomes increased. In this instance the 20% FcDA liposome 
precipitated out of the water before DLS could be measured. As can be 
seen from Table 4.2, the sizes of liposomes formed varied from one batch 
to another. This may be due to the amounts of ferrocene diacetylene that 
successfully dissolved into the aqueous media at the formation of the 
liposomes prior to polymerisation. It was also found that the liposomes 
started to aggregate under the fluorescent lighting over time. 
 
Liposome ZAv (nm) PdI Diameter  (nm) %age  Width 
(nm) 
100% FcDA  134.6  0.251  186.9  100  111.4 
100% FcDA  132.8  0.223  175.0  100  99.22 
10% FcDA  123.8  0.196  155.3  100  75.67 
40% FcDA  133.3  0.169  164.6  100  81.05 
100% PCDA  146.6  0.361  207.1  98.2  129.6 
Table 4.2. DLS measurements for the liposomes formed. 
 
As the 100% Fc DA liposome consistently formed under the 
conditions described above we decided to concentrate upon the 
interactions that could be observed compared to those found with the 
100% PCDA liposomes. It was also found that the PCDA liposome was 
generally a larger size with ZAv (d.nm) = 146.6nm while the 100% FcDA 
liposome had ZAv
  (d.nm) = 132.8nm liposome. Figure 4.16 shows the 
graphical data obtained for the 100% ferrocene diacetylene liposome. 
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Figure 4.16 DLS data recorded for FcDA liposome. 
 
Cyclic voltammery experiments were run in 0.1 M sodium chloride 
solutions against a silver/silver chloride electrode. The redox wave for the 
FcDA liposome was recorded, where the half wave potential E½ was 
recorded as 0.55 V. 10
-2 M of the β-cyclodextrin polymer was then added 
to the solution and the redox wave was then recorded for the complex. It 
was found that the half wave potential had shifted to 0.6 V. The shift in 
the half wave potential showed that the ferrocene had interacted with the  
β-cyclodextrin polymer in a manner that hindered the oxidation reduction 
process. The cyclic voltammogram for the 100% PCDA liposome was 
also performed to show that the redox activity came purely from the 
ferrocene moiety. The cyclic voltammograms for the FcDA liposome with 
the addition of β-cyclodextrin polymer is shown in part A of Figure 4.17. 
Part B shows the CV spectrum recorded for the PCDA liposome. 
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Figure 4.17. CVs of A) FcDA liposome (red) with β-cyclodextrin (blue) B) 100% PCDA 
liposome. 
 
Formation of liposomes using the naphthalene diacetylene 7 was 
also attempted. Different ratios of the naphthalene diacetylene with 
pentacosadiynoic acid were performed, however, on every occasion no 
liposome formation occurred. Increasing temperature and sonication 
times appeared to have no effect on the formation of the liposomes. 
Extended irradiation of the samples also had no effect on this substrate. 
After filtration there was a significant amount of the diacetylene starting 
materials remaining, indicating that the solubility of the material may have 
had a significant effect on the formation of the liposomes.  
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4.4 Conclusions and Future Work. 
4.4.1. Conclusions. 
 
In conclusion two functionalised diacetylenes have been 
synthesised in good yield from the chosen substrates. Using these 
functionalised diacetylenes, the formation of functionalised liposomes 
with pentacosadiynoic acid has been investigated with varying success. 
The most successful formulation came from the 100% ferrocene 
diacetylene.  
Analysis of the 100% ferrocene diacetylene liposome has shown 
that the ferrocene can undergo host-guest interactions with both   
β-cyclodextrin and β-cyclodextrin polymer. UV-Vis experiments showed 
that the chromaphoric shifts upon addition of β-cyclodextrin polymer for 
the ferrocene liposome was red shifted by up to 10 nm relative to the 
shifts observed for the PCDA liposomes with β-cyclodextrin polymer. 
Additionally, the colorimetric response for the ferroecene based 
liposomes was reduced in comparison to the measured response for the 
PCDA liposomes.  
DLS measurements have shown that the average size of the 
ferrocene liposomes is significantly smaller than that of the 
unfunctionalised PCDA liposome. From the cyclic voltammetry 
experiments it can be seen that the ferrocene liposomes are redox active, 
where addition of β-cyclodextrin polymer modulates the half wave 
potential by up to 0.05V. 
Failure to form the naphthalene functionalised liposomes may 
have been due to the insolubility of this substrate in aqueous media.  
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4.4.2. Future Work. 
 
As an extension to the work carried out, further investigation into 
the different percentages of functionalised diacetylene liposomes would 
have been carried out. The effect of lower percentages of FcDA on the 
redox activity could be investigated. 
Further tuning of the procedure to form the naphthalene 
functionalised liposomes could be investigated, where variation of the 
ratios of naphthalene diacetylene : pentacosadiynoic acid could be 
performed. Once these liposomes had been formed, analysis to 
investigate host-guest complexation with CBPQT
4+ and the displacement 
by the addition of TTF could have been carried out using techniques such 
as UV-Vis, fluorescence, ITC and CV.  
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5.  
Pseudorotaxanes as tunable micelles. 
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5.1. Introduction. 
 
Surfactant molecules consist of a polar head group and a non-
polar tail. The polar head group can be cationic, anionic, amphoteric or 
non-ionic.
[109] Examples of the different types of surfactant include sodium 
dodecyl sulfate (SDS), cetyl trimethylammonium bromide (CTAB), 
cocamidopropyl betaine (CAPB) and palmityl alcohol.
[109] Surfactant 
molecules lower surface tension and can reduce the interfacial tension 
between two liquids.
[110] Surfactants can be naturally occurring or 
synthetic. The general structure is illustrated in Figure 5.1. 
 
 
Figure 5.1. Illustration of a typical surfactant molecule. 
 
Surfactant molecules in solution will spontaneously form 
disordered aggregates called micelles once the concentration of 
surfactant molecules has reached or surpassed a critical level, referred to 
as the critical micelle concentration (CMC).
[109] The formation of these 3-D 
structures is fully reversible where the individual molecules are held 
together by non-covalent interactions such as the hydrophobic effect.
[111] 
Micelles tend to be either spherical or cylindrical in shape. It has been 
shown that spherical micelles will aggregate to form rod-like structures 
when the concentration of the micelle solution rapidly increases.
[112]  
Micelles have two forms in which they can assemble: micellar and 
reverse micellar structures. Normal micelles present the polar head 
groups to the aqueous solvent, while the alkyl, non-polar tails are found 
inside the structure.
[112] Reverse micelles have the non-polar tails on the  
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outside; presented to the solvent, while the head groups are found inside 
the micelle.
[112] Reverse micelles mimic cellular environments, where the 
non-polar tails form an effective barrier between the organic solvent and 
the water within the cavity of the micelle and can fit proteins within the 
cavity formed.
[113] 
[114] The two forms are shown in Figure 5.2. The 
formation of reverse micelles over micelles can be controlled by tuning 
the proportions of water to non-polar solvent ratios present. It has been 
found that micelles are fairly stable, where there is evidence of the 
retained structures in the gas phase.
[112] The applications for micelles and 
individual surfactant molecules are wide ranging: from detergents,
[111] to 
use in biomolecule trapping
[112] and protein folding
[113] to the mediation of 
nanoparticle formation processes.
[115] 
[116] 
 
 
A B 
Figure 5.2 Illustration of A) Micelle structure. B) Reversed micelle structure. 
 
Examples of the potential applications include work carried out by 
Sharon and co-workers.
[112] The properties of CTAB micelles were 
investigated by electrospray mass spectroscopy. CTAB micelles were 
prepared by two different methods in order to form normal and reversed 
micelles. Micelles were first formed by the dissolution of CTAB into 
aqueous solutions of ammonium acetate at pH 7.0 or 8.0. The 
concentration of the CTAB used was 8.5 mM to ensure that micelle  
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formation occurred.
[112] The reverse micelle form was produced by 
dissolving the CTAB into hexanol under sonication conditions. Aliquots of 
water, 10 mM ammonium acetate, or 200 mM ammonium acetate were 
added to enhance the solubility and so the micellisation process. After 
allowing the solution to equilibrate for 24 hours, horse heart myoglobin in 
water was added, and the mixture was sonicated until a clear micelle 
solution was formed.
[112] The structure of CTAB and illustrations of the 
resulting micelles are shown in Figure 5.3.
[112] 
 
A 
 
B 
 
C 
Figure 5.3. A) Structure of CTAB molecule and illustrations of B) micelle and  
C) reversed micelle.
[112] 
 
Analysis by electrospray mass spectroscopy and tandem mass 
spectroscopy was carried out on the micelle samples. 
[112] The solutions 
were rapidly evaporated under high pressure to create the mass 
spectroscopy samples. The results showed that ion exchange had 
occurred with the micelles created from the aqueous method, where the 
bromide was exchanged with acetate ions.
[112] Salt exchange did not 
occur with the reverse micelles where the polar head group was 
orientated within the core of the micelle structure.
[112] 
The results showed that the micellar structures were retained in 
the gas phase. Additionally, it was found that the micelles were larger 
than the expected size of ~ 90 CTAB molecules per micelle.
[112] The 
normal micelles were measured to by > 500 molecules in size. Mass 
spectroscopy of the reversed micelles showed that the horse heart 
myoglobin was successfully incorporated into the cavity of the micelle. It  
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was also found that for every 1 myoglobin there were 230 - 310 CTAB 
molecules per micelle.
[112] The large micelle sizes were attributed to the 
aggregation and coalescence of smaller spherical micelles into larger   
rod-like structures as a result of the evaporation processes used to create 
the samples for MS analysis.
[112] The MS results are shown in   
Figure 5.4.
[112] 
 
 
Figure 5.4. Comparison of tandem mass spectra at m/z 10 000 for regular micelles in 200 
mM ammonium acetate (A), reverse micelles in H2O (B), and reverse micelles incorporating 
myoglobin in 10 mM ammonium acetate (C). 
[112] 
 
Furthermore, work carried out by He on the formation polymer 
based micelles shows the phase transfer applications for micellar 
constructs.
[117] 
[118] Block co-polymers made of poly((1,2-butadiene)-block-
ethylene oxide) (PB-PEO) spontaneously form micelles with the 
poly(butadiene) block segregated within the core of the micelle,  
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presenting the poly(ethyleneoxide) chains to the solvent of choice. Ionic 
liquid; 1-butyl-3-methylimidazolium hexafluorophosphate [BMIM] [PF6] 
and water will readily form these micelle structures.
[118] The general 
structures whether spherical, cylindrical or vesicle form was dictated by 
the length of the PEO block relative to the PB block of the polymer.  
The micelles were formed from a 1 wt% solution into [BMIM] [PF6]. 
Water was then added to reach from a 1:1 ratio of water to [BMIM] [PF6]. 
The mixtures were agitated to allow the micelles to adequately form. After 
equilibration at room temperature, it was found that the micelles resided 
within the aqueous layer.
[117] The micelles were a pale blue colour, so the 
location of the micelles were easily identified by the colour change of the 
layer from clear to opaque blue.
[117] Upon gradual heating up 75 °C with 
gentle stirring, the micelles started to migrate from the aqueous layer into 
the BMIM.
[117] By 90 °C all micelles resided within the ionic liquid layer. 
Cooling to room temperature led to the transfer back to the aqueous 
layer.
[117] This process was repeated successfully ten times, showing that 
the micelles are thermally stable to repeated heating and cooling 
cycles.
[117] 
The hydrodynamic radius (Rh) and size distribution was measured 
by DLS for micelles at 25 °C, 75, and 90 °C.
[117] It was found that the 
typical size of the micelles formed was ~80 nm. In aqueous solutions with 
increasing temperature it was found that the solvent character changed, 
and the ability of the water to solvate the PEO decreased, leading to a 
contraction of the Rh from 61 nm down to 57 nm.
[117] Previously it had 
been shown that the Rh for micelles in [BMIM] [PF6] did not vary 
significantly with increasing temperature up to 100 °C.
[117] The cycling 
from the aqueous to the ionic liquid with increasing temperature is shown 
in Figure 5.5. 
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Figure 5.5. Schematic illustration of the round trip of PB-PEO micelles between the [BMIM] 
[PF6] and water layers, accompanied by experimental images at each temperature. 
[117] 
 
Formation of the micelles in water under similar conditions to the 
formation in [BMIM] [PF6], led to a change in size distribution, the shape 
of the micelles formed, and the Rh of the micelles
[117],
[118]. However, from 
the data recorded, transfer from the [BMIM] [PF6] layer into the aqueous 
layer, showed very little variation in size distribution and Rh.
[117] This 
indicated that the micelles were preserved and crossed the liquid 
interface intact, rather than dissociating and then reforming from one 
layer to the other. The Rh data recorded is shown in Figure 5.6. 
[117] 
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Figure 5.6. Hydrodynamic radius of the PB-PEO micelles in three different solutions  
(1 wt %) by DLS at ambient temperature. 
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5.2.  Aims and Objectives. 
 
The aims of this project were to produce derivatised 
trimethylammonium bromide surfactant molecules that could form 
pseudorotaxanes with the cyclophane CBPQT
4+. Additionally it was 
hoped that these surfactant molecules could form mxed micelles with the 
surfactant sodium dodecyl sulfate (SDS), such that further host-guest 
interactions with CBPQT
4+ could be used to control the assembly and 
disassembly of the micelle. Initial targets focused upon naphthalene and 
tetrathiafulvalene systems as shown in Figure 5.7. 
 
 
 
Figure 5.7. Naphthalene trimethylammonium bromide (9) and  
Tetrathiafulvalene trimethylammonium bromide (45). 
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5.3.  Results and Discussion. 
 
5.3.1.  Synthesis of functionalised trimethylammonium bromide 
surfactants. 
 
5.3.1.1.  Synthesis of naphthalene based surfactant (9). 
 
 
Scheme 5.1. Synthesis of the naphthalene compound 9. 
 
The synthesis of the naphthalene functionalised trimethyl 
ammonium bromide compound 9 from the starting naphthalene diol 2 is 
shown in Scheme 5.1. The reaction of the naphthalene diol 2 to form the 
naphthalene bromide 8 proceeded with the major product formed being 
the required monobrominated product 8 in a 44% yield. Any unreacted 
starting material was recovered in the purification step such that it could 
be recycled as required. The transformation of the monobrominated 
naphthalene product 8 into the trimethylammonium bromide 9 was high 
yielding with very little work up required. The removal of the solvent by 
reduced pressure also removed the majority of any unreacted 
trimethylamine from the product. The material was precipitated out of 
solution and washed thoroughly to remove any traces of the unreacted 
trimethylamine to afford target 9 in a 90% yield. 
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5.3.1.2.  Synthesis of TTF hexan-1-one-6-Trimethyl ammonium 
bromide.  
 
 
Scheme 5.2. The synthesis of compound 54 from TTF. 
 
Starting from tetrathiafulvalene (51), the trimethylammonium 
bromide functionalised TTF compound (54) was prepared in a two-step 
synthesis, as shown in Scheme 5.2. First the TTF was reacted with   
n-butyl lithium at -78°C to form the lithiated species (52).
[119] This 
compound was then reacted in situ with 6-bromohexanoyl chloride to 
form the 6-bromo-hexanoyl TTF compound (53).
[119] Purification of this 
product was non-trivial requiring three silica column chromatographs to 
gain pure product in a 12% yield. Displacement of the bromide by heating 
to reflux in methanol with trimethylamine gave the compound 54 as a 
dark red/ brown solid. The pure product was recovered by repeated 
precipitation from methanol by the addition of diethyl ether. Due to the 
reduced amounts of the TTF derivative that were synthesised only the 
minimal analysis was carried out, and optimisation of experimental 
procedures was carried out using the naphthalene derivative. 
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5.3.2.  Complexation of 9 with CBPQT
4+. 
 
The interaction between the monomer 9 with CBPQT
4+ 61 to form 
the pseudorotaxane as shown in Scheme 5.3, was investigated by a 
number of techniques including ITC, 
1H NMR, fluorescence and UV-Vis 
prior to studying the effects of incorporation of compound 9 into SDS 
micelles. 
 
 
Scheme 5.3. Pseudorotaxane formation of compound 9 with CBPQT
4+ 61. 
 
5.3.2.1. Isothermal  Titration  Calorimetry of compound 9 with 
CBPQT
4+. 
 
ITC was carried out on the naphthalene trimethylammonium 
bromide 9 with CBPQT
4+ in water. The experimental details are shown in 
Table 5.1. Initially the interaction appeared to be incomplete such that the 
intensity of the peaks produced did not diminish fully to that of dilution 
effects. However, reduction of the cell concentration had very little effect 
on the data produced. The data collected for the titration using the lower 
cell concentration were fitted to a single-set-of-sites binding model. The 
thermodynamic data calculated from the single set-of-sites binding model 
are shown in Table 5.2. The recorded data is shown in Figure 5.8. 
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Experiment  Contents of Cell  Contents of Syringe 
1 Water  CBPQT
4+ 4Cl
- 1.00 mM 
2 Nap  Me3N
+ Br
- 0.051 mM  CBPQT
4+ 4Cl
- 1.00 mM 
3 Nap  Me3N
+ Br
- 0.021 mM  CBPQT
4+ 4Cl
- 1.00 mM 
Table 5.1. Experimental details of for the ITC of the naphthalene trimethylammonium 
bromide with CBPQT
4+. 
 
N  3.18 ± 0.22 
Ka (M
-1)  8265 ± 553.3 
∆H (cal mol
-1)  -6527 ± 590.7
∆S (cal mol
-1K
-1) -3.97 
Table 5.2. Thermodynamic data from the titration of CBPQT
4+4Cl
- into NapMe3N
+Br
- 9. 
 
The binding stoichiometry N was found to be greater than 1. This 
may be associated with salt exchange with the bromide / chloride counter 
ions, or a change in pH with increasing injections of CBPQT
4+ 4Cl
- into 
naphthalene trimethylammonium bromide, 9. It may indicate that weak 
external stacking interactions occur between the CBPQT
4+ and the 
naphthalene moiety, although this interaction is not evident in other 
analyses of the complex.  
The binding constant Ka was found to be diminished in value 
relative to the Ka recorded for the diol 2 with CBPQT
4+, where the Ka was 
measured as 1.48 x10
6 M
-1.
[86] The reduction in Ka indicates that the 
trimethylammonium moiety has a slightly repulsive interaction with 
CBPQT
4+ which in turn reduces the overall binding stability of the 
complex. 
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Figure 5.8. ITC data for 9 with CBPQT
4+ in water. 
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5.3.2.2. 
1H NMR study with CBPQT
4+.  
 
The 
1H NMR spectrum of the complex formed by CBPQT
4+ and 9 
was obtained in D2O. The solution was an intense purple colour upon 
mixing the two components together, indicating that the pseudorotaxane 
had formed. The spectrum produced exhibited the typical shifts expected 
for the formation of the pseudorotaxane, where the H4/8 protons had 
shifted from their position in the aromatic region at 7.87 ppm and 7.81 
ppm down to 2.47 ppm. The proton shifts for the complex relative to each 
component is shown in Table 5.3. The stacked spectra for these 
experiments are shown in Figure 5.9. 
 
δ : CBPQT
4+  
(ppm) 
δ : Complex 
(ppm) 
δ : NapMe3N
+Br
-
(ppm) 
∆δ component 
(ppm) 
9.03 (Hα) 
9.07 
 
+0.04 
8.89 -0.14 
7.55 (Hben) 7.96  +0.41 
8.20 (Hβ) 
7.53 -0.67 
7.41 -0.79 
 
6.36 7.44  (H2/6) -1.08 
6.07 
7.05 (H3/5) -0.98 
7.04 (H3/5) -0.97 
5.77 (CH2) 5.79    +0.02 
 
4.33 4.30  +0.03 
4.27 4.25  +0.02 
4.19 3.91  +0.04 
3.95 3.65  +0.30 
3.80 3.41  +0.40 
3.28 2.99  (Me3) +0.29 
2.47 
7.87 (H4/8) -5.4 
7.81 (H4/8) -5.34 
Table 5.3. 
1H NMR Shifts of CBPQT
4+ and NapMe3N
+ upon complexation.  
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Figure 5.9. Stacked 1H NMRs of NapMe3N
+ (red), CBPQT
4+(blue) and 
 the 1:1 complex (green). 
 
 
5.3.2.3.  UV-Vis and Fluorescence Spectroscopy. 
 
In addition to the 
1H NMR experiments, UV-Vis and fluorescence 
spectroscopy experiments were carried out on the complex with 
CBPQT
4+. The UV-Vis spectrum was performed on 1 mM solution of the 
complex in water. The recorded spectrum showed that band expected for 
the formation of the psuedorotaxane with λmax = 518 nm. Fluorescence 
measurements were recorded for the naphthalene trimethylammonium 
bromide in water at a concentration of 1 x 10
-5 M. The spectrum produced 
with the excitation wavelength of λ = 295 nm was found to be of the form 
expected for the naphthalene moiety. Addition of one equivalent of 
CBPQT
4+ to the aqueous solution formed a pink solution that was typical 
for the pseudorotaxane formation. The fluorescence spectrum produced 
by the complex was found to be reduced in intensity, indicating that the 
CBPQT
4+ was quenching the fluorescence of the naphthalene moiety.  
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The graphs for both the UV-Vis and the fluorescence are shown in   
Figure 5.10. 
 
 
 
Figure 5.10. A). UV-Vis spectrum of 9+ 61 10
-3 M B). Fluorescence spectra recorded for  
9 + 61 10
-5 M. All measurements recorded at room temperature in water. 
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5.3.3.  Micelle Formation and Analysis. 
 
5.3.3.1. 
1H NMR titration studies of Naphthalene 
trimethylammonium bromide 9 with SDS. 
 
 
The micelle formation with monitoring by 
1H NMR was based upon 
a procedure published by Nowick and co-workers.
[120] To a sample of the 
naphthalene trimethylammonium bromide (9) in D2O at a concentration of  
1 mM, were added sequentially 1.8 µl aliquots of a 0.8 M solution of SDS 
in D2O. After each addition the 
1H NMR spectrum was recorded. The 
positions of key protons are shown in Table 5.4. The combined spectra 
recorded for the naphthalene trimethylammonium bromide 9 with SDS 
added is shown in Figure 5.11, where the key protons noted in Table 5.4 
are labelled. 
 
Peak 
(δ) / 
ppm 
A B  c1  c2  d1  d2  I 
0µl  7.87 7.81  7.44  7.44  7.05 7.04 2.99 
1.8µl  7.76 7.73  7.36  7.26  6.87 6.76 2.95 
3.6µl  7.79 7.76  7.38  7.28  6.91 6.79 2.99 
5.4µl  7.80 7.77  7.40  7.30  6.96 6.85 3.05 
7.2µl  7.81 7.78  7.41  7.31  6.98 6.87 3.07 
9.0µl  7.81 7.79  7.42  7.32  6.99 6.89 3.08 
10.8µl  7.82 7.79  7.42  7.32  6.99 6.89 3.09 
12.6µl  7.82 7.79  7.42  7.32  6.99 6.89 3.09 
14.4µl  7.82 7.79  7.42  7.32  6.99 6.89 3.09 
16.2µl  7.82 7.79  7.42  7.32  6.99 6.89 3.09 
Table 5.4. Positions of key protons on the naphthalene trimethylammonium bromide with 
increasing amounts of SDS. 
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Figure 5.11. 
1H NMR spectra of 9 with increasing aliquots of SDS. 
 
As the SDS was added to the 9 a negative movement of the 
aromatic naphthalene protons occurred. The two doublets at 7.87 ppm 
and 7.81 ppm started to draw closer together. Subsequent titrations 
showed a shift up towards 7.82 ppm and 7.79 ppm, eventual peak 
movement stopped after 9.0 µl SDS. The triplet at 7.44 ppm split into two 
smaller triplets with a negative shift of ~0.1 and 0.2 ppm towards 7.36 
ppm and 7.26 ppm was observed. Again, the signals started to shift up to 
a maximum position of 7.42 ppm and 7.32 ppm with increasing SDS, 
where the signals reached their final positions after 9.0µl had been 
added. The merged doublets at 7.05 ppm and 7.04 ppm also separated 
and shifted towards 6.89 ppm and 6.75 ppm. The signals then migrated 
back to settle at 6.99 ppm and 6.89 ppm after the addition of 9.0 µl of 
SDS. This splitting of signals indicates that the naphthalene protons are 
no longer in the same environments.  
The alkyl protons on the naphthalene substrate also exhibited 
shifts with the addition of the SDS. The protons for the trimethyl 
ammonium group also moved in a manner that could be measured; 
starting from 2.99 ppm the singlet moved down to 2.89 ppm then moved 
back to 2.99 ppm after the second aliquot of SDS was added. With further  
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additions the singlet moved up until it reached 3.09 ppm. The details of 
shifts are presented in Table 5.5. 
 
δ of 9 
(ppm) 
δ of 9 after 1eq SDS. 
(ppm) [∆δ] 
δ of 9 after 7eq SDS. 
(ppm) [∆δ] 
7.87 7.76  [-0.11]  7.82    [-0.05] 
7.81 7.73  [-0.08]  7.79    [-0.02] 
7.44 7.36  [-0.08]  7.42    [-0.02] 
7.44 7.26  [-0.18]  7.32    [-0.12] 
7.05 6.87  [-0.18]  6.99    [-0.06] 
7.04 6.76  [-0.28]  6.89    [-0.15] 
2.99 2.95  [-0.04]  3.09    [+0.10] 
Table 5.5. Shifts exhibited for 9 with SDS equivalents. Change in shift relative to 0eq SDS 
recorded in brackets. 
 
The initial shifts were attributed to aggregation of the SDS and 9. 
As the SDS concentration increased to reach its critical micelle 
concentration (CMC) of 8.3 mM
[109] the protons shifted to a more positive 
position, downfield. Full incorporation of compound 9 occurred when all 
signals ceased to move with increasing concentration of SDS. This point 
was reached 9.0 µl of SDS had been added. The concentration of SDS 
corresponded to 14.1 mM. 
 
5.3.3.2. Fluorescence  Spectroscopy Titration Studies  
 
In collaboration with Prof Woisel’s group, the CMC of naphthalene 
trimethylammonium bromide functionalised SDS micelles was determined 
by the titration of SDS into a solution of 9. To a solution of 3.6 mM 9 were 
added aliquots of SDS. The intensity of the naphthalene moiety was 
measured at λEx = 295 nm.
[121] The intensity of the naphthalene emission 
signal (λ= 329 nm) gradually diminished until the concentration of SDS 
reached 4 mM where the intensity dropped dramatically. The sudden 
change in intensity implied that the onset of micelle formation had  
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occurred. After this point addition of more SDS produced an increase in 
fluorescence thus indicating that the naphthalene moiety was displaced 
from the micelle by the additional SDS molecules. The change in 
fluorescence intensity at λEm = 329 nm relative to increasing SDS 
concentration is shown in Figure 5.12. These results would show that the 
CMC of these micelles is lower than the measured CMC of SDS by itself, 
implying that compound 9 promotes the micellisation process when mixed 
with SDS.
[121] 
 
 
Figure 5.12. Graph showing the change in the fluorescence at λEx= 295nm. λEm = 329 nm of 
9 as a function of SDS concentration. Recorded in H2O at 25 °C. 
 
Addition of CBPQT
4+ to the micellar solutions gave unexpected 
results, where instead of the distinct colour change upon formation of the 
pseudorotaxane; a white precipitate formed. Close inspection showed 
that the solid formed was the product of a salt exchange between the 
CBPQT
4+ 4Cl
- with the Na
+ DS
- to form CBPQT
4+ 4DS
- and 4NaCl. 
Furthermore, the addition of SDS to a solution of the pre-formed 
pseudorotaxane also formed a white precipitate. Investigation of the 
supernatant showed that micelles of naphthalene trimethyl ammonium 
bromide  9 with SDS had formed successfully, while the solid was 
CBPQT
4+. 4DS
-. The 
1H NMR spectra recorded for this investigation are 
shown in Figure 5.13.  
 
187 
 
 
 
Figure 5.13. Partial 
1H NMR spectra of: (a) 9 + 61 in D2O. (b) 9 + 61 + SDS (supernatant),  
(c) 9 recorded in D2O; (d) precipitate from 9 + 61 + SDS in d6-DMSO ~10
–4 M at 40°C. 
 
Experiments with sodium methylsulfate (SMS) and compound 9 
showed that the micellular structures were not formed.
[121] Moreover, the 
addition of SMS to aqueous solutions of the pseudorotaxane of 
compound  9 with CBPQT
4+ ( 61) did not produce a precipitate from 
potential salt exchange. Similar experiments with the naphthalene diol 2 
with SDS showed that the trimethyl ammonium group was required for 
the formation of functionalised micelles.
[121] Addition of SDS to solutions 
of the pseudorotaxane of compound 2 with CBPQT
4+ gave a purple 
precipitate showing that the pseudorotaxane was intact during and after 
salt exchange. These results indicate that for the decomplexation and 
precipitation to occur the trimethylammonium group of 9 and the SDS 
surfactant is required, where the long chain alkyl precipitates the 
CBPQT
4+ out of solution and the charge on the naphthalene species 
induces dissociation of the complex due to charge repulsion between 
positive charges present on each compound.
[121] 
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5.4. Conclusions and Future Work. 
 
5.4.1. Conclusions. 
 
Two functionalised trimethylammonium bromide compounds have 
been successfully synthesised. It has been found that the naphthalene 
functionalised surfactant (9) can undergo complexation with CBPQT
4+ to 
form the pseudorotaxane. The complex has been investigated by a 
number of techniques including ITC, UV-Vis, fluorescence and 
1H NMR. 
The 
1H NMR studies have shown that the H4/8 protons on the 
naphthalene core shift by up to 5.5 ppm upon complexation, indicating 
that the pseudorotaxane had formed. 
ITC experiments show that the complexation of the monomer and 
CBPQT
4+ occurs readily although the association constant Ka is reduced 
in comparison with unfunctionalised 1,5-dihydroxynaphthalene systems 
indicating that there is some charge-charge repulsion interactions 
exhibited by the complex.  
The formation of micelles with SDS has been investigated for the 
naphthalene derivatised compound by means of 
1H NMR and 
fluorescence spectroscopy. It has been shown that the naphthalene 
promotes micellisation of SDS in aqueous media. Addition of CBPQT
4+ to 
the formed naphthalene micelles causes a salt exchange of the chloride 
counter ions with the dodecyl sulfate producing a precipitate of 
CBPQT
4+.4DS from the solution of naphthalene SDS. 
 
5.4.2. Future  Work. 
 
With additional time and material, investigation of the TTF 
functionalised trimethylammonium bromide (54) with SDS would have 
been carried out.  
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6.    
Modification of BSA via Pseudorotaxane 
Formation. 
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6.1. Introduction. 
 
Proteins can be modified at various stages of formation
[122] from 
amino acid coding at the genetic level to create chimeric proteins
[123] 
[91] 
where specific areas have been re-coded to suit a particular need or 
application. This is a highly involved biological genetic engineering 
process that gives precise modifications at required positions. Protein 
synthesis to form structures at the amino acid level have also been 
carried out where the growing peptide is immobilised to a surface and 
selectively coupled with Fmoc protected amino acids.
[124] This method 
gives a synthetic route to proteins where there is full chemical control 
over the peptide chains produced. 
Examples of proteins modified at the amino acid level include the 
synthesis of a chimeric integrin-like protein carried out by Mrksich and co-
workers to introduce additional specificity for cell binding to the extra-
cellular matrix. The intracellular and transmembrane domains from β1 
integrin were joined to the extracellular stalk domain of the cell signalling 
protein cytokine, fractalkine, and carbonic anhydrase IV domain was 
coded for at the terminus of the chimeric receptor.
[123] 
The domains from β1 integrin used permitted the cell adhesion 
function to be retained, where the intracellular signalling processes that 
promote actin cytoskeleton reorganisation required for cell spreading and 
adhesion functions could still occur. The fractalkine domain was 
incorporated to elongate the CAIV binding domain by ~26 nm from the 
cell surface. The CAIV domain was utilised for its selective interaction 
with benzenesulfonamide, the dissociation constant Kd = 6 μM which is 
similar to the Kd for the interaction between α5β1 integrin with its natural 
binding partner fibronectin.
[123] 
Chinese hamster ovary cells (CHO) were transfected with this 
chimeric receptor and seeded onto surfaces presenting 
benzenesulfonamide and triethylene glycol groups. It was shown that 
these cells selectively adhered to the surface where binding occurred via  
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the chimeric receptor. Cell spreading was observed across these 
surfaces, showing that the receptor also functioned in the same way as 
integrin proteins with the actin cytoskeleton. Cell adhesion could also be 
inhibited by the addition of soluble benzenesulfonamide confirming the 
adhesion was via benzenesulfonamide binding.
[123] 
Alternatively, proteins that are fully formed can be modified by 
reaction with several different types of reagents to functionalise as 
required. This method is useful for peptide mapping, labelling and the 
incorporation of unnatural conjugates such polymers. The main site of 
modification is cysteine residues, where the free thiol will react to form 
linkages with the modifier. 
Maleimide groups will react selectively with cysteine residues in a 
Michael type addition.
[125] Maleimide groups can tolerate a great deal 
functionality including polymer initiators.
[126] [127] An example where 
maleimide cysteine bonding has been used with good success is with the 
immobilisation of α-helical peptide cecropin P1 functionalised with a 
single cysteine residue at the C terminal (CP1c) to polystyrene-maleimide 
surfaces, for bacterial capture and sensing applications.
[128] Through 
extensive work it has been shown that biological activity of these surfaces 
is dependent upon the conformation and orientation of the peptide on the 
surface. Work was pursued with the aim to control the orientation and 
conformation of the CP1c in solution in order to reduce the variables in 
the activity of the surfaces.
[128] An illustration of immobilisation is shown in 
Figure 6.1. 
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Figure 6.1. Immobilisation of CP1c onto polystyrene-maleimide surface. 
 
Varying the concentration of the peptide in potassium phosphate 
buffer showed that immobilisation and equilibration times were reduced 
with increasing concentration. It was shown that the conformation and 
orientation of these surfaces was the appropriate α-helical form and was 
associated with reorientation to avoid steric interactions with the close 
proximity of the substrate onto the surface with increasing molecules 
immobilised.
[128] The addition of the hydrophobic solvent 2,2,2-
trifluoroethanol (TFE) has been shown to induce the conformational 
change from random coil to the α-helical form in solution of peptides via 
hydrophobic interactions. The addition of TFE in the phosphate buffer led 
to changes in the conformation of PC1c to form the α-helix in solution for 
percentages of 50% and above TFE: phosphate buffer. This then affected 
the immobilisation of the peptide, by the virtue that there was no longer a 
need for conformational rearrangement prior to immobilisation.
[128] 
Additionally, during the immobilisation process the reducing agent  
tris(2-carboxyethyl)phosphine, (TCEP) is used to ensure that there are no 
dimerised products where cysteines from two peptides react to form 
disulfide bonds. When TCEP is not present immobilisation does not 
occur, and adsorption with random orientation is observed and biological 
activity is reduced. By applying high concentrations of peptide with the 
presence of upto 75% solution of TFE in addition to TCEP, it has been 
shown that immobilisation of the PC1c onto polystyrene can be 
completed using maleimide cysteine linkages with no loss of bioactivity 
against bacteria.
[128]  
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Methanethiosulfonate reagents will react with the thiol sites with 
high selectivity to form disulfide bonds with the cysteine.
[129] These 
molecules tolerate a great deal of functionality. However these reagents 
are hygroscopic and rapidly hydrolyse in aqueous conditions at room 
temperature.
[129] The synthesis of polyethyleneglycol (PEG) modified 
proteins selectively at cysteine residues for potential drug delivery 
systems have been investigated.
[130] It has been shown that the addition 
of PEG to drug systems increase the circulation retention times by 
masking the drug system from the immune system. PEG also increases 
the hydrodynamic size of the drug, which then leads to lower renal 
clearance and a greater resistance to proteolysis.  
MethoxyPEG (mPEG) was functionalised with either methane 
thiosulfonate (MTS) or phenylthiosulfonate (PTS) for the modification of 
two proteins. The reagents were synthesised from the bromo-mPEG 
derivative with freshly converted thiosulfonates from methanesulfinate 
and phenylsulfinate respectively in high yields.
[130] 
Initially the mPEG-MTS and mPEG-PTS were reacted with papain 
to verify the reaction conditions and selectivity of the MTS for the cysteine 
thiol groups. Once this was confirmed by gel electrophoresis, the protein 
modification was carried out on the pharmaceutically active protein 
recombinant human granulocyte colony stimulating factor, rhG-CSF. 
RhG-CSF is used in the treatment of neuthropenia, a disorder where 
there is a reduced number of neutrophils circulating in the blood.
[131]  
G-CSF stimulates bone marrow to produce granulocytes and stem 
cells.
[130] Cell viability studies with Murine myeloblastic leukemia NFS-60 
cells that are rich in G-CSF receptors were treated with native G-CSF and 
rhG-CSF-mPEG for 48 hours. After this time MTT experiments were used 
to measure the bioactivity of the mPEG-protein against the activity of the 
native protein.
[130] The results are shown in Table 6.1. This value was 
found to be comparable to other G-CSF modified systems, and showed 
that the modification may be a viable option for other pharmaceutical 
proteins.
[130]  
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Protein  Specific Activity (IU/mg)  % Activity
* 
Native G-CSF  1.08 x10
8 100 
mPEG G-CSF  6.25 x10
7 59 
*% Activity was expressed as the percent residual bioactivity as compared with native G-
CSF. Results are the mean values (n = 4) 
Table 6.1. Bioactivity of m-PEG-rhG-CSF versus native G-CSF in murine myeloblastic NFS-
60 cell line.
[130] 
 
Halogenated acetate and acetamides will also react at cysteine 
residues to form thioester linkers.
[132] Iodoacetamides have been found to 
be fairly unselective and will readily react with lysine to form additional 
adducts in addition to reaction at the cysteine residues.
[133] The less 
reactive chloro derivatives have been shown to be selective for the 
cysteine residues only. Iodoacetamide is regularly used during reductive 
protein digestion,
[134] 
[135] where it is used to react with the free cysteine 
residues in order to avoid the reformation of random disulfide linkages 
and further degradation of the cysteine. Mass spectroscopy of protein 
mapping shows the cysteine residues in the S-acetamide-alkylated form. 
N-alkylation also occurs at a slower rate and can be generally avoided by 
reduced reaction times of use of the chloro equivalent reagent.
[133]  
The haloacetamides and acetates have also been used to attach 
functionality to proteins via the cysteine thiol group. One example was the 
incorporation of redox active N-(ferrocenyl)iodoacetamide to a number of 
thiol-containing compounds with the aim to form redox mediators for 
glucose oxidase activity.
[40] The structure of N-(ferrocenyl)iodoacetamide 
is shown in Figure 6.2. 
 
Fe
N
H
O
I
 
Figure 6.2. The structure of N-(ferrocenyl) iodoacetamide.
[40]
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The compounds derivatised were: cysteine, glutathione, a 
sulfhydryl modified BSA, and a sulfhydryl oligonucleotide chain M13-R-
Comp-SH. The glutathione and cysteine conjugates are shown in   
Figure 6.3. The electrochemical properties were measured using cyclic 
voltammetry (CV). The redox half wave potential, E½,for the parent 
compound N-(ferrocenyl) iodoacetamide in acetonitrile was measured as 
E½ = +0.342 V.
[40] The CVs for the conjugates formed were measured in  
50 mM potassium phosphate at pH 7.4. E½ for the oligonucleotide was 
measured as +0.16 V. The half wave potential with the oxidation / 
reduction potentials measured for the conjugates reported is shown in 
Table 6.2.
[40] 
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Figure 6.3. Structure of A) Fc-glutathione, B) Fc-cysteine. 
[40]
 
 
Conjugate Eox / V  Ered / V  E½ / V 
Fc-Cysteine  +0.1 +0.034  0.067 
Fc-Glutathione  +0.09 0.021 0.056 
Fc-BSA  +0.108 0.023  0.066 
Table 6.2. CV data recorded for the ferrocene conjugates. 50mM potassium phosphate pH 
7.4 at 298K vs SCE. 
 
Addition of glucose to the conjugates had no effect upon the CV 
redox wave. Further addition of glucose oxidase in low concentrations, to 
the cysteine and glutathione conjugates in the presence of glucose gave  
 
197 
 
rise to a change where the ferrocene conjugate in its oxidised form 
reacted with the reduced form of the glucose oxidase. The glucose 
present was then converted into gluconolactone catalytically. 
Experiments with the larger nucleotide derivative and the BSA gave no 
response to the glucose oxidase.
[40] This was attributed to the size of the 
conjugates, where the ferrocene was sterically blocked from reaching the 
active site of the glucose oxidase. The CV spectra recorded for the 
 Fc-glutathione are shown in Figure 6.4. 
 
 
Figure 6.4. CV of Fc-glutathione (0.4 mM) and glucose (32.5 mM) in 50 mM potassium 
phosphate buffer in the (a) absence, (b) presence of glucose oxidase (40 μM). 
[40]
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6.2 Pseudorotaxane protein modification aims and objectives. 
 
The aim of this project was to synthesise a naphthalene 
functionalised conjugate that could be used to modify proteins by 
covalent interactions that could then lead to the incorporation of unnatural 
functionality to the protein. By the virtue of the host-guest interactions that 
naphthalene exhibits with CBPQT
4+ it was thought that by the introduction 
of the naphthalene moiety to the protein, it would be possible to introduce 
additional supramolecular interactions to the protein, where interactions 
could be measured by UV-Vis, fluorescence spectroscopy and 
electrochemistry. 
The protein could be modified by a number of methods. One of the 
methods used a maleimide functionalised compound that could be 
coupled to cysteine residues. For the maleimide route the aim was to 
proceed via click chemistry as shown in Scheme 6.1. Another method 
was by activation and reaction with chloro acetates. The target molecule 
is shown below in Figure 6.5. 
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Scheme 6.1 Reaction scheme to produce a naphthalene maleimide for protein modification. 
 
 
Figure 6.5.Naphthalene chloroacetate target molecule. 
  
 
199 
 
6.3. Results and Discussion. 
6.3.1. Attempted synthesis for 1-Azido-propyl-3-maleimide (43) for 
click chemistry. 
 
 
Scheme 6.2. Synthesis of azido propyl maleimide from bromo propylamine. 
 
The synthesis of compound 42
[136] was fairly straightforward; 
however, it was found that the product also evaporated under the 
reduced pressure conditions such that it was found in the rotary 
evaporator trap essentially impurity free. For later experiments the solvent 
used in the reaction and workup was changed to DCM with good 
success, where the crude material was taken on to the next stage without 
further workup required. The subsequent reaction to form compound 43 
produced a bright orange foamy solid rather than the orange oil expected 
from the literature procedure that had been followed.
[136] The foamy 
orange solid was not sufficiently soluble in all solvents tried, whereas the 
product described in the literature had been soluble in chloroform and 
DCM. After extensive sonication and heating, a small amount of the crude 
material went into d6-DMSO such that a 
1H NMR spectrum could be run. 
The results of which showed that the majority of the signals were not from 
the expected product. As this compound was a key intermediate in the 
synthetic pathway, and that we could not form the product this synthesis 
was abandoned at this stage. 
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6.3.2 Synthesis of 1-(2-(2-(chloroacetyloxy)ethoxy) ethoxy)-5-(2-(2-
hydroxyethoxy)ethoxy) naphthalene (19a). 
 
 
Scheme 6.3. Synthesis of 19a from diol 2. 
 
Starting from the naphthalene diol 2, the chloroacetate product 19a 
was synthesised in a one step reaction
[137] that produced both the mono 
and diacylated compounds, where the monoacylated product 19a 
predominated with a good yield of 52% while the bisacylated product 19b 
was formed in a 5% yield. The remaining unreacted diol was easily 
recovered and could be recycled as required. 
 
 
6.3.3 Modification of BSA with 1-(2-(2-(chloroacetyloxy)ethoxy) 
ethoxy)-5-(2-(2-hydroxyethoxy)ethoxy) naphthalene (19a). 
 
 
Scheme 6.4. Modification of BSA with compound 19a. 
 
As BSA is readily available it was decided that this protein would 
be a practical substrate for proof of concept and the optimisation of the  
 
201 
 
experimental procedure. The procedure for protein functionalisation as 
reported by Lo et al
[40] was followed. Typically the iodoacetamides are 
used for reaction with cysteine residues in proteins, however, it has been 
shown within the literature that iodoacetamides can also react with lysine 
residues to form covalent adducts that are unwanted. It has also been 
shown that the chloroacetamides can perform this reaction equally well 
without the additional unwanted reaction with lysine.
[133] By using 
compound 19a with the BSA meant that an additional conversion to the 
iodo acetate was not required. 
The BSA in 50mM potassium phosphate was first reacted with N-
succinimidyl-S-acetyl-thioacetate (SATA) so as to increase the number of 
thiol groups available to react with the chloroacetamide. The reaction with 
the SATA gave a protected thiol. The mechanism for the reaction is 
shown in Scheme 6.5. After the reaction with SATA, the removal of the 
by-products and any excess reagent was performed using dialysis tubing 
with a MWCO of 4000-6000 in 50mM potassium phosphate buffer at pH = 
7.2. Following the dialysis, hydroxylamine was used to form the reactive 
deprotected thiol species. After further dialysis to remove the excess 
reagent and by-products, the mixture was reacted with 19a, to complete 
the modification. Upon addition of 19a, a white solid precipitated which 
was removed by centrifugation at the end of the reaction. Extraction of 
the supernatant with ethyl acetate removed any remaining chloroacetate 
19a from the protein mixture. Further dialysis removed any dissolved 
ethyl acetate from the aqueous buffered solution. The reaction 
mechanism for the deprotection followed by treatment with a 
chloroacetate is shown in Scheme 6.6. The protein buffered solution was 
then dialysed with the same tubing as before in water to remove the 
phosphate buffer so that mass spectroscopy using MALDI TOF could be 
carried out. 
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Scheme 6.5. Reaction mechanism SATA with BSA. 
 
 
Scheme 6.6. Deprotection of the thiol followed by addition of a chloroacetate. 
 
6.3.4. Analysis of the modified BSA. 
 
Several techniques were used to analyse the degree of 
modification that had occurred on the BSA from the treatment described 
above. MALDI TOF was used to determine the degree of naphthalene 
modification by the change in the molecular mass compared to 
unmodified BSA.  
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6.3.4.1 MALDI TOF analysis. 
 
 
Figure 6.6. Structure of the modification per amino group on the protein BSA. 
 
Samples of the modified BSA (m-BSA) 45 and unmodified BSA 
were analysed using MADLI TOF analysis. The expected changes to be 
observed were that the molecular weight (MW) of the m-BSA 45 would be 
higher by multiples of 451, the total mass of each unit that would be 
added to each amino group, the structure of which is shown in Figure 6.6. 
Samples of m-BSA, 45 and BSA were run on an AXIMA-CFR MALDI-
TOF Kratos spectrometer using a matrix of sinapinic acid 10 mg /mL in 
1:1 acetonitrile/ water 0.1% TFA. Sample mixture with matrix solution 
ratio of 1:1, with the exception of the BSA sample where a 1 to 5 dilution 
was used. Due to the nature of the BSA exact values for the MW of the 
protein could not be produced, where each run gave slightly different 
results. The typical value for the unmodified BSA starting material was 
66839 g/mol or 66849 g/mol. The values for the m-BSA varied from 
67493 g/mol to up to 68330 g/mol. The increased masses would indicate 
a minimum of one naphthalene group was added to a maxiumum of three 
naphthalene’s added. From these results the degree of functionalisation 
that occurred onto the BSA appears to be that two naphthalene 
molecules have been added. The results are shown in Figure 6.7. 
  
 
204 
 
Figure 6.7. MALDI TOF results for m-BSA 45 and BSA. 
 
6.3.4.2 Investigation of binding to CBPQT
4+ by ITC. 
 
To investigate whether the m-BSA could bind CBPQT
4+ in aqueous 
solutions, ITC experiments were carried out. Solutions of the m-BSA 45, 
BSA and CBPQT
4+ were made in 20 mM potassium phosphate at   
pH = 6.8. The interaction between BSA and CBPQT
4+ gave no binding 
event, where dilution effects were the only thermal changes present. 
However, the interaction between CBPQT
4+ and the modified BSA gave a 
good binding curve with a binding stoichiometry (N) of around 1. The raw 
data for the interaction of CBPQT
4+ with both modified and unmodified 
BSA is shown in Figure 6.8. Figure 6.9 shows the analysed data for the 
interaction of CBPQT
4+ with the modified BSA 45 which gave the 
thermodynamic values shown in Table 6.3 from a single-set-of-sites 
binding model.  
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Figure 6.8. Raw ITC data for CBPQT
4+ with BSA and m-BSA. 
 
N  1.184 ± 0.1639 
Ka (M
-1)  9.9x10
4 ± 2.052x10
4 
∆H (cal mol
-1)  -5023 ± 834.3 
∆S (cal mol
-1K
-1)  6.010 
Table 6.3. Thermodynamic data recorded for CBPQT
4+ with the naphthalene modified BSA. 
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Figure 6.9. Analysed data for CBPQT
4+ into m-BSA. 
 
6.3.4.3 UV-Vis Spectroscopy. 
 
The UV-Vis spectra of m-BSA 45 upon the addition of CBPQT
4+ 
were recorded. On addition of increasing aliquots of CBPQT
4+ to the   
m-BSA 45, a pale pink colour was observed. By the third equivalent the 
maximum intensity of the band that was observed in the region of 450 -
650 nm was reached. This band is in the region expected for naphthalene 
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- CBPQT
4+ pseudorotaxane formation. The presence of this band 
indicates that the pseudorotaxane had formed with little or no adverse 
effects from the presence of buffer.The combined spectra recorded for 
the addition of CBPQT
4+ are shown in Figure 6.10. 
 
 
Figure 6.10. UV-Vis spectrum for the addition of CBPQT
4+to m-BSA at room temperature. 
 
The interaction of the cyclophane with unmodified BSA showed 
negligible effects whereby a small shoulder appeared with increasing 
amounts of CBPQT
4+. The lack of a band at 450-650 nm would suggest 
that the band observed in the modified BSA comes purely from the 
naphthalene moiety attached to the protein. The spectroscopic data for 
the unmodified BSA with CBPQT
4+ is shown in Figure 6.11. 
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Figure 6.11. UV-Vis spectrum for the addition of CBPQT
4+to BSA at room temperature. 
 
6.3.4.4 Fluorescence Spectroscopy. 
 
Solutions of BSA and the m-BSA 45 at 8.3x10
-6 M were prepared 
in 50 mM phosphate. Equivalents of CBPQT
4+ in water were added,   
6.2 µl of a 4.1 mM solution per equivalent, and the changes in 
fluorescence at two excitation wavelengths were measured. Blank 
experiments with 6.2 µl per aliquot of water added to the proteins were 
also carried out. For the unmodified BSA, the maximum fluorescence 
emission peak came from the excitation λ at 282 nm. Excitation at 
 λ = 295 nm showed the same band as the Ex282nm,  but at a lower 
intensity of around half the height. The addition of aliquots of CBPQT
4+ 
showed a drop in fluorescence intensity, indicating that the CBPQT
4+ was 
interacting with the BSA in some way in order to quench the 
fluorescence. As it is known that CBPQT
4+ non-selectively interacts with 
π-electron rich substrates including amino acids, the quenching of the 
fluorescence may be attributed to this form of interaction with the BSA.
[138] 
Addition of aliquots of water, gave no discernible change in the emission 
intensity for both excitation wavelengths. The spectra for both Ex282nm and 
Ex295nm are shown in Figure 6.12.  
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Figure 6.12. Fluorescence emission spectra of BSA upon addition of A) CBPQT
4+ B) H2O  
(1- Ex=282nm, 2- Ex=295nm) All measurements were carried out at room temperature. 
 
Fluorescence spectroscopy for the m-BSA 45 gave a maximum 
emission spectrum at the excitation wavelength of 295 nm. The emission 
spectrum was of the form typical for naphthalene groups. Excitation at  
λ = 282 nm gave the same emission band as observed for λ = 295nm, 
however, the intensity of the signal had dropped by ~17%. Addition of 
CBPQT
4+ aliquots exhibited a drop in fluorescence emission for both 
excitation wavelengths. With the significant quenching of fluorescence 
and the colour change observed, it would appear that the pseudo-
rotaxane of CBPQT
4+ with the m-BSA had formed. Addition of aliquots of 
water to the m-BSA 45 had the same lack of effect on the fluorescence 
emission as observed with the BSA fluorescence emission experiments. 
These results show that it is only the CBPQT
4+ that is affecting the 
fluorescence emission, and that the quenching of the fluorescence is not 
by dilution effects caused by the change in volume of the solutions. The 
spectra for the experiments carried out with the m-BSA are shown in 
Figure 6.13.  
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Figure 6.13. Fluorescence emission spectra of M-BSA upon addition of A) CBPQT
4+ B) H2O 
(1- Ex=282nm, 2- Ex=295nm) All measurements were carried out at room temperature. 
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6.4 Conclusions and Future Work. 
6.4.1 Conclusions. 
 
To conclude, the naphthalene chloroacetate 19a has been 
successfully synthesised in a good yield such that it has been coupled to 
the protein BSA. Using a number of techniques including MALDI TOF, it 
has been shown that the chloroacetate derivative 19a was successfully 
incorporated into the BSA protein via cysteine thioester linkages. It has 
been shown that the modified protein can undergo reversible host-guest 
interactions with CBPQT
4+ in a way that can be observed using a variety 
of analytical techniques including ITC, fluorescence spectroscopy and 
UV-Vis spectroscopy.  
 
6.4.2. Future Work. 
 
Additional investigation by electrochemistry to investigate the 
changes in the redox couple of CBPQT
4+ upon complexation with the 
protein could be investigated. With futher time available, the addition of 
this substrate to other more complicated proteins, followed by full analysis 
of the resulting modified protein could be performed. 
Further investigation of the reaction to form the azido propylmaleimde in 
order to gain the product or a similar substrate for click chemistry and/or 
in situ Staudinger/amide reactions with either functionalised primary 
alkynes or functionalised carboxylic acids would have been carried out 
had time permitted. This type of modification would have allowed for 
greater scope of modification possible and the incorporation of other 
functional groups such as ferrocene, TTF or CBPQT
4+. 
. 
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7 
Functionalised Biotin Compounds and their 
implementation as pseudorotaxane based 
bioconjugates. 
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7.1 Introduction. 
 
Avidin is a naturally occurring protein that has four degenerate 
binding sites.
[139] There are several different types of avidin proteins 
including streptavidin and neutravidin.
[140] Biotin, the vitamin B7, interacts 
strongly with the avidin family of proteins such that the complex formed 
has one of the strongest non-covalent interactions found within 
biochemistry.
[140] The structure of biotin is shown in Figure 7.1. The 
binding constant, Ka of the complex is ~10
15 M
-1 and is almost completely 
irreversible. 
[140] Upon complexation the protein undergoes conformational 
changes that lead to the increase in thermal stability and rigidity.
[141] The 
interaction between avidin and biotin occurs via a complex network of 
multiple hydrogen bonds which results in a large favourable change in the 
enthalpy.
[33] The entropy of complexation is close to zero where the 
unfavourable re-arrangement of the protein is balanced out by the highly 
favourable desolvation of the binding sites. The interaction overall is 
remarkably favourable, which in turn leads to the high binding constant.
[33] 
The binding of biotin to avidin can be observed by UV-Vis 
spectroscopy using displacement of 4’-hydroxyazobenzene-2-carboxylic 
acid (HABA) from the binding sites with biotin.
[142] HABA, a yellow 
coloured compound will change colour to red upon complexation with 
avidin. Biotin displaces the HABA from the avidin binding site, resulting in 
the loss of colour to the solution where the red colour changes to 
yellow.
[142] 
 
 
Figure 7.1. Structure of biotin. 
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The Ka for HABA to avidin has been measured as ~6 x10
-6 M.
[142] 
The interactions between avidin and HABA can be tuned by the 
functionalisation of HABA. Changing the position of the carboxylic acid 
leads to a drop in binding association, where up to one order of 
magnitude is lost upon movement from the 2-position to the 4-position.
[142] 
Substitution of the 4’-hydroxybenzene group with a 4-hydroxynaphthalene 
substituent leads to an increase by an order of magnitude. The addition of 
substituents around the 3’- and 2’-positions can also modulate the binding 
affinity to avidin.
[142] Examples of the modifications of HABA and their 
apparent binding constants Ka are shown in Figure 7.2. Ka was calculated 
from the DSC measurement for the complexes with avidin. The complex 
between avidin and HABA can be reversed by the addition of biotin.
[142] 
 
HABA. 
HO O
N
N
OH
Ka = 2.9x105 M-1
 
HO O
N
N
OH
Ka = 5.0x106 M-1
 
N
N
OH
Ka = 2.0x104 M-1
HO
O
 
HO O
N
N
OH
Ka =1.2x106 M-1
 
N
N
OH
Ka = 5.4x103 M-1
HO
O
 
Figure 7.2. Modified HABA derivatives with their binding constants Ka. 
 
The functionalisation of biotin at the carboxylic acid group allows 
the introduction of groups while retaining strong binding with avidin  
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proteins.
[143] 
[144] 
[145] These interactions have been utilised to create 
functionalised molecules that have known specific protein interactions 
that may interact with other substrates.
[143] 
[144] 
[145] 
Examples include the formation of SAMs presenting biotin 
functionality on a quinone propionic ester moiety linker on gold, as shown 
in Figure 7.3, selectively adsorbed avidin proteins onto the surface while 
repelling all other proteins from the surface.
[56] Upon the application of an 
electrical potential of -700 mV to the underlying gold surface, the quinone 
is converted to the hydroquinone species and a lactonisation occurs 
where the biotin is cleaved off of the substrate.
[56] Changes in the 
adhesive properties were measured by SPR where the application of the 
electrical potential was carried out directly prior to the investigation by 
SPR.
[56] The removal of the biotin leads to a complete loss of binding of 
the streptavidin to the surface. After release of the biotin group, the 
surface was also still inert to other protein adsorption.
[56] It has been 
shown that the application of the electrical potential of -700 mV had no 
effect on the behaviour of the SAMs to proteins.
[56] However, it was found 
that by increasing the voltage potential to -1100 mV caused the 
monolayer to become damaged such that the complex of streptavidin / 
biotin started to adsorb onto the surface of the gold, indicating that the 
monolayer was no longer active in the repulsion of non-specific protein.
[56] 
The structure of the monolayers and the transformation upon the 
application of the electrical potential is shown in Figure 7.3. The SPR 
data recorded are shown in Figure 7.4. 
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Figure 7.3. SAMs with biotin that is released by the application of an electrical potential. 
[56] 
 
 
Figure 7.4. SPR data for the SAMs before and after addition of an electrical potential. 
[56] 
 
Biotin can incorporate functionality that can itself undergo host-
guest interactions where either does not inhibit the separate interactions. 
Work has been carried out by Cooke and co-workers where a  
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naphthalene group was attached via a diethylene glycol linker to biotin
[146]. 
It was found that the naphthalene biotin conjugate could perform 
interactions with both avidin proteins and with the cyclophane 
CBPQT
4+.
[146] The structure of the naphthalene biotin conjugate is shown 
in Figure 7.5. 
 
 
Figure 7.5. Structure of the naphthalene biotin conjugate.
[146] 
 
The interactions with avidin were investigated by UV-Vis 
experiments with avidin/HABA complex displacement with the 
naphthalene biotin conjugate.
[146] It was shown that the conjugate 
displaced the HABA successfully from the binding sites of the avidin. 
Addition of CBPQT
4+ to the conjugate gave a distinctive purple colour with 
a  λmax of 520 nm, which was typical for the formation of the 
pseudorotaxane.
[147] UV-Vis experiments showed that the CBPQT
4+ did 
not interact with avidin itself as mixtures did not exhibit colour changes 
until the naphthalene conjugate was added.
[146] Subsequent addition of 
TTF caused the solution to change colour from purple to green showing 
that the naphthalene group had been displaced from the cavity of the 
cyclophane.
[146] The spectra recorded are shown in Figure 7.6. 
1H NMR 
studies also indicated that the pseudorotaxane had formed by the shift of 
the H4/8 protons on the naphthalene by ~5.5 ppm upon complexation with 
CBPQT
4+.
[146] 
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Figure 7.6. UV-Vis recorded in water/ethanol 70:30. avidin + CBPQT (grey); Plus 
Naphthalene biotin (purple); Plus TTF (green). 
 
ITC was used to measure the binding interactions between the 
naphthalene biotin conjugate and avidin and CBPQT
4+.
[146] From the 
experiments the binding constants were measured as Ka = 7.3x10
6 M
-1 for 
biotin-avidin and Ka = 4.7x10
4 M
-1 for the interaction between naphthalene 
CBPQT
4+.
[146] The titration of CBPQT
4+ into avidin only, showed purely 
heats of dilution, confirming that there was no interaction between the 
cyclophane and the protein.
[146] The ITC data recorded for the interactions 
plotted heat vs time is shown in Figure 7.7. 
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Figure 7.7. Heat vs time plot of A) naphthalene biotin into avidin. B) CBPQT
4+ into 
naphthalene biotin / avidin complex. C) CBPQT
4+ into avidin. 
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7.2 Aims and Objectives. 
 
The aim of this project was to synthesise two ferrocene 
functionalised biotin conjugates for investigating the interactions between 
avidin proteins and the conjugates. Investigation into the effects of 
cyclodextrin on the binding interactions with avidin and the redox 
properties of the ferrocene were also planned. The effects of chain length 
between the biotin moiety and the ferrocene group would be studied by 
the comparison of the two compounds.  
Moreover, investigation into a long chain naphthalene biotin 
conjugate and the affect on binding interactions with CBPQT
4+ and avidin 
was an additional area of interest. The added glycol chain enhances the 
water solubility of the compound and provides an interesting comparison 
to the ferrocene functionalised systems. 
 The target molecules are shown in Figure 7.8, where the solubility 
in aqueous media should be enhanced by the extended linker chain in 
compound 21 and 29. A schematic of the interactions to be investigated 
is shown in Figure 7.9. 
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Figure 7.8. Functionalised biotin conjugates for investigation. 
 
Figure 7.9. Illustrative schematic of the complexation of the functionalised biotins to avidin 
with additional complexation of a guest molecule. 
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7.3  Results and Discussion. 
 
7.3.1 Synthesis  of  biotinylated ferrocene compounds 28 and 
29. 
 
Starting with the ferrocene amine 25a, the biotin conjugates were 
formed by EDCI couplings with either biotin or the long chain biotin 
derivative, O-[2-(biotinylamino)ethyl]-O’-[2-carboxyethyl] undecaethylene 
glycol in reasonable yields as indicated in Scheme 7.1. 
 
 
Scheme 7.1. Synthesis of ferrocene biotin compounds 28 and 29 from ferrocene amine 25a. 
 
The EDCI coupling of 25a with biotin to gain the biotinylated 
product 28 in a yield of 36% was fairly straightforward such that removal 
of impurities by column chromatography achieved the pure product as a 
glassy orange solid that had a tendency to stick to the sides of its 
container making manipulation for analysis slightly difficult. Solubility in 
aqueous media was low, and precipitation was an issue if the solutions 
were left for long periods. The reaction between 25a and the long chain  
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biotin compound via an EDCI coupling similar to that of the reaction 
above, gave the ferrocene long chain biotin product 29 as a very greasy 
dark brown oil in 47% yield that did not require any purification after 
extraction in DCM. The oil was highly soluble in water, however, the 
consistency of the oil made handling the material non-trivial.  
 
7.3.2 Analysis of the biotinylated conjugates.  
 
7.3.2.1 UV-Vis Spectroscopy. 
 
4’-Hydroxyazobenzene-2-carboxylic  acid (HABA) can moderately 
bind to avidin at the proteins biotin binding site. The complex produced 
between HABA and avidin is a bright red colour that is lost upon removal 
of the HABA from the binding site.
[142] Biotin will competitively displace 
HABA from the avidin binding sites such that, upon complete 
decomplexation of the HABA from the avidin binding sites, the solution 
goes from bright red to pale yellow. As a result, the competitive binding of 
biotin to avidin can be monitored by UV-Vis experiments. This interaction 
was utilised to confirm the retention of biotin binding activity to avidin and 
its derivatives after modification with ferrocene in both compounds 28 and 
29. To a solution of neutravidin and HABA (3 mL) was added 10µl 
aliquots of 0.03 M aqueous solution of the required ferrocene biotin. Each 
aliquot corresponded to 1 molar equivalent of the biotin compound. After 
each addition an UV-Vis spectrum was ran. A total of 10 equivalents were 
added to the neutravidin HABA complex. The change in the absorbance 
at λ= 500 nm for ferrocene biotin compounds 28 and 29 are shown below 
in Figure 7.10 and Figure 7.11. 
From the figures, it can be seen that the biotin moiety of 28 and 29 
was still capable of displacing the HABA from the binding sites of the 
neutravidin. In the cases of 29, after the 5
th equivalent almost all HABA  
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had been displaced and the solutions had lost most of the red colour, and 
were dark yellow. By the 8
th equivalent the solutions were very pale 
yellow and complete irreversible displacement had occurred.  
 
 
Figure 7.10. Changes in the absorbance at 500nm with increasing equivalents of 28 to 
HABA-Neutravidin complex. Experiments were run at room temperature in water at a 
concentration of 10
-3 M. 
 
 
Figure 7.11. Changes in absorbance at 500 nm with increasing equivalents of 29 to the 
HABA –Neutravidin complex. Experiments were run at room temperature in water at a 
concentration of 10
-3 M. 
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The UV-Vis analysis of the naphthalene conjugate 22 with HABA 
and avidin showed that the compound also readily displaced the HABA 
from the avidin binding sites. By the fourth equivalent total displacement 
of the HABA had occurred. This indicates that the naphthalene substrate 
displaces the HABA more readily than that of the ferrocene conjugates. 
The results are shown in Figure 7.12. 
 
 
Figure 7.12. UV-Vis of naphthalene biotin into HABA/avidin. Black = avidin 10
-5 M.  
Red = avidin with 4eq HABA. Blue = upon addition of 4eq of 22 into the HABA/avidin 
complex. Experiment run at room temperature. 
 
Furthermore, the complex between 22 and CBPQT
4+ was 
investigated by UV-Vis and fluorescence spectroscopy. As the complex 
formed the typical band for the pseudorotaxane formation was observed 
in the UV-Vis spectrum, while quenching of the naphthalene fluorescence 
was observed in the fluorescence emission spectrum. The results are 
shown in Figure 7.13 and Figure 7.14. Addition of avidin to the 
pseudorotaxane had no effect on the UV-Vis absorbance. The 
fluorescence spectrum for the complex between compound 22 and avidin 
was also recorded to investigate the effect on the fluorescence emission 
upon binding. The emission spectrum showed that upon complexation 
with avidin, there was very little effect on the fluorescence of the 
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naphthalene, indicating that quenching did not occur. The spectra 
produced are shown in Figure 7.14. 
 
 
Figure 7.13 UV-Vis spectrum of 22 with CBPQT
4+. Red line = 22 (10
-4M). Blue line = 22 + 
CBPQT
4+ Recorded at room temperature in water. 
 
 
Figure 7.14. Fluorescence emission spectrum of 22 with CBPQT
4+. Black line = 22 (10
-
5M).Grey line = 22 + CBPQT
4+. Run at room temperature in water. 
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Figure 7.15. Fluorescence emission spectrum of 22 with avidin recorded at room 
temperature in water. Black line = 22 (10
-5M). Grey line = 22 + avidin. 
 
 
7.3.2.2 ITC experiments. 
 
To probe the binding interactions between neutravidin and the 
ferrocene biotin compounds, ITC was carried out in water. The interaction 
with  β-cyclodextrin was also investigated. Table 7.1 below gives the 
details of each experiment carried out for compound 28.  
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Experiment Contents of cell  Contents of syringe 
1 Water 
Ferrocene SC Biotin 
(28) 0.7mM 
2 
Neutravidin 
0.0125mM 
Ferrocene SC Biotin 
(28) 0.7mM 
3 
Neutravidin / Fe SC Biotin (28) 
Complex (formed in expt 2) 
β-cyclodextrin 
0.7mM 
4 
Ferrocene SC Biotin  
0.02mM 
β-cyclodextrin 
0.7mM 
5 
Ferrocene SC Biotin (28) 
0.02mM (50°C) 
β-cyclodextrin 
0.7mM 
Table 7.1. Experimental details for 28, neutravidin, and β-cyclodextrin. All experiments 
unless otherwise indicated were carried out at 25°C. 
 
Starting with the interaction between the short chain ferrocene 
biotin conjugate (28) and neutravidin, the investigation revealed a strong 
binding curve that gave the data shown in Table 7.2 from a single-set-of-
sites binding model. The binding curve exhibited by the interaction 
between compound 28 and the β-cyclodextrin appeared to be purely 
dilution effects. The experiment was then repeated at 50°C in order to 
observe any weak interactions that could not be observed at the lower 
temperature. Again, the data recorded showed no binding interaction was 
observable. This may have been due a low isotherm form binding or that 
the binding was particularly weak. The raw data produced, and the 
analysed data for the short chain ferrocene biotin conjugate (28) with the 
neutravidin are shown in Figure 7.16 and Figure 7.17. 
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N  4.02 
Ka (M
-1)  1.32 x10
7 ± 1.84 x10
6 
∆H (cal mol
-1)  -1.66 x10
4 ± 100.2 
∆S (cal mol
-1K
-1)  -23.07 
Table 7.2. Thermodynamic data recorded for titration of 28 into neutravidin. 
 
Figure 7.16. Raw ITC data collected for compound 28 with neutravidin and β-cyclodextrin. 
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Figure 7.17. ITC data for the titration of 28 into neutravidin solution. 
 
Table 7.3 gives the details of each experiment carried out for the 
long chain biotin compound. The ITC experiment with compound 29 with 
neutravidin gave a strong binding curve that gave the data shown in 
Figure 7.18, from a single-set-of-sites binding model. It can be noted that 
the Ka of these conjugates with neutravidin is significantly less than for 
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biotin to avidin, however the values are still high and in the range of   
10
7 M
-1 for the short chain ferrocene biotin conjugate 28 and 10
5 M
-1 for 
the long chain ferrocene biotin conjugate 29. The differences in Ka may 
be associated to the steric bulk of biotin conjugates, where the larger 
molecule has a lower Ka by almost two orders of magnitude. It may be 
that the larger molecule disrupts the change in conformation of the 
neutravidin protein that is required for binding. 
The binding curves for the addition of β-cyclodextrin to the 
complex and to compound (29) only were very weak; however, by the 
subtraction of the dilution data for β-cyclodextrin into water we were able 
to fit the data when the binding stoichiometry N was kept at 1. The data 
for the interaction of β-cyclodextrin with compound (29) are shown in 
Table 7.4. From this data it can be observed that the binding is very 
weak, but in the range expected for ferrocene cyclodextrin which is 
typically 10
3-10
4 M
-1[31]. The analysed data for each experiment are shown 
in Figure 7.18. 
 
Table 7.3. Experimental details for 29, neutravidin, and β-cyclodextrin. 
All experiments were carried out at 25°C. 
 
Experiment  Contents of cell  Contents of syringe 
1 Water 
Ferrocene LC Biotin 
(29) 0.7 mM 
2 
Neutravidin 
0.0125 mM 
Ferrocene LC Biotin 
(29) 0.7 mM 
3 
Neutravidin / Fe LC Biotin (29) 
Complex from expt 2 
β-cyclodextrin 
0.7 mM 
4  
Ferrocene LC Biotin (29) 
0.05 mM 
β-cyclodextrin 
0.7 mM 
5 Water 
β-cyclodextrin 
0.7 mM  
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  29 into NA  β-CD into 29/NA  β-CD into 29 
N  3.64 ± 0.0478  1.00  1.00 
Ka (M
-1) 
9.69 x10
5 ±  
1.63 x10
5 
404.7 ± 205.6  1283 ± 519.4
 
∆H (calmol
-1) 
-1.43 x10
4 ± 
299.2 
-9.32 x10
4 ± 
4.50 x10
4  -3890 ± 1327 
∆S (calmol
-1K
-1)  -20.91 -300.7  1.75 
Table 7.4. Thermodynamic data recorded for the ITC of 29 with neutravidin and β-CD. 
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A   
B 
 
C 
Figure 7.18. ITC titration data for A) 29 into neutravidin. B) addition of β-cyclodextrin to 29 / 
neutravidin. C) β-cyclodextrin into 29. 
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ITC analysis of the naphthalene biotin compound 22 with avidin, 
neutravidin and CBPQT
4+ was carried out in water. The experiments were 
carried out to investigate the effect on the strength of binding Ka upon 
changing from avidin to neutravidin. The effect of chain length upon 
CBPQT
4+ with the naphthalene biotin compound 22 was also 
investigated. 
The interaction between 22 and avidin showed a strong interaction 
with a Ka = 2.35 x10
7 M
-1. The interaction between 22 and neutravidin 
was lower with a Ka = 4.7 x10
6 M
-1. The difference is attributed to the 
change in the protein used. It has been shown that the lower binding 
affinity observed for neutravidin is typical for avidin related proteins.
[148]. 
The binding stoichiometry N for the two proteins with compound 22 was 
found to be 3 rather than the expected 4. However, this loss of a binding 
site is attributed to the oligomeric nature of conjugate. The interaction 
between compound 22 with CBPQT
4+ was also strong where the   
Ka = 2.05 x10
5 M
-1 showing that the affinity for the formation of the 
pseudorotaxane is reasonably unaffected by the presence of the biotin 
moiety. The thermodynamic data recorded for the interactions are shown 
in Table 7.5. The analysed data for each interaction are shown in   
Figure 7.19. 
 
  avidin + 22  Neutravidin + 22 CBPQT
4+ + 22 
N  2.9 ± 0.01  3.2 ± 0.03  1.19 ± 0.01 
Ka (M
-1)  2.35x10
7 ± 
3.81x10
6 
4.69x10
6 ± 
1.1x10
5  2.05x10
5 ± 7142
∆H (cal mol
-1)  -1.90x10
4 ± 
123.4  -1.91 ± 345.5  -1.23x10
4 ± 
95.36 
∆S (cal mol
-1 K
-1)  -29.9 -33.4  -16.8 
Table 7.5. Thermodynamic data recorded for ITC titration experiments of 22 with avidin, 
neutravidin and CBPQT
4+. 
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A  B 
 
C 
Figure 7.19. ITC graphs of A) 22 into avidin. B) 22 into neutravidin. C) CBPQT
4+ into 22. 
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7.3.2.3 Cyclic Voltammetry. 
 
For ferrocene to undergo the redox processes observed in a cyclic 
voltammetry experiment, it must be available to perform oxidation and 
reduction processes. When it has formed an inclusion complex with β-
cyclodextrin it cannot participate in the redox chemistry and must exit the 
cavity of the β-cyclodextrin in order to do so. As the amount of β-
cyclodextrin present in solution increases, the ferrocene does not leave 
the cavity of one β-cyclodextrin molecule long enough before re-entering 
another  β-cyclodextrin cavity and so gradually becomes unable to 
perform the redox cycle. 0.5 mM solutions of the ferrocene biotin 
compounds with 0.1 M NaCl were used for the CV studies where up to 5 
equivalents of β-cyclodextrin were added. The cyclic voltammograms 
were run after each equivalent of β-cyclodextrin was added. The results 
of the CV studies for the ferrocene biotin compounds 28 and 29 are 
shown in Figure 7.20 and Figure 7.21. 
As the β-cyclodextrin was added the half wave potential E½ shifted 
and the intensity of the signal was reduced as the redox activity of the 
ferrocene’s were reduced. By the fourth equivalent the redox wave was 
completely diminished for both systems, and the ferrocene was 
completely saturated with β-cyclodextrin. This indicates that the ability of 
ferrocene to form inclusion complexes with β-cyclodextrin was uninhibited 
by the functional group attached.  
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Figure 7.20. CV of compound 28 with increasing equivalents of β-cyclodextrin. 
 
Figure 7.21. CV of compound 29 with increasing equivalents of β-cyclodextrin. 
 
From the data produced in Figure 7.20 and Figure 7.21 it was 
observed that the redox activity was modulated with chain length such 
that the short chain system had an intensity of almost double that of the 
long chain system. The long chain system had a slightly higher E½ than 
the short chain system, this would indicate that it was slightly more 
difficult for the long chain ferrocene compound to undergo the oxidation 
Key 
0eq of CD 
1eq of CD 
2eq of CD 
3eq of CD 
4eq of CD 
5eq of CD 
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reduction wave. The data recorded for these systems are shown in Table 
7.6 and Table 7.7. The reduction in the intensity may be associated with 
dilution effects as the aliquots of β-cyclodextrin were added. The shift in 
the half wave potential upon addition of β-cyclodextrin was comparable to 
literature results.  
 
Table 7.6. Intensity and E½ of CVs collected for compound 28 and β-cyclodextrin. 
 
Table 7.7. Intensity and E½ of CVs collected for compound 29 and β-cyclodextrin. 
 
 
 
 
Equivalents of   
β-Cyclodextrin 
Half Wave 
Potential E½ 
Intensity of Signal 
0  +0.42 V  +2.63 E
-6  -2.82 E
-6A 
1  +0.43 V  +1.92 E
-6  -2.19 E
-6A 
2  +0.48 V  +1.40 E
-6  -1.84 E
-6A 
3  +0.49 V  +1.22 E
-6  -1.62 E
-6A 
4 N/A  N/A 
5 N/A  N/A 
Equivalents of   
β-Cyclodextrin 
Half Wave 
Potential E½ 
Intensity of Signal 
0  +0.42 V  +1.46 E
-6  -1.85 E
-6A 
1  +0.46 V  +1.05 E
-6  -1.49 E
-6A 
2  +0.48 V  +9.70 E
-7  -1.31 E
-6A 
3  +0.50 V  +9.02 E
-7  -1.20 E
-6A 
4 N/A  N/A 
5 N/A  N/A  
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7.3.2.4 
1H NMR studies with β-cyclodextrin. 
 
1H NMR spectra recorded in D2O were obtained for ferrocene 
biotin compounds with and without solvent suppression. Without solvent 
suppression, the signals for the compounds were swamped by the water 
and most of the detail was lost. By running with solvent suppression 
almost all signals were then visible. The ferrocene Cp ring resonances 
were diminished in intensity due to the overlap with the water signal. One 
equivalent of β-cyclodextrin was then added to each sample and the   
1H NMR spectra were re-run with and without solvent suppression. Upon 
addition of the β-cyclodextrin a slight shift of the Cp ring protons to the 
right was observed, indicating interaction with the cyclodextrin.  
There was also a shift to the right for some of the aliphatic protons 
that were in close proximity to the ferrocene Cp rings. The shifts indicate 
that the ferrocene protons had become shielded by the cyclodextrin, 
which in turn would suggest that the inclusion complex had been formed. 
The additional shifts in the alkyl and biotinyl protons observed in both 
systems would indicate an increase in steric effects and or a change in 
structural conformation, suggesting that the cyclodextrin has interacted 
with the ferrocene moiety in such a way that the structural conformation in 
solution has changed. This change would also imply that the inclusion 
complex has been formed in both cases. Although the typical splitting of 
the Cp rings was not observed, this may be associated with the weak 
interaction that occurs, as observed by the ITC results, and that there is 
no saturation of the with β-cyclodextrin in the NMR sample. Addition of an 
excess of β-cyclodextrin may have produced the expected splitting 
pattern. The 
1H NMR spectra recorded with solvent suppression of the 
biotin compounds with the spectra recorded for the addition of β-
cyclodextrin overlayed are shown in Figure 7.22 and Figure 7.23. 
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Figure 7.22. Spectra of the ferrocene SC biotin 28 with β-cyclodextrin added. 
 
Figure 7.23. Spectra of the ferrocene LC biotin 29 with β-cyclodextrin added. 
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7.4.Conclusions and Future Work. 
 
7.4.1. Conclusions. 
 
Two ferrocene functionalised biotin conjugates 28 and 29 have 
been successfully synthesised and it has been shown that these 
conjugates will successfully displace HABA from the binding sites of 
avidin protein, neutravidin. 
ITC experiments have shown that the Ka of binding between the 
avidin proteins and the conjugates is still strong, although reduced 
relative to native biotin avidin interactions. The interactions between β-
cyclodextrin and the ferrocene moieties were investigated by 
1H NMR 
studies, where the changes in the proton shifts were recorded as β-
cyclodextrin was added to aqueous solutions of each conjugate. The 
defined shifts indicated that the β-cyclodextrin formed inclusion 
complexes with the ferrocene moiety of the conjugates.  
Cyclic voltammetry experiments showed that these conjugates 
retained their redox activity and that the addition of cyclodextrin 
modulated the redox behaviour exhibited by the ferrocene systems of 
these compounds. 
A naphthalene functionalised biotin conjugate with a shorter tether 
had also synthesised within Prof G Cooke’s group for the investigation of 
its interactions with avidin, and neutravidin in addition to CBPQT
4+. ITC 
showed that the conjugate had a high affinity for both avidin and 
neutravidin. UV-Vis and fluorescence spectroscopy showed that the 
interactions between CBPQT
4+ and the naphthalene moiety were 
unaffected by both the biotin group and when complexed to avidin, where 
the pseudorotaxane formed was unhindered by the biotin and the avidin. 
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7.4.2. Future Work. 
 
Further investigation of the effects of neutravidin on the redox 
activity of the conjugates by cyclic voltammetry experiments would have 
been pursued with more time available. 
Additional investigation of the host-guest interactions could be 
performed where the use cucubit-[7]-uril could be used in place of β-
cyclodextrin. This investigation could yield interesting results where the 
binding interactions could be measured by ITC, NMR and cyclic 
voltammetry. 
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8 
Experimental. 
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8.1 General Experimental and Materials. 
 
1H NMR spectra were run on Bruker Avance 400MHz, and Bruker 
Avance 500MHz spectrometers. All NMR spectra used tetramethylsilane 
(TMS) as reference (δ = 0.0 ppm) 
MS spectra were obtained from the Mass Spectrometry laboratory 
in the Chemistry Department of the University of Glasgow. Measurements 
were run on a JEOL JMS 700 Mass Spectrometer [FAB, EI, CI, Accurate 
Mass] MALDI tof mass spectroscopy was obtained from the Mass 
Spectroscopy lab at the University of Strathclyde. The measurements 
were run on an AXIMA-CFR-MALDI TOF Mass Spectrometer. 
Transmission IR spectra were recorded on Perkin-Elmer RX FT-IR 
system. 
All melting points recorded are uncorrected. 
Calorimetry experiments were run on a MicroCal VP-ITC 
Microcalorimeter. CT-DNA was supplied by Sigma-Aldrich and used as 
supplied. The synthetic Dickerson DNA was supplied by MWG-Biotech 
AG   Sequence d(CGCGAATTCGCG)2 lypholised. 
Cyclic Voltammetry experiments were carried out on a CH-
Instruments Electrochemical Workstation. 
UV-Vis Spectrometers used were Perkin-Elmer LAMBDA 25 UV-
Vis Spectrometer and a THERMO HELIOS B UV-Vis Spectrometer. 
Fluorescence measurements were run on a Shimadzu 
Spectrophotometer RF-5301PC. 
Microscopy work was carried out on a Leitz DMIRB with a Zeiss 
Axiocam attached. 
All chemicals were supplied from Sigma Aldrich and were used 
without purification unless stated.  
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8.2 Synthesis. 
 
1,5-Bis (2-(2-hydroxyethoxy)ethoxy) naphthalene (2).  
 
 
 
To a solution of 1,5-dihydroxynaphthalene (15 g, 0.094 mol) in 
acetonitrile (100 mL) was added first potassium carbonate (37.5 g,   
0.28 mol), allowing the reaction mixture to stir for ~5 minutes.   
2-(2-chloroethoxy)ethanol (30 mL, 0.28 mol) was then added slowly 
portionwise. The reaction mixture was heated under reflux at 80°C for 
one week. An additional equivalent of potassium carbonate (12.5 g) and  
2-(2-chloroethoxy)ethanol (10 mL) was added and the reaction mixture 
was heated under reflux for a further two days. Once cool the reaction 
mixture was filtered washing with acetonitrile. The filtrate was evaporated 
to yield a very dark oily solid. This solid was taken up in DCM (250 mL) 
and water (250 mL). The DCM layer was removed and the aqueous layer 
was washed with DCM (3x 50 mL). The combined organic layers were 
then extracted with saturated potassium carbonate solution (2 x 100 mL) 
and saturated brine (1 x 100 mL). The organic layer was then dried over 
magnesium sulfate, filtered and evaporated in vacuo to yield a dark solid. 
The product was separated by flash silica column chromatography, 
eluting with a gradient of 0-100% EtOAc in DCM. The product was 
recovered in a 36% yield as a pale green solid. 
[10] 
[149] 
1H NMR in CDCl3, 400 MHz, δ: 7.80 (2H, d, J=8.4Hz, 2x CH), 7.29 
(2H, t, J = 8.0Hz, 2x CH), 6.79 (2H, d, J = 8.0Hz, 2x CH), 4.24 (4H, m, 2x 
CH2), 3.94 (4H, m, 2x CH2), 3.69 (8H, m, 4x CH2), 1.86 (2H, br.s, 2x OH) 
13C NMR in CDCl3, 400 MHz, δ: 154.29 (QC), 126.77 (QC), 125.20 (CH),  
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114.63 (CH), 105.81 (CH), 72.61 (CH2), 69.77(CH2), 67.90(CH2), 61.85 
(CH2), 60.42 (CH2). IR (cm
-1) 3505(OH), 2929(CH2), 2895(CH2), 2866 
(CH2), 1596(Ar CH), 1513 (Ar CH), 1421 (Ar CH), 1399 (Ar CH), 1272 (Ar 
CH). Mass spectrum [M+H]
+ = 337.3 CI/ISO. 
 
 
1-(2-(2-(toluene-4-sulfonyl)ethoxy)ethoxy)-5-(2-(2-
hydroxyethoxy)ethoxy) naphthalene (3a). 
 
 
 
To a solution of 2 (2,050 mg, 6.1 mmol) in DCM (100 mL) was 
added triethylamine (0.95 mL, 6.71 mmol) followed by tosyl chloride 
portionwise (1,160 mg, 6.1 mmol). The reaction mixture was stirred at 
room temperature overnight. The solvent was then removed in vacuo to 
yield a dark brown oil. Separation of impurities by flash silica column 
chromatography using 100% ethyl acetate followed by a second 
purification by flash column chromatography eluting with pet ether and 
ethyl acetate in 25% step-wise gradient starting with 100% pet ether. The 
required product was obtained a pale solid in a 32% yield of 3a and 30% 
yield of 3b.
[150] 
1H NMR of 3a, CDCl3, : 7.89 (1H, d, J = 8.4Hz, CH), 7.85 (1H, d, 
J = 8.4Hz, CH), 7.83-7.79 (2H, m, 2x CH), 7.39 (2H, dt, J1 = 8.4Hz, J2 = 
2.4Hz, 2x CH), 7.27 (2H, d, J = 8.6Hz, 2x CH), 6.88 (1H, d, J = 7.6Hz, 
CH), 6.83 (1H, d, J = 7.6Hz, CH), 4.35 (2H, t, J = 4.6Hz, CH2), 4.27-4.21 
(4H, m, 2x CH2), 4.04 (2H, t, J = 4.8Hz, CH2), 3.95 (2H, t, J = 4.8Hz, 
CH2), 3.86(2H, t, J = 4.8Hz, CH2), 3.84-3.76 (4H, m), 2.39 (3H, s, CH3) IR  
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(cm
-1): 3509(OH), 2970, 2925, 2902, 2865, 1595, 1512, 1458, 1416, 
1357, 1269, 1168, 1067. Mass spectrum = [M+H]
+ 491.2. 
1H NMR of 3b, 
CDCl3, : 7.83 (2H, d, J = 8.6Hz, 2x CH), 7.78 (4H, d, J = 8.1Hz, 4x CH), 
7.35 (2H, d, J = 8.1Hz, 2x CH), 7.25 (4H, d, J = 8.3Hz, 4x CH), 6.82 (2H, 
d, J = 8.1Hz, 2x CH), 4.24-4.20 (8H, m, 4x CH2), 3.93 (4H, t, J = 4.6Hz, 
2x CH2), 3.84 (4H, t, J = 4.6Hz, 2x CH2), 2.37 (6H, s, 2x CH3) IR (cm
-1): 
2949, 2920, 2907, 2884, 1596, 1514, 1415, 1346, 1271, 1163, 1067. 
Mass spectrum [M+H]
+ = 644.8. 
 
 
1-(2-(2-(azido)ethoxy)ethoxy)-5-(2-(2-hydroxyethoxy)ethoxy) 
naphthalene (4).  
 
 
 
To a solution of 3a (1,110 mg, 2.27 mmol) in DMF (30 mL) was 
added slowly sodium azide (340 mg, 5.22 mmol). The reaction mixture 
was heated gently to ~55-60 °C for 24 hours. The reaction was then 
partitioned between diethyl ether (50 mL) and water (50 mL). The organic 
layer was separated and then washed three times with water (3x 30 mL). 
The organic layer was then dried over magnesium sulfate, filtered and 
evaporated in vacuo. The resulting oil was purified by flash silica column 
chromatography eluting with 0-60% EtOAc DCM. The product was 
recovered as a pale oil in a 70% yield.
[151] 
1H NMR, CDCl3 : 7.90 (1H, d, J = 4.2Hz, CH), 7.88 (1H, d, J = 
4.2Hz, CH), 7.39 (2H, dt, J1 = 8.0Hz, J2 = 2.5Hz, 2x CH), 6.88 (2H, d, J =  
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8.1Hz, 2x CH), 4.34 (4H, t, J = 5.0Hz, 2x CH2), 4.05-4.01 (4H, m, 2x 
CH2), 3.86 (2H, t, J = 5.0Hz, CH2), 3.84-3.75 (4H, m, 2x CH2), 3.46 (2H, t, 
J = 5.0Hz, CH2). 
13C NMR CDCl3 : 154.29 (QC), 126.7 (QC), 125.2 (CH), 
125.1 (CH), 114.6 (CH), 105.8 (CH), 72.6 (CH2), 70.4 (CH2), 69.9 (CH2), 
69.81 (CH2), 68.0 (CH2), 61.9 (CH2), 50.86 (CH2). IR (cm
-1): 3488(OH), 
2933, 2909, 2885, 2866, 2102(N3), 1595, 1510, 1414, 1267. Mass 
spectrum [M+H]
+ = 362.2. 
 
 
1-(2-(2-(amino)ethoxy)ethoxy)-5-(2-(2-hydroxyethoxy)ethoxy) 
naphthalene (5). 
 
 
 
To a solution of 4a (795 mg, 2.02 mmol), in methanol (50 mL) was 
added palladium on carbon (5 mol%, 147 mg). The reaction mixture was 
degassed and H2 gas was introduced into the flask. The mixture was 
stirred for three and a half hours. After this time the mixture was filtered 
by vacuum under an atmosphere of nitrogen gas, and washed with 
acetone and methanol. Due to suck back of water into the vacuum flask, 
the filtrate was evaporated to remove the acetone and methanol. The 
resulting aqueous solution was extracted with DCM (50 mL), separated 
and then washed with DCM (3x 30 mL). The organic layers were 
combined, dried over magnesium sulfate filtered and evaporated in vacuo 
to yield a pale green oil. 
1H NMR in CDCl3 showed significant impurities, 
the TLC showed no movement of the mixture. An acid/base extraction 
was carried out, taking the impure mixture up DCM washing first with 1 M  
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HCl. The organic layer was recovered, dried over magnesium sulfate, 
filtering and evaporating in vacuo. Mass spectrum [M+H]
+ = 332.2. The 
aqueous layer was then neutralised with saturated sodium bicarbonate 
solution, extracting with DCM. The organic layer was dried over 
magnesium sulfate, filtering and evaporating in vacuo. Mass spectrum 
[M+H]
+ = 336.2 
1HNMR in CDCl3 still showed significant impurities. 
 
 
1-(2-(2-(N-hexamethylenetetrammonium)ethoxy)ethoxy)-5-(2-(2-
hydroxylethoxy)ethoxy) naphthalene (10).
[152] 
 
 
 
To a solution of hexamethylenetetramine (73 mg, 0.52 mmol) 
stirring at reflux in chloroform was added a solution of 3a  (212 mg,   
0.43 mmol) in chloroform dropwise over a period of ~20 minutes. Once all 
of compound 3a was added, the reaction mixture was heated under reflux 
for three hours. Once cool the reaction was sampled, 
1H NMR was run in 
CDCl3 and a Mass Spectrum was run. 
1H NMR was inconclusive as there 
was a 1:1 mixture of hexamethylene tetramine and the naphthalene 
compound. Mass spectrum [M+H]
+  = 490 which relates to the starting 
material. Thin layer chromatography (TLC) showed one spot only. The 
reaction solvent was changed to 50:50 DMF chloroform and NaI (23 mg) 
and additional hexamethylenetetramine (50 mg) was added and the 
reaction mixture was heated to reflux for 24 hours. The mass spectrum 
showed starting material present only after this time.   
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1-(2-(2-(2-(cyano)ethoxy)ethoxy)ethoxy)-5-(2-(2-hydroxylethoxy) 
ethoxy) naphthalene (13a). 
 
 
 
To a solution of 2 (500 mg, 1.48 mmol) in DMF (20 mL) was added 
sodium hydride (60% dispersion, 59 mg, 1.48 mmol). The reaction 
mixture changed colour from light yellow/green to cloudy green colour. 
Bromopropionitrile (198 mg, 1.48 mmol, 0.12 mL) was added dropwise. 
The solution became a more opaque colour and gradually became 
translucent over the course of 1 hour. TLC, mass spectrum and 
1H NMR 
showed no reaction.  
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1-(2-(2-(2-(cyano)ethoxy)ethoxy)ethoxy)-5-(2-(2-hydroxyethoxy) 
ethoxy) naphthalene (13a).
[83]  
 
 
 
To a solution of 2 (1000 mg, 2.97 mmol) in DCM (30 mL) at 0°C 
was added first acrylonitrile (158 mg, 2.97 mmol, 0.2 mL), followed by 
TRITON B
* (50 mg, 0.3 mmol, 0.12 mL) 
*([Benzyltrimethylammonium 
hydroxide] 40wt.% solution in water). The reaction mixture was stirred at 
0°C for one hour then warmed slowly to room temperature where it was 
stirred for a further ten minutes. The reaction mixture was then added 
dropwise to saturated ammonium chloride solution (50 mL). An extraction 
in water / DCM (50 mL) was carried out. The aqueous layer was washed 
with DCM (3x 50 mL). The organic layer was then dried over magnesium 
sulfate, filtered and evaporated in vacuo to yield a yellow oil. The 
products were separated by flash silica column chromatography, eluting 
with 0-50% EtOAc in DCM followed by 7:1 EtOAc in acetone. The mono 
propionitrile naphthalene 13a was recovered in a 26% yield as a pale oil 
(288 mg), while the bis propionitrile naphthalene 13b was recovered in a 
20% yield as a light brown oil (248 mg). 
1H NMR CDCl3 Mono-alkylated product 13a. δ : 7.86 (2H, d, J = 
8.4Hz, 2x CH), 7.33 (2H, t, J = 8.0Hz, 2x CH), 6.76 (2H, t, J = 6.9Hz, 2x 
CH), 4.16 (4H, dt, J1 = 4.3Hz, J2 = 13Hz, 2x CH2), 3.86 (4H, dt, J1 = 
4.3Hz, J2 = 13Hz, 2x CH2), 3.68 (4H, d, J = 3Hz, 2x CH2), 3.62-3.54 (6H, 
m, 3x CH2), 2.46 (2H, t, J = 6.2Hz, CH2). 
13C NMR, δ: 154.3 (QC), 126.7 
(QC), 125.3 (CH), 118.2 (QC), 114.5 (CH), 105.8 (CH), 72.8 (CH2), 70.8 
(CH2), 70.6 (CH2), 69.8 (CH2), 69.6 (CH2), 67.8 (CH2), 65.8 (CH2), 61.6  
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(CH2), 18.7(CH2). IR (cm
-1): 3540(OH), 2937, 2875, 2175(CN), 1594, 
1510, 1415, 1267. Mass spectrum [M+H]
+ = 390.2 
1H NMR, CDCl3 Bis-alkylated product 13b. δ : 7.78 (2H, d, J = 
8.4Hz, 2x CH), 7.27 (2H, t, J = 8.0Hz, 2x CH), 6.75 (2H, d, J = 8.0Hz, 2x 
CH), 4.83-4.20 (4H, m, 2x CH2), 3.9-3.88 (4H, m, 2x CH2), 3.69 (4H, d, J 
= 4.4Hz, 2x CH2), 3.6-3.52 (8H, m, 4x CH2), 2.46 (4H, t, J = 6.2Hz, 2x 
CH2). IR (cm
-1): 2962, 2923, 2876, 2248(CN), 1593, 1511, 1416, 1266. 
Mass spectrum [M+H]
+ = 443.2 
 
 
1-(2-(2-(3-aminopropoxy)ethoxy)ethoxy)-5-(2-(2-hydroxyethoxy) 
ethoxy) naphthalene (14). 
 
 
 
To a flask containing mono propionitrile naphthalene 13a (270 mg, 
0.69 mmol) in THF (40 mL) was added lithium aluminium hydride   
(240 mg, 1.73 mmol). The reaction mixture was stirred at room 
temperature for 24 hours. After this time the mixture was cooled to 0°C 
and quenched with 10% sodium hydroxide solution (40 mL). The resulting 
suspension was filtered, and the aqueous layer was washed with with 
DCM (3x 200 mL). The aqueous liquor was separated, and was washed 
with DCM (2 x 200 mL). The combined organic layers were washed with 
water (2x 200 mL) and brine (200 mL). The combined organic layer was 
concertrated under vacuum. Silica column chromatography eluting with 
initially 100% DCM, then 50% acetone in ethyl acetate, then flushing the  
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column with methanol failed to produce either the product or starting 
material. Repetition of the reaction showed that a retro-Michael reaction 
took place to give dialkoxynaphthalene 2 as the only product. 
 
 
1-(2-(2-(N-(9-fluorenylmethyloxycarbonyl)-gamma-butanoyl) 
oxyethoxy)ethoxy)-5-(2-(2-hydroxyethoxy)ethoxy) naphthalene (15). 
 
 
 
To a solution of 2  (1,000 mg, 3.0 mmol) in DMF (40 mL) was 
added 4-(Fmoc-amino)-butyric acid (960 mg, 3.0 mmol), EDCI (570 mg, 
3.0 mmol), and DMAP (360 mg, 3.0 mmol). The reaction mixture was 
stirred at room temperature for 24 hrs. The reaction was taken up in DCM 
(100 mL) and extracted three times with water (3x 50 mL). The organic 
phase was dried over magnesium sulfate, filtered and evaporated in 
vacuo to yield a pale yellow oil. The product was separated by flash silica 
column chromatography, eluting with a gradient of 0-100% EtOAc / pet 
ether. Column chromatography was not completely successful with EDCI  
by-products present on 
1H NMR. 
1H NMR CDCl3, , δ : 7.86 (2H, d, J = 9Hz, 2x CH), 7.75 (2H, d, J = 
7.4Hz, 2x CH), 7.57 (2H, d, J = 7.4Hz, 2x CH), 7.40-7.28(6H, m, 6x CH), 
6.81(2H, t, J = 6.8Hz, 2x CH), 4.39(2H, d, J = 10.3Hz), 4.29-4.23(6H, m), 
4.18(1H, t, J = 6.7Hz), 3.81(2H, t, J = 4.5Hz), 3.77-3.75(2H, m), 3.73-
3.70(2H, m), 3.13(1H, q, J = 4.8Hz), 2.31(2H, t, J = 7.2Hz), 1.77(2H, p, J 
= 6.9Hz) Mass spectrum [M+H]
+ = 644.3 the [-Fmoc M+H]
+ = 423.2 was 
also present in the mass spectrum.  
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Attempted Synthesis of 1-(2-(2-(6-aminohexanoyl)oxyethoxy)ethoxy) 
-5-(2-(2-hydroxyethoxy)ethoxy) naphthalene (6). 
 
 
 
To a solution of dialkoxynaphthalene 2 (500 mg, 1.4 mmol) in DMF 
(50 mL) was added EDCI (268 mg, 1.4 mmol), DMAP (170 mg, 1.4 mmol) 
and 6-amino caproic acid (195 mg, 1.4 mmol). The reaction mixture was 
stirred at room temperature for 3 days, monitoring by TLC. As there was 
no reaction after 3 days, the mixture was heated under reflux for 16 
hours. After this point there was still no reaction. The starting material 
was recovered by silica column chromatography. 
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1-(2-(2-(amino)ethoxy)ethoxy)-5-(2-(2-hydroxyethoxy)ethoxy) 
naphthalene (5).
[153] 
 
 
 
To a solution of 4a (1,723 mg, 4.77 mmol), in dry THF (100 mL) 
was added triphenylphosphine (3,120 mg, 11.9 mmol). The reaction 
mixture was stirred at room temperature for 24 hrs. Water (1 mL) was 
added to the reaction mixture and allowed to stir for a further three hours. 
The solvent was then removed in vacuo to yield a pale oil. Flash silica 
column chromatography eluting with 0-97 % acetone in DCM with 3 % 
triethylamine held constant throughout the chromatography yielded the 
imine form (5b) of the product in an 86 % yield. Imine readily converts 
back to the amine 5a in both mildly acidic and basic conditions. 
1H NMR of Naphthalene amine 5a, CDCl3:   7.88 (1H, d, J = 
5.7Hz, CH), 7.86 (1H, d, J = 5.7Hz, CH), 7.38-7.31 (2H, m, 2xCH), 6.84 
(2H, d, J = 7.6Hz, 2xCH), 4.29 (2H, t, J = 5.7Hz, CH2), 4.28 (2H, t, J = 
5.7Hz), 3.99 (2H, t, J = 4.5Hz, CH2), 3.94 (2H, t, J = 4.5Hz, CH2), 3.7-3.8 
(4H, m, 2x CH2), 3.63 (2H, t, J = 5.7Hz, CH2), 2.89 (2H, t, J = 5.7Hz, 
CH2), 1.98 (3H, broad s NH2 and OH). 
13C NMR CDCl3:  154.4 (QC), 
154.3 (QC), 126.83 (QC), 126.77 (QC), 125.2 (CH), 125.1 (CH), 114.7 
(CH), 114.5 (CH), 105.8 (CH), 73.5 (CH2), 72.7 (CH2), 69.8 (CH2), 69.6 
(CH2), 67.9 (CH2), 61.8 (CH2), 41.8 (CH2). Mass Spectrum. [M+H]
+  = 
336.2 Exact mass (335.2) also found. IR (cm
-1): 3509 (OH), 3385 (NH2), 
3312, 2950, 2929, 2896, 2866, 1596, 1512, 1456, 1422, 1398, 1269. 
1H NMR of Naphthalene imine 5b. CDCl3:  7.86 (1H, d, J = 8.2Hz, 
CH), 7.86 (1H, t, J = 8.3Hz, CH) *overlapping signals, 7.38-7.31 (2H, m,  
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2xCH), 6.84 (2H, d, J = 7.6Hz, 2xCH), 4.33-4.24 (4H, m, 2xCH2), 4.02-
3.94 (4H, m, 2xCH2), 3.88 (2H, t, J = 6.2Hz, CH), 3.76 (4H, dt, J = 8.1Hz, 
J = 3.8Hz, 2xCH2), 3.44 (2H, t, J = 6.2Hz, CH), 2.03 (3H, s, CH3), 1.85 
(3H, s, CH3). 
13C NMR in CDCl3 was very complicated with a mixture of 
the imine and amine present.
 13C NMR CDCl3:  207.0 (Acetone), 169.3 
(QC), 154.4 (QC), 154.3 (QC), 126.84 (QC), 126.76 (QC), 125.2 (CH), 
125.1 (CH), 125.0 (CH), 114.9 (CH), 114.7 (CH), 114.5 (CH), 114.4 (CH), 
105.8 (CH),105.75(CH),105.72(CH), 73.5 (CH2), 72.7 (CH2), 71.9 (CH2), 
69.8 (CH2), 69.6 (CH2), 67.9 (CH2), 61.8 (CH2), 51.49(CH3),41.8 (CH2), 
30.97(CH3), 29.3(Acetone), 18.95 (CH2). Mass spectrum = 375.2 and 
335.2. 
 
1-(2-(2-(10,12-pentacosadiynoyl)aminoethoxy)ethoxy)-5-(2-(2-
hydroxyethoxy)ethoxy) naphthalene (7). 
 
 
 
To a solution of the naphthalene amine 5 (1,290 mg, 3.85 mmol) in 
DCM (50 mL) was added sequentially EDCI (570 mg, 3.85 mmol), DMAP 
(470 mg, 3.85 mmol), and 10,12-pentacosadiynoic acid (1.44 g,   
3.85 mmol). The reaction mixture was then stirred at room temperature 
for 3 days in the dark. The solvent was then removed in vacuo in the dark 
to yield pink/orange oily solid. Purification by silica column  
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chromatography, eluting with a 20 % stepwise gradient of 0-100% ethyl 
acetate in DCM gave the product as an off white solid in a 60% yield. 
1H NMR in CDCl3, δ: 7.87 (2H, t, J = 8.1Hz, 2x CH), 7.39-7.34 (2H, 
m, 2x CH), 6.87 (2H, d, J = 7.6Hz, 2x CH), 5.85 (1H, br t, J = 5.3Hz, NH), 
4.34-4.29 (4H, m, 2xCH2), 4.03-4.01 (2H, m, CH2), 3.98-3.96 (2H, m, 
CH2), 3.82-3.74 (4H, m, 2x CH2), 3.7 (1H, d, J = 5.1Hz), 3.69 (1H, d, J = 
5.1Hz), 3.52-3.48 (2H, m, CH2), 2.26-2.21(4H, m, 2xCH2), 2.07-2.02 (3H, 
m), 1.55-1.45 (6H, m, 3x CH2), 1.41-1.30 (5H, m), 1.26 (16H, s, 8x CH2), 
1.22-1.21 (5H, m), 0.9-0.87 (3H, m). 
13C NMR in CDCl3, δ: 173.14 (QC), 
154.28 (QC), 154.27 (QC), 126.83 (QC), 126.76 (QC), 125.2 (CH), 
114.71 (CH), 114.49 (CH), 105.82 (CH), 77.63 (QC), 77.47 (QC), 72.6 
(CH2), 70.15 (CH2), 69.78 (CH2), 69.57 (CH2), 67.93 (CH2), 67.78 (CH2), 
65.31 (QC), 65.23 (QC), 61.87 (CH2), 39.13 (CH2), 36.67 (CH2), 31.92 
(CH2), 29.63 (CH2), 29.49 (CH2), 29.35 (CH2), 29.11 (CH2), 28.88 (CH2), 
28.77 (CH2), 28.36 (CH2), 28.30 (CH2), 25.62 (CH2), 22.69 (CH2), 19.19 
(CH2), 14.12 (CH3). IR (cm
-1): 3407 (OH), 3283, 2922, 2894, 2848, 
1638(Amide), 1594, 1546, 1514, 1414, 1266. Mass spectrum [M+H]
+ = 
692.48 Accurate Mass (691.48). 
 
1,5-Bis (2-(2-(azido)ethoxy)ethoxy) naphthalene (11). 
 
 
 
To a solution of 3b (2,040 mg, 3.07 mmol) in DMF (30 mL) was 
added slowly sodium azide (920 mg, 14.12 mmol). The reaction mixture 
was heated gently to ~55-60°C for 24 hours. Once cool the reaction was 
then poured into diethyl ether (50 mL) and water (50 mL). The organic  
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layer was separated and washed with water (3x 30 mL). The organic 
layer was then dried over magnesium sulfate, filtered and evaporated in 
vacuo. The resulting oil was purified by flash silica column 
chromatography eluting with 0-60% EtOAc DCM. The product was 
recovered as a pale oil in a 73% yield (887 mg).  
1H NMR, CDCl3 : 7.87 (2H, d, J = 7.8Hz, 2x CH), 7.36 (2H, t, J = 
7.7Hz, CH), 6.86 (2H, d, J = 8.2Hz, 2x CH), 4.32 (4H, t, J = 4.7Hz, 2x 
CH2), 4.01 (4H, t, J = 4.7Hz, 2x CH2), 3.83 (2H, t, J = 4.9Hz, CH2), 3.44 
(4H, t, J = 4.9Hz, 2x CH2). 
13C NMR CDCl3 : 154.29 (QC), 126.7 (QC), 
125.1 (CH), 114.7 (CH), 105.8 (CH), 70.4 (CH2), 69.9 (CH2), 68.0 (CH2), 
50.9 (CH2). Mass Spectrum [M+H]
+ = 387.4. IR (cm
-1): 2947, 2922, 2876, 
2102 (N3), 2080 (N3), 1590, 1508, 1414, 1269. 
 
 
1,5-Bis (2-(2-(amino)ethoxy)ethoxy) naphthalene (12).
[153]  
 
 
 
To a solution of 11 (880 mg, 2.3 mmol), in dry tetrahydrofuran 
(50mL) was added triphenylphosphine (1,500 mg, 5.75 mmol). The 
reaction mixture was stirred at room temperature for 24 hrs. Water (0.4 
mL) was added to the reaction mixture and allowed to stir for a further 
three hours. The solvent was then removed in vacuo to yield a pale oil. 
The oil was taken up in DCM (100 mL) and 1.2 M hydrochloric acid (100 
mL) was added. After separation the aqueous layer was washed with 
DCM (2x 100 mL). After the organic layer was removed, the hydrochloric  
 
259 
 
acid layer was neutralised with sodium bicarbonate. DCM was then 
added and the mixture was partitioned. The aqueous layer was washed 
with DCM (3x 100 mL). The organic fractions after neutralisation were 
combined and dried over MgSO4, filtered and evaporated under reduced 
pressure to yield a white oily solid. Flash silica column chromatography 
eluting with 0-45 % acetone in DCM with 3 % triethylamine held constant 
throughout the chromatography failed to yield the required product. 
 
 
1-(2-(2-(bromo)ethoxy)ethoxy)-5-(2-(2-hydroxyethoxy)ethoxy) 
naphthalene (8).
[154] 
 
 
 
To a solution of the naphthalene diol 2 (1000 mg, 3.0 mmol), in 
acetonitrile (50 mL) at 0°C, under an atmosphere of nitrogen, was added 
carbon tetrabromide (990 mg, 3.0 mmol). The solution was stirred for 10 
minutes, then triphenylphosphine (780 mg, 3.0 mmol) was added. The 
reaction mixture was slowly allowed to warm to room temperature and 
then stirred for a further 24 hours. The solvent was removed in vacuo to 
yield a dark red solid. Silica column chromatography eluting with 20% 
acetone in DCM gave the required product as a pale pink solid in a 44% 
yield. 
[154] 
1H NMR (400 MHz, CDCl3)  7.79 (d, J = 8.4 Hz, 2H), 7.29 (t,  
J = 8 Hz, 2H), 6.77 (d, J = 7.6 Hz, 2H), 4.23 (t, J = 4.6 Hz, 4H), 3.95-3.87 
(m, 6H), 3.68 (m, 4H), 3.45 (t, J = 6 Hz, 2H).
13C NMR (400MHz, CDCl3) δ: 
154.28 (QC), 126.79 (QC), 125.23 (CH), 125.15 (CH), 114.75(CH), 
114.61(CH), 105.86 (CH), 105.82 (CH), 72.61 (CH2), 71.50 (CH2), 69.79 
(CH2), 69.77 (CH2), 67.97 (CH2), 67.93 (CH2), 61.73 (CH2), 30.40 (CH2).  
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IR (cm
-1): 3513 (OH) 2963, 2929, 2905, 2844, 1595, 1510, 1416, 1275, 
1186. Mass spectrum [M+H]
+ = 398.1 and 400.1 (
79Br and 
81Br). 
 
 
1-(2-(2-((trimethyl)ammonium)ethoxy)ethoxy)-5-(2-(2-
hydroxyethoxy)ethoxy) naphthalene bromide (9). 
 
 
 
 
To solution of the naphthalene bromide 8 (460 mg, 1.16 mmol) in 
methanol (70mL) was added dropwise trimethylamine (4.40 mL,   
17.6 mmol). The reaction mixture was heated under reflux for 18 hours. 
After this time the reaction mixture was allowed to cool. The volume of 
methanol was reduced from 70 mL to 10 mL under reduced pressure. 
Diethyl ether (150 mL) was slowly added until total precipitation of the 
product had occurred. Vacuum filtration recovered the product as a white 
solid that was washed thoroughly with diethyl ether. The product was 
recovered in a 90% yield. 
1H NMR (400 MHz, MeOD)  7.85 (d, J =  8.4 Hz, 1H), 7.78 (d, J = 
8.4 Hz, 1H), 7.35 (t, J = 7.4 Hz, 2H), 6.96 (d, J = 7.6 Hz, 1H), 6.95 (d, J = 
7.6 Hz, 1H), 4.36-4.29 (m, 4H), 4.09-3.98 (m, 6H), 3.71 (s, 4H), 3.62 (t, J 
= 4.6 Hz, 2H), 3.16 (s, 9H). 
13C NMR (400MHz, D2O) δ: 126.08 (CH), 
126.01 (CH), 114.60 (CH), 114.26 (CH), 107.54 (CH), 107.25 (CH), 72.00 
(CH2), 69.44 (CH2), 69.21 (CH2), 68.11 (CH2), 67.98 (CH2), 65.31 (CH2), 
64.56 (CH2), 60.42 (CH2), 53.78 (CH3) IR(cm
-1): 3339, 3313, 3236, 3211, 
2977, 2943, 2922, 2872, 2852, 2365, 2339, 1593, 1510, 1415, 1268, 
1133. Mpt. 51-53 
oC (dec). Mass Spectrum (ESI
+): [M
+] = 378.2.  
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1-(2-(2-methoxyethoxy)ethoxy),-5-(2-(2-hydroxyethoxy)ethoxy) 
naphthalene (17a).  
 
 
 
To a solution of 2  (2,960 mg, 8.8 mmol) in DMF (50 mL) was 
added sodium hydride (352 mg, 8.8 mmol, 60 % dispersion). The reaction 
mixture was stirred for five minutes. Methyl iodide (0.55 mL, 8.8 mmol) 
was then added and the reaction was stirred at room temperature for 24 
hours. The mixture was taken up in ethyl acetate (200 mL) and washed 
thoroughly with water (3x 500 mL). The organics were dried over MgSO4, 
`filtered and evaporated to yield a dark oil. Flash silica column 
chromatography eluting with 0-100% EtOAc DCM recovered the products 
17a  (1.08 g) and 17b (411 mg) as oils in a 43% and 16% yield 
respectively. 
[13] 
1H NMR of 17a in CDCl3, δ : 7.87 (2H, t, J = 9.3 Hz, 2x CH), 7.36 
(2H, t, J = 8.1 Hz, 2x CH), 6.85 (2H, d, J = 7.63Hz, 2x CH), 4.32 (4H, t, J 
= 4.24Hz, 2x CH2), 4.01 (4H, t, J = 4.24Hz, 2x CH2), 3.83 – 3.77 (4H, m, 
2x CH2), 3.77 – 3.73 (2H, m, CH2), 3.61 (2H, t, J = 4.0Hz, CH2), 3.41 (3H, 
s, CH3). IR (cm
-1): 3461 (OH), 2975, 2918, 2897, 2875, 2806, 1592, 1509, 
1413, 1353, 1263. Mass spectrum [M+H]
+ = 350.17 Accurate Mass 
(350.17)  
1H NMR of 17b in CDCl3, δ : 7.87 (2H, d, J = 8.5Hz, 2x CH), 7.35 
(2H, t, J = 7.8Hz, 2x CH), 6.85 (2H, d, J = 8.5Hz, 2x CH), 4.32 (4H, t, J = 
5.0Hz, 2x CH2), 4.02 (4H, t, J = 4.7Hz, 2x CH2), 3.83 – 3.79 (4H, m, 2x 
CH2), 3.63 – 3.59 (4H, m, 2x CH2), 3.41 (6H, s, 2x CH3). 
13C NMR CDCl3 
: 154.3 (QC), 126.7 (QC), 125.1 (CH), 114.6 (CH), 105.6 (CH), 72.0  
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(CH2), 70.9 (CH2), 69.8 (CH2), 67.9 (CH2), 59.1 (CH3). IR (cm
-1): 2975, 
2918, 2896, 2876, 2806, 1592, 1510, 1413, 1353, 1264. Mass Spectrum, 
[M+H]
+ = 364.19 Accurate Mass (364.19) 
 
 
2-(2-(1-(2-(2-methoxyethoxy)ethoxy)naphthalen-5-
yloxy)ethoxy)ethyl-3-(triethoxysilyl)propylcarbamate (18).
[155] 
 
 
 
To a solution of the 17a  (1,080 g, 3.08 mmol) in dry pyridine   
(30 mL) was added isocyanatopropyl triethoxysilane (0.8 mL,   
3.18 mmol). The reaction mixture was heated under reflux for 18 hours. 
Once cool, the pyridine was then removed in vacuo, to yield a dark oil. 
The silane product was purified by silica column chromatography, eluting 
with 0 – 60 % EtOAc DCM to gain the product as a yellow oil (1.45 g, 
78%) 
1H NMR in CDCl3, δ: 7.87 (1H, d, J = 8.2 Hz CH), 7.86 (1H, d, J = 
8.2 Hz, CH), 7.35 (2H, t, J = 8.1 Hz, 2x CH), 6.84 (2H, d, J = 7.6Hz, CH), 
4.95 (1H, br s, NH), 4.34-4.24 (6H, m, 3x CH2), 4.03-3.97 (4H, m, 2x 
CH2), 3.81 (10H q, J = 6.7 Hz, 5x CH2), 3.6 (2H, t, J = 4.3 Hz, CH2), 3.41 
(3H, s, CH3), 3.16 (2H, q, J = 6.2 Hz, CH2), 1.61 (2H, quintet, J = 7.6Hz, 
CH2), 1.22 (9H, t, J = 6.9Hz, 3x CH3), 0.61 (2H, t, J = 8.1 Hz, CH2).  
13C NMR in CDCl3, δ: 156.39 (QC), 154.34 (QC), 154.30 (QC), 126.77 
(QC), 126.75 (QC), 125.16 (CH), 125.06 (CH), 114.71 (CH), 114.59 (CH), 
105.66 (CH), 105.63 (CH), 72.06 (CH2), 70.93 (CH2), 70.08 (CH2), 69.88  
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(CH2), 69.73 (CH2), 67.91 (CH2), 63.91 (CH2), 59.16 (CH3), 58.47 (CH2), 
43.47 (CH2), 23.30 (CH2), 18.32 (CH3), 7.61 (CH2). Mass spectrum failed 
to show the required mass ion. IR (cm
-1): 3475, 3398, 3363, 2924, 2874, 
2827, 2360, 2341, 1666, 1593, 1508, 1412, 1265, 1065. 
 
1-(2-(2-(chloroacetyloxy)ethoxy)ethoxy)-5-(2-(2-
hydroxyethoxy)ethoxy) naphthalene (19a).
[137] 
 
 
 
To a solution of 2 (500 mg, 1.48 mmol) in THF was added 
triethylamine (0.25 mL, 1.79 mmol) allowed to stir at room temperature for 
~ twenty-five minutes. Chloroacetyl chloride (0.12 mL, 1.48 mmol) was 
added slowly dropwise. As the chloroacetyl chloride was added, HCl gas 
was evolved and the reaction mixture went cloudy. The reaction mixture 
was stirred at room temperature for one and a half hours under an 
atmosphere of N2 gas. The solvent was removed in vacuo to yield a pale 
oil. The required product was separated by flash silica column 
chromatography eluting with 0-100 % EtOAc DCM. The monoalkylated 
and bis-alkylated products were recovered as waxy solids; 19a in a 52 % 
yield and 19b in a 5 % yield. 
1H NMR CDCl3, bis-alkylated compound 19b, δ : 7.78 (2H, d, J = 
8.4Hz, 2x CH), 7.29 (2H, t, J = 8.0Hz, 2x CH), 6.78 (2H, d, J = 8.0Hz, 2x 
CH), 4.33 (2H, m, 2x CH2), 4.24 (4H, q, J = 4.6Hz, 2x CH2), 4.00 (2H, s, 
CH2), 3.94 (4H, m, 2x CH2), 3.82 (2H, m, 2x CH2), 3.70 (4H, m, 2x CH2) 
13C NMR δ: 167.4 (QC), 154.3 (QC), 126.8 (QC), 125.2 (CH), 114.7 (CH), 
105.8 (CH), 69.8 (CH2), 69.1 (CH2), 67.9 (CH2), 65.3 (CH2), 40.87 (CH2).  
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IR (cm
-1): 2951, 2928, 2883, 1743 (C=O), 1594, 1512, 1415, 1330, 1269. 
Mass spectrum [M+H]
+ = 412.1 
1H NMR CDCl3, mono-alkylated compound 19a, δ : 7.79 (2H, m, 
2x CH), 7.30 (2H, t, J = 8.0Hz, 2x CH), 6.78 (2H, m 2x CH), 4.33 (4H, m, 
2x CH2), 4.24 (4H, m, 2x CH2), 4.04 (4H, s, 2x CH2), 3.94 (4H, m, 2x 
CH2), 3.82 (4H, m, 2x CH2) 
13CNMR δ: 167.4 (QC), 154.3 (QC), 126.7 
(QC), 125.2 (CH), 114.6 (CH), 105.8 (CH), 72.7 (CH2), 69.8 (CH2), 69.7 
(CH2),69.0 (CH2), 67.9 (CH2), 65.3(CH2), 61.8 (CH2), 40.90 (CH2).  
IR (cm
-1): 3514 (OH), 2961, 2929, 2903, 2883, 2865, 1747 (C=O), 1595, 
1512, 1417, 1328, 1270. Mass spectrum [M+H]
+ = 488.1 
 
1-(2-(2-(iodoacetyloxy)ethoxy)ethoxy)-5-(2-(2-hydroxyethoxy)ethoxy) 
naphthalene (20). 
 
 
 
To a solution of 19a (632 mg, 1.5 mmol) in acetone (20 mL) was 
added sodium iodide (390 mg, 2.6 mmol). The reaction mixture was 
refluxed for 2 days. The solvent was then removed in vacuo. A dark 
yellow-red oil was produced in a 62% yield. Mass Spectrum [M+H]
+ = 
505.4. 
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N-(2-(2-(2-aminoethoxy)ethoxy)ethylamido) ferrocene (25a). 
 
 
 
To ferrocene-carboxylic acid (500 mg, 2.16 mmol) in DMF   
(100 mL) was added EDCI (414 mg, 2.16 mmol),   
2,2’-(ethylenedioxy)diethylamine (0.32 mL, 2.16 mmol), and DMAP 
  (264 mg, 2.16 mmol). The reaction mixture was then stirred at room 
temperature for 3 days. The mixture was filtered, and the solid was 
washed with DCM. The solution was concentrated and subjected to flash 
silica column chromatography. Eluting with 0-100% acetone in DCM 
failed to yield either the starting material or the product. 
 
Attempted Synthesis of N-(2-(2-(2-(N-tert-
Butylcarbonoylamino)ethoxy)ethoxy)ethylamido) ferrocene (27). 
 
 
 
To ferrocene carboxylic acid (930 mg, 4 mmol) in DCM (100 mL) 
was added EDCI (770 mg, 4 mmol) followed by pentafluorophenol (740 
mg, 4 mmol). The reaction mixture was stirred at room temperature for 
two hours. After this time N-Boc-2,2’-(ethylenedioxy)diethylamine (1,000 
mg, 4 mmol) was added. The reaction mixture was then stirred at room 
temperature for 16 hours. The solvent was removed in vacuo to yield a  
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dark brown oil. Flash silica column chromatography eluting with 0-97 % 
acetone DCM with 3 % triethylamine failed to yield the product. 
 
Ferrocene Acid Chloride Formation (26).
[94] 
 
 
 
To a solution of ferrocene-carboxylic acid (1,000 mg, 4.35 mmol) in 
dry toluene (100 mL) was added dropwise, oxalyl chloride (0.55 mL,   
6.1 mmol). Two drops of DMF were added and the reaction mixture was 
heated reflux under at 60C for one hour. The mixture was allowed to 
cool and the solvent was removed in vacuo to yield a dark red solid. The 
solid was taken up into DCM and impurities were precipated out by the 
addition of hexane. The mixture was filtered, and washed with hexane. 
The liquid was collected and solvent was removed in vacuo to yield a 
dark red oil. The product was taken on to react with ethylenedioxy 
bis(ethylamine) with no further analysis or purification. Assumed 100% 
yield. 
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N-(2-(2-(2-aminoethoxy)ethoxy)ethylamido) ferrocene (25a).
[94] 
 
 
 
To a solution of 2,2’-(ethylenedioxy) bis(ethylamine) (1.2 mL,   
8.7 mmol) and triethylamine (1.2 mL, 8.7 mmol) in DCM (125 mL) was 
added the ferrocene acid chloride 26 (1,080 g, 4.35 mmol) in DCM (125 
mL).,  via a pressure equalising dropping funnel over a period of   
30 minutes. The reaction mixture was allowed to stir for 16 hours at room 
temperature. The reaction mixture was poured water (150 mL), and the 
organic layer was separated, then washed with water (3x 100 mL). The 
organic layer was then collected and the solvent was removed in vacuo. 
Flash silica column chromatography eluting with 0-20 % MeOH in DCM 
with 3 % triethylamine yielded products 25a (870 mg) and 25b (405 mg) 
in a 55 % and 32 % yield respectively. 
1H NMR of ferrocene amine 25a in CDCl3, δ : 6.53 (1H, br s, NH 
amide), 4.73 (2H, s Cp ring, 2x CH), 4.33 (2H, s, Cp ring, 2x CH), 4.20 
(5H, s, Cp ring 5x CH), 3.69-3.63 (6H, m, 3x CH2), 3.59 (2H, t, J = 5Hz, 
CH2), 3.54 (2H, t, J = 4.5Hz, CH2), 2.90 (2H, t, J = 5Hz, CH2), 1.69 (2H, br 
s, NH2)* overlaps with H2O signal. 
13C NMR of ferrocene amine 25a in 
CDCl3, δ : 170.38(QC), 73.29(QC), 70.38(CH), 70.27(CH2), 70.20(CH2), 
69.78(CH), 68.22(CH), 41.71(CH2), 39.31(CH2), 30.98(CH). IR (cm
-1): 
3384, 3321, 3074, 2929, 2914, 2893, 2884, 2850, 1643, 1629, 1542, 
1103. Mass spectrum [M+H]
+ = 361.2  
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1H NMR of ferrocene dimer 25b in CDCl3, δ : 6.17 (2H, br s, 2x NH 
amide), 4.67 (4H, s, 2x Cp ring, 4x CH) 4.34 (4H, s, 2x Cp ring, 4x CH), 
4.22 (10H, s, 2x Cp ring, 10x CH), 3.69 (4H, s, 2x CH2), 3.66 (4H, t, J = 
5Hz, 2x CH2), 3.60(4H, t, J = 5.4Hz, 2x CH2) Mass spectrum [M+H]
+ = 
573.1 
 
 
N-(2-(2-(2-(biotinoylamino)ethoxy)ethoxy)ethylamido) ferrocene (28). 
 
 
 
To a solution of 25a (500 mg, 1.38 mmol) in DMF (30 mL) was 
added biotin (337 mg, 1.38 mmol), EDCI (204 mg, 1.38 mmol), and 
DMAP (168 mg, 1.38 mmol). The reaction mixture was stirred at room 
temperature for 48 hours. The crude reaction mixture was taken up in 
DCM (100 mL) and extracted with water (150 mL). The aqueous layer 
was washed with DCM (3x 100 mL) then the organic layers were 
combined and washed with brine (2x 100 mL). The organics were dried 
over MgSO4, filtered and evaporated to yield a dark oil. The product was 
purified by silica column chromatography, eluting with a 10 % stepwise 
gradient of 0 to 50 % methanol in ethyl acetate to gain the product as an 
orange glassy solid in a 36% yield.  
Mass Spectrum [M+H]
+ = 587.20 Accurate mass (587.2). 
1H NMR 
in CDCl3, δ: 6.57 (1H, t, J = 5.0Hz, NH), 6.44 (1H, t, J = 5.1Hz, NH), 6.34 
(1H, s, NH), 5.29 (1H, s, NH), 4.74 (2H, s, 2x CH Cp ring), 4.51 (1H, br t, 
J = 6.0Hz, CH biotin), 4.34 (2H, s, 2x CH Cp ring), 4.33-4.29 (1H, m, CH  
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biotin), 4.21 (5H, s, 5x CH Cp ring), 3.70-3.63 (6H, m, 3xCH2), 3.62-3.55 
(4H, m, 2xCH2), 3.52-3.39 (2H, m, CH2), 3.17-3.13 (1H, m, CH biotin), 
2.91 (1H, dd, J1 = 4.6Hz, J2 = 12.8Hz, CH biotin), 2.76 (1H, d, J = 12.7Hz, 
CH biotin), 2.21 (2H, t, J  = 7.4Hz, CH2), 1.73-1.61 (4H, m, 2x CH2), 
1.44(2H, h, J = 7.5Hz, CH2). 
13C NMR in CDCl3, δ: 173.3 (QC), 170.62 
(QC), 164.02 (QC), 76.07 (QC), 70.51 (CH), 70.25 (CH2), 70.21 (CH2), 
70.06 (CH2), 69.95 (CH), 69.82(QC), 68.29 (CH), 61.79 (QC), 60.22(QC), 
55.59(CH), 40.49(CH2), 39.43(CH2), 39.09 (CH2), 36.00 (CH2), 28.21 
(CH2), 28.11 (CH2), 25.61 (CH2). IR (cm
-1): 3277, 3108, 3092, 3081, 
2932, 2912, 2895, 2886, 2853, 1702(C=O), 1641, 1629, 1540, 1105 
CHN: 52.25/ 52.14 (55.29), 6.30/6.38 (6.53), 8.70/8.74 (9.55) 
 
 
N-(2-(2-(2-(O-(2-(biotinoylamino)ethyl)-O'-(2-
carboxethyl)undecaethyleneglycol)ethoxy)ethoxy)ethyl)amido 
ferrocene. (Ferrocene LC biotin) (29).  
 
 
 
To ferrocene amine 25a (56 mg, 0.15 mmol), in DCM (5mL) was 
added EDCI (34.5 mg, 0.18mmol), and DMAP (1.5 mg, 0.01 mmol). The 
mixture was stirred for 5 minutes under an atmosphere of nitrogen.   
O-[2-(biotinylamino)ethyl]-O’-[2-carboxyethyl] undecaethylene glycol   
(100 mg, 0.12 mmol) was added to the stirring mixture. The reaction was  
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then stirred for 24 hours at room temperature under an inert atmosphere. 
The crude mixture was diluted to 25 mL with DCM and then washed with 
water (1x 20 mL) and brine (2x 20 mL). The organic layer was separated 
and dried over sodium sulfate, filtered and evaporated to yield the product 
as a dark brown oil in a 47 % yield.  
1H NMR (500MHz, CDCl3) δ: 6.73 (2H, br q, J = 7Hz, 2xNH), 6.41 
(1H, br t, J = 5.2Hz, NH), 6.21 (1H, s, NH), 5.40 (1H, s, NH), 4.71 (2H, t, J 
= 2Hz, Cp ring), 4.50 (1H, br t, J = 7.2Hz, CH biotin), 4.33 (2H, s, 2xCH 
Cp ring), 4.32-4.29 (1H, m, CH biotin), 4.20 (5H, s, 5xCH Cp ring), 3.73 
(2H, t J = 6Hz, CH2), 3.68-3.60 (49H, m, Alkyl), 3.59-3.54 (7H, m, Alkyl), 
3.48-3.40 (4H, m, 2xCH2), 3.17-3.11(1H, m, CH biotin), 2.90 (1H, dd, J = 
6.25Hz, J = 8.3Hz, CH biotin), 2.75 (1H, d, J = 14Hz,CH biotin), 2.47 (2H, 
t, J = 5.8Hz), 2.25-2.20 (2H, m CH2), 1.79-1.71(1H, m, CH alkyl), 1.71-
1.62 (3H, m 3xCH alkyl), 1.48-1.42 (2H,m, CH2). Mass Spectrum : M
+ = 
1186.7 FAB NOBA. CHN: 49.41/49.32 (54.68), 7.36/7.31 (7.73), 
5.11/5.11 (5.90) 
 
 
1-(2-(2-(2-(ferrocenoylamino)ethoxy)ethoxy)ethyl)-3-(3-
(triethoxysilyl)propyl)urea (31).
[155] 
 
 
 
To a solution of the ferrocene amine 25a (500 mg, 3.08 mmols) in 
dry pyridine (30 mL) was added isocyanatopropyl triethoxysilane (0.8 mL,  
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3.18 mmols). The reaction mixture was heated to reflux for 18 hours. 
Once cool the pyridine was then removed in vacuo, to yield a dark oil. 
Column Chromatography failed to recover either the product or the 
starting material. 
 
 
N-(2-(2-(2-(thioctinoylamino)ethoxy)ethoxy)ethylamido) ferrocene 
(32). 
 
 
 
To a solution of 25a (510 mg, 1.4 mmol) in DCM (50 mL) was 
added EDCI (210 mg, 1.4 mmol), DMAP (172 mg, 1.4 mmol), and thiotic 
acid (292 mg, 1.4 mmol). The reaction mixture was stirred at room 
temperature for 48 hours. The crude reaction mixture was taken up in 
DCM (100 mL), extracted with water (150 mL). The aqueous layer was 
separated and washed with DCM (3x 100 mL) then the organic layers 
were combined and washed with brine (2x 100 mL). The organics were 
dried over MgSO4, filtered and evaporated to yield a dark oil. The product 
was purified by silica column chromatography, eluting with 100% 
petroleum ether followed by a 10% step-wise gradient of 0 to 60% 
acetone in ethyl acetate to afford 32 as a glassy orange solid in a 35% 
yield.  
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Mass Spectrum. M+ = 548.15 Accurate Mass (548.14) 
1H NMR in 
CDCl3, δ: 6.48 (1H, t, J = 5.3Hz, NH), 6.31 (1H, t, J = 4.9Hz, NH), 4.69 
(2H, t, J = 1.88Hz, 2x CH Cp ring), 4.32 (2H, t, J = 2.0Hz, 2x CH Cp ring), 
4.18 (5H, s, 5x CH Cp ring), 3.65-3.60 (6H, m, 3x CH2), 3.58-3.49 (5H, 
m), 3.42 (2H, br q, J = 5.1Hz, CH2), 2.46-2.38 (1H, m, CH), 2.14 (2H, t, J 
= 7.4Hz, CH2), 1.93-1.83 (1H, m, CH), 1.72-1.54 (4H, m, 2x CH2), 1.49-
1.34 (2H, m, CH2) 
13C NMR in CDCl3, : 173.08 (QC), 170.69 (QC), 75.93 
(QC), 70.54 (CH), 70.29 (CH2), 70.25 (CH2), 70.05 (CH2), 69.82 (CH), 
69.74 (QC), 68.24 (CH), 56.49 (CH), 40.27 (CH2), 39.32 (CH2), 39.14 
(CH2), 38.49 (CH2), 36.32 (CH2), 34.64 (CH2), 28.91 (CH2), 25.39 (CH2). 
IR (cm
-1): 3275, 3110, 3093, 3082, 2934, 2911, 2895, 2888, 2851, 
1705(C=O), 1641, 1632, 1543, 1104 
 
 
N-(2-(2-(2-(10,12-pentacosadynoylamino)ethoxy)ethoxy)ethylamido) 
ferrocene (33).
[107] 
 
 
 
To a solution of 10,12-pentacosadyinoic acid (500 mg, 1.3 mmol) 
in dry DCM (50 mL) was added dropwise oxalyl chloride (0.2 mL,    
 
273 
 
1.3 mmol) followed by two drops of DMF. The reaction was then stirred 
for 3 hours in the dark. The solution was then added dropwise to a stirring 
solution of the ferrocene amine 25a (396 mg, 1.1 mmol) and triethylamine 
(0.46 mL, 3.3 mmol) in DCM (50 mL). The reaction was then stirred in the 
dark for 16 hours.The solvent was then removed in vacuo to yield a black 
oily solid. 
1H NMR indicated that the product formed was not the desired 
compound. 
 
 
N-(2-(2-(2-(10,12-pentacosadynoylamino)ethoxy)ethoxy)ethylamido) 
ferrocene (33). 
 
 
 
To a solution of the ferrocene amine 25a (862 mg, 2.4 mmol) in 
DCM (50mL) was added sequentially EDCI (355 mg, 2.4 mmol), DMAP 
(292 mg, 2.4 mmol), and 10,12-pentacosadiynoic acid (897 mg,   
2.4 mmol). The reaction mixture was then stirred at room temperature for 
3 days in the dark. The solvent was then removed in vacuo in the dark to 
yield a dark oil. Purification by two silica column chromatographies, 
eluting with 100% ethyl acetate gave the product as an orange glassy 
solid in a 34% yield 
Mass Spectrum. [M+H]
+  = 716.3 CHN: 70.22/70.40 (70.37), 
9.07/9.09 (9.00), 4.05/4.06 (3.91) 
1H NMR in CDCl3, δ: 4.68 (2H, t, J =  
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1.9Hz, 2x CH Cp ring), 4.34 (2H, t, J = 1.9Hz, 2x CH Cp ring), 4.19 (5H, 
s, 5x CH Cp ring), 3.67-3.62 (6H, m, 3x CH2), 3.60-3.54 (4H, m, 2x CH2), 
3.45 (2H, q, J = 5.3Hz, CH2), 2.23 (4H, t, J = 6.8Hz, 2xCH2), 2.13 (2H, t, J 
= 7.6Hz, CH2), 1.62-1.55 (2H, m), 1.54-1.46 (4H, m, 2x CH2), 1.39-1.32 
(4H, m), 1.31-1.26 (6H, m), 1.25 (16H, br. s), 0.89-0.85 (3H, m) 
13C NMR 
in CDCl3, δ: 173.24 (QC), 170.43 (QC), 77.61 (QC), 77.44 (QC), 70.45 
(CH2), 70.31 (CH2), 70.28 (CH2), 70.18 (CH2), 70.06 (CH2), 68.17 (CH2), 
65.31 (QC), 65.23 (QC), 39.29 (CH2), 39.09 (CH2), 36.69 (CH2), 31.91 
(CH2), 29.47 (CH2), 29.34 (CH2), 29.24 (CH2), 29.19 (CH2), 29.09 (CH2), 
28.94 (CH2), 28.86 (CH2), 28.77 (CH2), 28.35 (CH2), 28.30 (CH2), 25.67 
(CH2), 22.69 (CH2), 19.20 (CH2), 19.18 (CH2), 14.13 (CH3). IR (cm
-1): 
3312, 3057, 2919, 2849, 1645, 1629, 1544, 1301, 1106. 
 
 
Ferrocene ethylamine (37). 
 
 
 
To a solution of ferrocene acetonitrile (500 mg, 2.2 mmol) in dry 
tetrahydrofuran (100 mL) was added portionwise lithium aluminium 
hydride (60% dispersion, 614 mg, 4.4 mmol). The reaction mixture was 
stirred at room temperature for 2.5 hours. The reaction mixture was then 
cooled to 0˚C in an ice bath and quenched with 15 % aq NaOH (100 mL), 
and filtered. The solution was extracted with DCM (100 mL), where the 
organic layer was washed with saturated brine solution (3x 75mL). The 
organic layer was dried over MgSO4, filtered and the solvent was 
removed  in vacuo. Flash silica column chromatography eluting with 0- 
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97% acetone in DCM with 3% triethylamine held constant throughout the 
chromatography failed to yield either starting material or product. 
 
 
1,1’-Ferrocene dicarboxylic acid chloride Formation (39).
[156] 
 
 
 
To a solution of ferrocene dicarboxylic acid (1,000 mg, 3.65 mmol) 
in dry toluene (100mL) was added dropwise, oxalyl chloride (0.98 mL,  
11 mmol). DMF (10 mL) was added to aid solubility and as a catalyst. The 
reaction mixture was heated under reflux at 60C for one hour. Once 
cooled, the solvent was removed in vacuo to yield a dark red solid that 
was taken on to react with ethylenedioxy bis(ethylamine) with no further 
analysis or purification. Assumed 100% yield. 
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1,1'-Bis(N-(2-(2-(2-aminoethoxy)ethoxy)ethylamido) ferrocene 
(40).
[156] 
 
 
 
To a solution of 2,2’-(ethylenedioxy) bis(ethylamine) (2.2 mL,   
14.6 mmol) and triethylamine (2 mL, 14.6 mmol) in DCM (100 mL) was 
added the ferrocene diacid chloride 39 (3,700 mg, 3.7 mmol) in DCM   
(200 mL) via a pressure equalising dropping funnel over a period of   
30 minutes. The reaction mixture was allowed to stir for 16 hours at room 
temperature. The reaction mixture added to water (150 mL) and 
partitioned. The organic layer was separated and washed with water (3x 
100 mL). The aqueous layer was evaporated under reduced pressure, 
and then washed with ethanol. It was found the residue was highly 
impure and failed to travel on TLC in any solvent. 
 
Synthesis of 1-Azido-propyl-3-amine (42).
[136]  
 
 
 
To a solution of bromo propylamine (3,200 mg, 14.7 mmol) in 
15mL distilled water was added dropwise a solution of sodium azide 
(2,900 mg, 44 mmol) in 10 mL water. The mixture was then refluxed for 
20 hours and then allowed to cool. 50 mL DCM followed by potassium 
hydroxide (4,000 mg, 71 mmol) was then added and the mixture was  
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stirred at room temperature until the potassium hydroxide had fully 
dissolved. The biphasic system was then separated, and the aqueous 
layer was washed with DCM (25 mL). The organic layer was dried over 
magnesium sulfate, filtered and evaporated. The product was taken onto 
the next stage without any further treatment. Assumed 100% yield. 
 
 
Synthesis of 1-Azido-propyl-3-maleimde (43).
[136] 
 
 
 
To a solution of 42 (1,470 mg, 14.7 mmol) in DCM (80 mL) at 0°C 
was added dropwise a solution of maleic anhydride (1,080 mg, 11 mmol). 
The reaction mixture was allowed to stir at 0°C for 2 hours, and then 
allowed to warm to room temperature overnight. The solvent was then 
removed  in vacuo to yield an insoluble orange solid. After extensive 
heating and sonication a 
1H NMR in d6-DMSO showed very impure 
product.  
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Naphthalene modified BSA (45).
[40] 
 
 
 
To a solution of bovine serum albumin (110 mg) in 50 mM 
phosphate buffer (18 mL), pH = 7.2, was added a solution of   
N-succinimidyl-S-acetyl-thioacetate (SATA) (10 mg) in anhydrous DMSO 
(2 mL). The reaction mixture was stirred for 30 minutes. The crude 
mixture was then dialysed in 50 mM potassium phosphate (4x 1L). The 
dialysis tubing had a molecular weight cut off of 4000-6000g. The 
dialysed mixture was returned to the reaction flask and hydroxylamine 
(100 mg) was added. The reaction mixture was stirred for a further two 
hours and then re-dialysed in 50 mM potassium phosphate buffer (4x 1L). 
The mixture was returned to the reaction flask whereby a solution of 19a 
(100 mg) in anhydrous DMSO (2 mL) was added. The reaction mixture 
was then stirred at room temperature for 24 hours. The reaction mixture 
went cloudy as the chloroacetate was added, the resulting suspension 
was centrifuged and the supernatant was collected. The solution was 
washed with ethyl acetate to remove any excess ligand. The aqueous 
layer was collected and dialysed in distilled water (6x 1L), to remove the 
potassium phosphate buffer. The aqueous solution was removed in 
vacuo to yield the modified BSA as a pale yellow glassy solid in a 14% 
yield. 
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4,5-bis(2-cyanoethylthio)-1,3-dithiole-2-thione (47).
[95] 
 
 
 
To a solution of bis(tetraethylammonium) bis(4,5-dimercapto-1,3-
dithiole-2-thione) zincate salt 46 (5,000 mg, 7 mmol) in acetonitrile (100 
mL) under reflux was added bromopropionitrile (2.9 mL, 35 mmol). The 
reaction mixture was heated to reflux for 1 hour. The mixture was then 
allowed to cool to room temperature overnight. The mixture was filtered 
and the solid was washed the acetonitrile (50 mL). The solvent was then 
removed  in vacuo. The crude residue was then taken up in DCM   
(100 mL) and washed with water (1x 75 mL) and brine (3x 75 mL). The 
organic layer was separated, and dried over MgSO4, filtered and 
evaporated to yield a yellow / orange solid. The solid was then taken up 
in toluene (100 mL) and petroleum ether (100 mL) was added to 
precipitate the product as a yellow solid (728 mg). The filtrate was 
evaporated to yield more crude material that was purified by silica column 
chromatography eluting with ethyl acetate, followed by 20% acetone in 
ethyl acetate, to yield the product as an oily solid. The greasy residue 
was then taken up in DCM and precipitated to yield the product as a 
yellow solid (1.5 g) total yield 100% 
1H NMR (400MHz, CDCl3) δ: 3.19 (4H, t, J = 6.8 Hz), 2.83 (4H, t, J =  
6.8 Hz). Mass Spectrum: [M]
+ = 304.1 
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4,5-bis(2-cyanoethylthio)-1,3-dithiol-2-one (48).
[95] 
 
 
 
To a solution of 47 (2.3 g, 0.007 mol) in chloroform (50 mL), was 
added mercuric acetate (6.2 g, 0.019 mol). The mixture was stirred for  
5 minutes where by glacial acetic acid (15 mL) was added. As the 
mercuric acetate was added the solution went opaque, which then turned 
transparent yellow upon addition of the acetic acid. The reaction mixture 
was stirred under an atmosphere of N2 gas for 16 hours. The mixture was 
filtered, and the solid was washed thoroughly with chloroform. The filtrate 
was extracted with 1.2 M aqueous sodium bicarbonate (200 mL) where 
the organic layer was washed with water (3x 150 mL). The organic layer 
was dried over MgSO4, filtered and evaporated in vacou to yield the 
product as a yellow solid (1.75 g) in 82% yield. 
1H NMR (400MHz, CDCl3)  δ : 3.16 (4H, t, J = 6.8 Hz), 2.82 (4H, t,   
J = 6.8 Hz). Mass Spectrum : [M]
+ = 288.31 
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Tetra(2-cyanoethanethio) tetrathiafulvalene (49).
[95] 
 
 
 
To a flask containing 48 (1.75 g, 0.006 mol), in toluene (125 mL) at 
reflux was added triethylphosphite (6.1 mL, 0.035 mol). The reaction 
mixture was stirred under reflux for 30 minutes. Once cool the mixture 
was cooled to 0°C and methanol (200 mL) was added to quench the 
reaction. The precipitate formed was then recovered by filtration and 
washed thoroughly with methanol. The filtrate was evaporated and 
purified by silica column chromatography eluting first with DCM to remove 
the triethylphosphite, then with 10-20% stepwise gradient of acetone in 
DCM to recover the product. The solid product and the material from the 
chromatograph were combined to give a 21% yield (346 mg) 
1H NMR (400MHz, CDCl3) δ: 3.17 (8H, t, J = 6.8 Hz), 2.82 (8H, t, J 
= 6.8 Hz). Mass Spectrum : [M]
+ 544.87 
 
 
1-(Tetra(2,2’-ethoxy)-ethanethio) tetrathiofulvalene (50). 
 
 
 
To a solution of 49 (364 mg, 0.64 mmol) in dry DMF (50 mL) was 
added sodium hydride (205 mg, 5.1 mmol). The mixture was stirred for 20  
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minutes at room temperature whereby the solution changed from orange 
to dark red/brown. 2-(2-Chloroethoxy) ethanol (2.1 mL, 19.2 mmol) was 
added dropwise. The mixture turned black/brown and heat was evolved. 
The reaction mixture was then stirred for 4 days at room temperature. 
Water (5 mL) was added cautiously to the reaction to quench the sodium 
hydride. The solvent was removed under reduced pressure to yield a dark 
oil. Silica column chromatography failed to yield either the starting 
material or product from the mixture. 
 
 
4-(6-bromohexanoyl) tetrathiafulvalene (53).
[119] 
 
 
 
To an oven dried flask containing tetrathiafulvalene (1,000 mg, 4.9 
mmol) in dry diethyl ether (100 mL) under a N2 atmosphere at -78° C was 
added n-butyl lithium (2.2 mL, 2.5 M in hexane, 5.4 mmol). The mixture 
turned from yellow to cloudy green as the lithiated species 43 was formed 
over a period of 1 hour. 6-Bromohexanoyl chloride (0.8 mL, 5.4 mmol) 
was added to the reaction mixture and stirred at -78°C under N2 for 2 
hours. As the reaction progressed, the solution turned dark red. The 
mixture was allowed to slowly warm to room temperature over 16 hours. 
The reaction mixture was quenched with water (100 mL) and extracted 
with diethyl ether (150 mL). The organic layer was washed with water (2x 
100 mL) and brine (2x 100 mL), separated and dried over MgSO4, filtered 
and evaporated under reduced pressure to yield the crude product as a 
dark red solid. The product was purified by silica column chromatography  
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eluting with a 10% step wise gradient of 0-100% DCM in petroleum ether, 
to yield the product as a dark red oil in a 12 % yield. 
1H NMR in CDCl3 (400MHz) δ: 7.28 (1H, s, CH), 6.33 (2H, br. s, 2x 
CH), 3.41 (2H, t, J = 6.6Hz, CH2), 2.70(2H, br.t, J = 6.6Hz, CH2), 1.88 
(2H, pent, J = 7.1Hz, CH2), 1.70 (2H, pent, J = 7.6Hz, CH2), 1.52-1.44 
(2H, m, CH2). 
13C NMR (400MHz) δ: 212.5(QC), 197.1(QC), 190.9(QC), 
119.4(CH), 118.7(CH), 38.2(CH2), 33.5(CH2), 32.5 (CH2), 27.7(CH2), 
23.5(CH2) Mass Spectrum : M
+ 379.90 and 381.90 (
79Br and 
81Br) 
Accurate Mass (379.9 and 381.9) 
 
4-(6-((trimethyl) ammonium)hexanoyl) tetrathiafulvalene bromide 
(54).
 
 
 
 
To a flask containing 53 (200 mg, 0.5 mmol) in methanol (50 mL) 
heated under reflux was added drop wise trimethylamine in ethanol   
(1 mL, 2.4 M in ethanol). The reaction mixture was stirred under reflux for 
16 hours. Once cool, the crude mixture was concentrated under reduced 
pressure until the volume was 10 mL. Diethyl ether (200 mL) was added 
to precipitate a dark red / orange solid, which was washed with diethyl 
ether. The solid product was taken up in methanol and re-precipitated to 
yield the product as a dark red solid (179 mg, 78%). 
1H NMR in d4-MeOH (500MHz) δ: 7.85 (1H, s, CH), 6.53 (2H, s, 2x 
CH), 3.67-3.32 (2H, m, CH2)*, 3.14 (9H, s, 3x CH3), 2.85 (2H, t, J = 
7.25Hz), 1.87-1.82 (2H, m, CH2), 1.80-1.72 (2H, m, CH2), 1.46-1.40 (2H, 
m, CH2).*MeOD solvent signal overlapping CH2 multiplet. 
13C NMR 
(500MHz) δ: 210.0(QC), 185.1(QC), 172.7(QC), 135.5(CH), 120.5(CH),  
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120.2(CH), 67.6(CH2), 53.5(CH3), 38.4 (CH2), 26.8(CH2), 24.9(CH2), 
23.7(CH2). MS: [M
+] = 360.0, 360.06 Accurate Mass. FAB, NOBA 
(360.06) 
 
 
Tetrathiafulvalene carboxylic acid (55).
[96] 
 
 
 
To an oven dried flask containing tetrathiafulvalene (1,000 mg, 4.9 
mmol) under an inert atmosphere was added dry diethyl ether (100 mL) 
at -78C in a carbon dioxide acetone bath. Butyl lithium (2.2 mL, 5.4 
mmol, 2.5 M in hexane) was added dropwise to the solution and the 
mixture was then stirred for 1 hour at -78C. Solid carbon dioxide (1 L) 
was then added and the reaction was stirred at -78C for 3 hours and 
then allowed to slowly warm to room temperature over 12 hours. The 
mixture was filtered under gravity and washed with diethyl ether. The red 
solid was recovered and dissolved in water, acidifying with 2 M H2SO4 
and stirred for 2 hours. The dark red precipitate was filtered by vacuum 
filtration. The product was then purified by column chromatography 
eluting with 100% THF to yield the impure product as a sticky red solid in 
a 60% crude yield. 
1H NMR in d6-acetone δ: 7.57 (1H, s), 6.67 (2H, s), 5.49 (br.s 1H) 
MS – [M+H]
+ = 248.37, Mpt 180-182°C (Literature Mpt : 182-184°C)
[96] 
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Tetrathiafulvalene acid fluoride (56).
[97] 
 
 
 
To TTF carboxylic acid 55  (762 mg, 3.0 mmol) in dry 
dichloromethane (50mL) at 0C was added pyridine (0.5 mL, 6.1 mmol) 
and cyanuric fluoride (0.5 mL, 6.1 mmol) under an atmosphere of N2 gas. 
The reaction was stirred at 0C for 2 hours under a N2 atmosphere. 
Distilled water (100 mL) was added to quench the reaction, extracting 
with DCM / water, washing with water (3x 75 mL). The organic layer was 
collected and carefully evaporated to yield a dark red solid. The aqueous 
layers were neutralised with calcium oxide (aq) (1 L suspension) until the 
pH was basic. The product was taken on with assumed 100% yield with 
no further treatment. 
 
 
N-(2-(2-(2-aminoethoxy)ethoxy)ethylamido) tetrathiafulvalene (57). 
 
 
 
To a flask containing 2,2’-(ethylenedioxy) bis(ethylamine) (0.9 mL, 
6.1 mmol) and triethylamine (0.9 mL, 6.2 mmol) in DCM (50mL) was 
added the 56 (767 mg, 3.0 mmol) in dichloromethane (100 mL) via a 
pressure equalising dropping funnel over a period of 1 hour. The reaction 
mixture was allowed to stir for 16 hours at room temperature. The 
reaction mixture was partitioned between dichloromethane (150 mL) and  
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water (150 mL).The organic layer was separated, and washed with water 
(3x 100 ml). The organics collected and the solvent was removed in 
vacuo. Flash silica column chromatography eluting with 0-20% methanol 
in DCM with 1% triethylamine, followed by a 5% stepwise gradient of 0-
20% methanol in DCM with 1% triethylamine then flushed with 99% 
methanol. This yielded the product with excess 2,2’-(ethylenedioxy) 
bis(ethylamine) that ran with the 57 on the silica column. (83 mg impure 
material, 8 % yield) 
1H NMR in d4-MeOH (400MHz) δ: 7.18 (1H,s, CH), 6.40 (2H, s, 2x 
CH), 3.61-3.45 (8H,m, 4xCH2)*, 3.40 (2H, t, J = 3.2 and 4.2Hz, CH2), 3.01 
(2H, t, J = 3.2 and 1,5Hz, CH2). *contains additional Hs from 2,2’-
(ethylene dioxy)bis(ethylamine). Mass Spectrum: [M+H]
+ 379.7. 
 
 
N-(2-(2-(2-(thioctinoylamino)ethoxy)ethoxy)ethylamido) 
tetrathiafulvalene (58). 
 
 
 
To a solution of compound 57 (83 mg, 0.22 mmol) in DCM (45 mL) 
/ DMF (5 mL) was added EDCI (33 mg, 0.22 mmol), DMAP (27 mg,   
0.22 mmol) and thiotic acid (45 mg, 0.22 mmol). The reaction mixture was 
stirred at room temperature for four days. The mixture was partitioned 
between DCM (100 mL) / water (100 mL), and the organic layer was 
washed with brine (3x 100 mL). The organic layer was separated and  
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dried over MgSO4, filtered and the solvent was removed in vacuo to yield 
impure product as a dark oil. The crude material was purified by flash 
silica column chromatography eluting with 100% petroleum ether followed 
by 0-20% acetone in ethyl acetate to yield the product as an orange red 
oily solid (57 mg) in a 46 % yield. 
1H NMR in CDCl3 (400MHz),  δ: 7.19 (1H, s, CH), 6.36 (2H, s, 
2xCH), 6.35 (1H, s, NH), 5.94 (1H, s, NH), 3.70-3.52 (12H, m, 6x CH2), 
3.51-3.48 (2H, m, CH2), 3.23-3.10 (2H, m, CH2), 2.48 (1H, hex, J = 6.2Hz, 
H from CH2), 2.22 (2H, t, J = 7.4Hz, CH2), 1.93 (1H, hex, J = 6.6Hz, H 
from CH2), 1.71-1.66 (4H, m, 2x CH2), 1.49-1.39 (1H, m, CH) It was found 
that the TTF moiety oxidised in CDCl3 so a 
13C NMR could not be run in 
this solvent. 
1H NMR in d4-MeOD (500MHz), δ: 7.30 (1H, s, CH), 6.53 (2H, d, J 
= 1.3Hz, 2x CH), 3.67-3.56 (10H, m, 5x CH2), 3.47 (2H, t, J = 5.5Hz, 
CH2), 3.39 (2H, t, J = 5.5Hz, CH2), 3.20-3.17 (1H, m, H from CH2), 3.14-
3.10 (1H, m, H from CH2), 2.48 (1H, hex, J = 6.4Hz, H from CH2), 2.23 
(2H, t, J = 7.4Hz, CH2), 1.91 (1H, hex, J = 6.7Hz, H from CH2), 1.78-1.61 
(4H, m, 2x CH2), 1.53-1.45 (1H, m, CH). 
13C NMR in d4-MeOD (500MHz), 
δ: 176.17 (QC), 161.85 (QC), 134.21(QC), 126.45 (CH), 120.50 (CH), 
120.22 (CH), 114.21 (QC), 107.47 (QC), 71.37 (CH2), 70.67 (CH2), 70.41 
(CH2), 57.64 (CH), 41.35 (CH2), 40.95 (CH2), 40.34 (CH2), 39.36 (CH2), 
39.89 (CH2), 35.78 (CH2), 29.92 (CH2), 26.75 (CH2). Mass spectrum:   
[M + Na]
+ = 588.7 (FAB, NOBA) 
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1,1’-[1,4-phenylenebis-(methylene)] bis(4,4’-bipyridinium) 
bis(hexafluorophosphate) (60). 
[9] 
 
 
 
To a solution of 4,4-dipyridyl (14.3 g, 0.09 mol) in dry acetonitrile 
(250mL) under reflux was added over a 3 hour period, a solution of   
α,α’-dichloro-p-xylene (6.7 g, 0.04 mol) in dry acetonitrile (200 mL). The 
reaction mixture was heated under reflux for 24 hours. As the reaction 
progressed it became cloudy and a yellow green precipitate formed. The 
mixture was allowed to cool, and the resulting precipitate was collected 
by filtration. The solid was washed with acetonitrile (50 mL) and diethyl 
ether (100 mL). The chloride salt of the product was taken up in water 
and precipitated with acetonitrile / diethyl ether mixtures. The product was 
then recrystallised from hot water with a final yield of 12% as a white 
solid. The product was then taken up into water (50 mL) and ammonium 
hexafluorophosphate (3.0 g, 17.8 mmol) was slowly added. The 
exchange reaction was stirred for 16 hours to allow full conversion to 
occur. The PF6 salt form of the product precipitated out as it formed as a 
white solid. 
1H NMR of chloride salt (D2O, 400MHz) δ : 8.89 (4H, d, J = 
6.6 Hz), 8.64 (4H, d, J = 5.7 Hz), 8.29 (4H, d, J = 6.6 Hz), 7.77 (4H, d, J = 
5.9 Hz), 7.47 (4H, s), 5.79 (4H, s). 
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Cyclobis(paraquat-p-phenylene) Tetrakis(hexafluorophosphate) 
(CBPQT
4+) (61).
[9] 
 
 
 
To a solution of 60 (706 mg, 1 mmol) in dry DMF (50 mL) was added α,α’-
dibromo-p-xylene (264 mg, 1 mmol) and 1,5-Bis (2,2-methoxy ethoxy 
ethoxy) naphthalene (17b) (1,100 mg, 3 mmol). The reaction mixture was 
stirred at room temperature under an atmosphere of nitrogen for 5 days. 
The solvent was removed by reduced pressure to yield the crude product 
as a dark purple solid. The material was taken up into aqueous 
ammonium chloride (1 M, 100 mL) and was continuously extracted with 
DCM for two days. Once the layers had become colourless the aqueous 
layer was separated and the solvent removed in vacuo. The product was 
purified by silica column chromatography, eluting with 60% methanol:   
30% water and 10% saturated ammonium chloride solution. The clean 
product was taken up in water and ammonium hexafluorophosphate was 
added until complete precipitation had occurred. The solid was collected 
by filtration and then washed with water and diethyl ether to recover the 
product as the PF6 salt in a 60% yield.
[9] 
1H NMR (400 MHz, CD3CN) δ: 5.74 (s, 8H), 7.52 (s, 8H), 8.14-8.18 
(m, 8H), 8.84-8.88 (m, 8H); 
13C NMR (400 MHz, CD3CN) δ: 65.7, 128.3, 
131.4, 137.0, 146.2, 150.4 
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N,N’-dibenzyl-4,4’-dipyridinium dichloride (65). 
 
 
 
To a solution of benzyl chloride (13.6 mL, 118 mmol) in DMF   
(30 mL) at 100 C was added dropwise a solution of 4,4’-bipyridine   
(500 mg, 3 mmol) in DMF. The reaction mixture was refluxed for 24 
hours. The mixture was allowed to cool, collecting the precipitate formed 
by filtration, washing with hot diethyl ether (30 mL). The solid was   
re-crystallised from hot ethanol to remove a single impurity from the solid 
(533 mg) in a 43% yield  
1H NMR D2O, δ : 8.95 (4H, d, J = 6.3 Hz, 4x CH), 8.32 (4H, d, J = 
6.2 Hz, 4x CH), 7.33 (10H, s, 10xCH), 5.73 (4H, s, 2x CH2).
13C NMR δ : 
145.5 (QC), 130.1 (QC), 129.7 (CH Aryl), 129.2 (CH Aryl), 127.0 (CH 
Aryl), 126.1 (CH Aryl), 64.8 (CH2 Alkyl). Mass spectrum : [M] = 338 (may 
be due to charge delocalisation) 
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Appendices 
Appendix 1. 
Experimental Procedures for the synthesis of the functionalised 
DIPs 23 and 30. 
 
1-[2-(2-{5-[2-(2-Hydroxy-ethoxy)-ethoxy]-naphthalen-1-yloxy}-
ethoxy)-ethyl]-2,3-dihydro-1H-imidazo[1,2-f]phenanthridin-4-ylium; 
bromide (23). 
 
 
 
To a solution of 5a (100 mg, 0.30 mmol, 1.0 eq) in 5% Na2CO3 
(aq) (10 mL) and EtOAc (10 mL) was added of 5-(2-bromoethyl)-
phenanthridinium bromide 110 mg, 0.30 mmol, 1.0 eq) amd the reaction 
stirred under N2 for 2 hrs. The reaction mixture was transferred to a 
separating funnel and layers were separated, the organic layer was 
washed with water (1 × 10 mL) and brine (1 × 10 mL). NBS (53 mg, 0.30 
mmol, 1.0 eq) was added to the EtOAc solution and the reaction was 
stirred for 10 min, upon which a sticky brown residue formed on the 
reaction vessel walls. The Mother liquor was decanted off and acetone 
was added to the sticky residue, upon sonication a brown suspension 
formed which was collected by filtration to yield the product as a beige 
powder (23) (18 mg, 0.029 mmol, 9.7%). 
1H NMR (DMSO, 400 MHz) δ: 
8.77 (d, 1H, J=8.0 Hz), 8.67 (d, 1H, J=8.0 Hz), 8.63 (d, 1H, J=8.0 Hz), 
8.05 (t, 1H, J=8.0 Hz), 7.80 (t, 1H, J=8.0 Hz), 7.72 (t, 1H, J=8.0 Hz), 7.60 
(t, 1H, J=8.0 Hz), 7.55 (d, 1H, J=8.0 Hz), 7.46 (m, 2H), 7.27 (t, 1H, J=8.0  
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Hz), 7.06 (t, 1H, J=8.0 Hz), 6.92 (d, 1H, J=8.0 Hz), 6.75 (d, 1H, J=8.0 Hz), 
4.69 (t, 1H, J=5.2 Hz), 4.52 (t, 2H, J=10.6 Hz), 4.32 (t, 2H, J=10.6 Hz), 
4.29 (t, 4H, J=4.2 Hz), 4.13 (m, 4H), 4.03 (m, 2H), 3.87 (m, 2H), 3.58 (m, 
4H);
 13C NMR (CDCl3, 100 MHz) δ: 154.27 (C), 154.01 (C), 135.37 (C), 
135.04 (CH), 132.7 (C), 132.48 (C), 131.36 (CH), 128.70 (CH), 128.45 
(CH), 126.23 (C), 126.36 (C), 125.46(CH), 125.09 (CH), 124.96 (CH), 
123.44 (CH), 123.28 (CH), 120.27 (C), 115.59 (CH), 114.43 (CH), 113.75 
(CH), 105.65 (CH), 105.3 (CH), 72.69 (CH2), 70.14 (CH2), 69.69 (CH2), 
67.74 (CH2), 67.51 (CH2), 67.12 (CH2), 61.79 (CH2), 51.77 (CH2), 51.45 
(CH2), 46.56 (CH2). IR (KBr, cm
-1) 3327 (w), 2870 (w), 1575 (s), 1415 (m), 
1265 (s), 1066 (s), 773 (s); MS (FAB) m/z (%) 539.3 (M
+) (100); HRMS 
(FAB) for (M
+) calcd 539.2546, obsd 539.2551. 
 
1-{2-[2-(2-ferrocenoylamino-ethoxy)-ethoxy]-ethyl}-2,3-dihydro-1H-
imidazo[1,2-f]phenanthridin-4-ylium bromide (30). 
 
 
 
To a solution of 25a (868 mg, 2.32 mmol, 1.0 eq) in DMF (100 mL) 
was added Triethylamine (970 L, 6.97 mmol, 3.0 eq) followed by 5-(2-
Bromo-ethyl)-phenanthridinium bromide (1.702 g, 4.64 mmol, 2.0 eq) and 
the reaction was stirred under N2 for 3 days. The reaction mixture was 
added to Et2O (400 mL) and the precipitate was filtered under vacuum, 
washing the residue thoroughly with Et2O. Trituration of the residue with 
acetone and drying under vacuum afforded a pale brown powder (30), 
(1.118 g, 1.61 mmol, 69.4%). Mpt 180-183 ˚C (degrad); 
1H NMR (CDCl3, 
400 MHz) δ : 8.61 (d, 1H, J=8.0 Hz), 8.59 (d, 1H, J=8.0 Hz), 8.42 (d, 1H, 
J=8.0 Hz), 8.05 (t, 1H, J=8.0 Hz), 7.78 (t, 2H, J=8.0 Hz), 7.61 (t, 1H,  
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J=8.0 Hz), 7.49 (d, 1H, J=8.0 Hz), 7.14 (brd, 1H), 4.89 (t, 2H, J=11.2 Hz), 
4.84 (s, 3H), 4.82 (t, 2H, J=11.2 Hz), 4.52 (t, 2H, J=4.5 Hz), 4.17 (s, 5H), 
4.15 (s, 3H), 3.81 (m, 2H), 3.71 (m, 4H), 3.58 (dt, 2H, J=5.0, 5.6 Hz);  
13C NMR (CDCl3, 100 MHz) δ : 171.03 (C), 154.08 (C), 135.56 (C), 
135.41 (CH), 132.72 (C), 131.71 (CH), 129.09 (CH), 128.18 (CH), 125.78 
(CH), 123.79 (CH), 123.47 (CH), 120.34 (C), 115.75 (CH), 115.48 (C), 
75.76 (C), 70.85 (CH2), 70.39 (2CH), 70.31 (CH2), 69.87 (CH2), 69.77 
(5CH), 68.41 (2CH), 68.15 (CH2), 51.54 (CH2), 51.41 (CH2), 46.70 
(CH2), 39.19 (CH2); IR (cm
-1) 3319 (w), 2862 (w), 1624 (s), 1602 (s), 1579 
(s), 1545 (s), 1313 (m), 1122 (s), 1033 (m); MS (FAB) m/z (%) 564.1 (M
+) 
(100); Anal. Calcd for C32H34BrFeN3O3 C, 59.65; H, 5.32; N, 6.52; Found 
C, 58.75; H, 5.27; N, 6.49; HRMS (FAB) for (C32H34BrFeN3O3)
+ calcd 
564.1950, obsd 564.1953. 
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Appendix 2. 
Standard procedures for using analytical equipment. 
 
Isothermal Titration Calorimetry. 
 
The calorimetric experiments were performed in aqueous media, 
at 25°C. Typically the cell contained the macromolecule at a 
concentration of ~0.05 mM relative to the binding sites available. The 
syringe contained ~0.7 mM solutions of the ligand required. The solutions 
were thoroughly degassed prior to use to remove air bubbles from 
solution as they cause interference in the spectrum when present. 
 
Cyclic Voltammetry. 
 
Voltammetry experiments were performed in aqueous media using 
0.01 mM solutions of the conjugates with 0.1 M NaCl as the supporting 
electrolyte. Cyclic voltammograms (CV) were recorded using a CH 
Instrument Inc (Austin, TX, USA.), 440a EC Analyser, employing a glassy 
carbon (GC) electrode (diameter 3.1 mm). Voltammograms were 
referenced against an Ag / AgCl electrode. 
 
 
 
 
 
 
  
 
301 
 
Appendix 2 continued. 
 
UV-Vis Spectroscopy. 
 
UV-Vis absorbance measurements were run on samples with a 
concentration of 10
-3 to 10
-5 M. For UV-Vis spectroscopy using a Perkin-
Elmer LAMBDA 25 UV-Vis spectrometer, the use of two paired quartz 
cuvettes was required. Initially both cuvettes were filled with the solvent 
used and a background scan was run. After this the solvent was replaced 
with the sample required, and the UV-Vis spectrum recorded. The data 
collected was analysed using excel.  
 
Fluorescence Spectroscopy. 
 
Fluorescence emission measurements were run on samples with a 
concentration of 10
-5 to 10
-7 M. The sample in a clear quartz cuvette is 
run, where the excitation wavelength chosen is the λMax found from the 
UV-Vis. The spectrum recorded is saved as a txt file that can be opened 
in excel for analysis. 
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Appendix 3. 
Cell Culture Protocols. 
 
DMEM Complete. 
400 mL   DMEM Dulbeccos Modified Eagles.  
100 mL   Medium 199. 
5 mL     Sodium Pyruvate. 
10 mL   Antibiotic. 
50 mL   Foetal Bovine Serum. 
 
Trypsin / Versine. 
20 mL   Versine. 
0.5 mL  Trypsin. 
 
Fixative. 
10 mL   Formaldehyde. 
90 mL   PBS. 
2 g     Sucrose. 
Directions for 24 well plate. 
Remove media then wash cells with PBS (2x ~1 mL / well).  
Add fixative (~0.5 mL / well) and leave for 20 minutes. 
Rinse with PBS (2x ~1 mL / well). 
Store at 4°C in PBS until use.  
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Appendix 3 continued 
 
Permeablising buffer. 
10.3 g   Sucrose. 
0.29 g   NaCl. 
0.06 g   MgCl2.6H2O. 
0.47 g   HEPES in 100 mL PBS. 
0.5 mL   Triton X. 
Adjust to pH 7.2.  
 
Directions for 24 well plate. 
After fixing.  
Remove PBS and add permeablising buffer (~0.5 mL / well) and leave to 
soak for 20 minutes.  
Wash with PBS (2x 1 mL / well). 
Store at 4°C in PBS until use. 
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Appendix 3 continued. 
 
MTT. 
Thiazoyl Blue Tetrazolium Bromide. 0.5 mg/ml in PBS.  
Store in the dark at 4°C. 
Directions for a 24 well plate. 
Seed cells into plate and incubate until suitable confluency has been 
reached. (in triplicate for treatment group and control) 
Add treatment and incubate for the desired time period. 
Wash with PBS (2x ~1 mL) to remove media and treatment material. 
Add 300 μL MTT per well.  
Incubate at 37°C for 1.5 hours. 
Remove MTT and add 150 μl DMSO, leave for 10 minutes. 
Pipette into 96 well plate. 
Place in plate reader at 550 nm. 
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Appendix 3 continued. 
 
Coomassie Blue. 
1.25 g   Coomassie ‘Bright’ blue R-250. 
50 mL   Glacial acetic acid. 
225 mL  Methanol. 
225 mL   Reverse osmosis water. 
Mix together the coomassie blue, methanol, acetic acid and water, allow 
to stand for 30 minutes and then filter through a No. 1 filter paper. 
 
Directions for 24 well plate. 
After fixing. 
Add coomassie blue solution (1 mL / well) and leave to soak for 20 
minutes. 
Remove stain. 
Wash with destain (10% glacial acetic acid, 10% methanol in water.) and 
leave 5 minutes per wash (3x 1 mL / well).  
Rinse with water (3x ~1 mL / well). 
Store in PBS at 4°C. 
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Appendix 3 continued 
 
Staining with antibodies. 
Rinse cells with PBS x1. 
Fix cells for 15 minutes at 37°C. 
Remove fixative add permeablising buffer and incubate at 5 minutes. 
Remove buffer and add PBS/BSA and incubate for 5 minutes at 37°C. 
Remove buffer and add primary antibody with phalloidin. Wrap in foil and 
incubate at 37°C for 1 hour. 
Remove antibody and wash with PBS/Tween x3. 
Remove PBS/Tween and add secondary antibody. Wrap in foil and 
incubate at 37°C for 1 hour. 
Remove antibody and wash with PBS/Tween x3. 
Remove PBS/Tween and add. Wrap in foil and incubate for 30 minutes. 
Remove streptavidin-FITC and wash with PBS/Tween x3. 
Place a small drop of vectorshield-DAPI on a labelled microscope slide 
and invert the coverslip onto the drop of vectorshield. 
Seal with a drop of clear nail varnish. 
Store in foil at 4°C until required for viewing under a microscope.  
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Appendix 4. 
Glass cleaning with Caro’s Acid. 
 
The Caro’s acid was made from hydrogen peroxide (20 mL) added to 
fuming sulfuric acid (40 mL). As the peroxide was added the acidic 
mixture started to boil and persulfuric acid was formed and oxygen was 
given off. It was at this point that the coverslips were carefully added. This 
highly acidic species reacted with any organic residue on the glass. Once 
the solution had cooled, after around 20 minutes, the acid was decanted 
off carefully into continuously running water. The coverslips’ were then 
rinsed with distilled water to remove any residual acid. They were then 
soaked for a further 10 minutes in distilled water, whereby 10 mL 5M 
NaOH was added the solution and after mixing briefly, the mixture was 
left to stand for 20 minutes in order to allow the NaOH to react with the 
now cleaned glass surface so as to increase the number of hydroxyl sites 
on the glass. The coverslips were then rinsed thoroughly with water, air 
dried and stored at 80°C for 1 hour. 
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Appendix 5. 
Monochromatic images from antibody cell staining experiments in § 3.3.4. 
 
 
Butyl SAM 
 
DAPI stain  
(blue) 
Actin stain  
(red) 
Tubulin stain 
(green) 
+ FeCl3  
 
+ β-CD 
 
 
 
Ferrocene 
SAM 
 
DAPI stain  
(blue) 
Actin stain 
(red) 
Tubulin stain 
(green) 
+ FeCl3 
 
+ β-CD 
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Appendix 5 continued. 
 
 
Butyl / Fc 
SAM 
 
DAPI stain  
(blue) 
Actin Stain 
(red) 
Tubulin Stain 
(green) 
+ FeCl3 
+ β-CD 
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The addition of the surfactant SDS to an aqueous solution
containing 12 results in the disassembly of the latter via the
simultaneous incorporation of 1 into a micelle and the precipitation
of 2 by an anion exchange reaction.
Pseudorotaxane-based host–guest assemblies have attracted a
great deal of attention as functional building blocks for the
creation of molecular machines.
1 In these systems, facile and
reversible control over the relative motion of the components
is required for the development of systems with bespoke
properties and applications. The electron-deﬁcient cyclophane
cyclobis(paraquat-p-phenylene)
2 (CBPQT
4+) has emerged as
an important host system for the fabrication of pseudo-
rotaxanes with tuneable complexation properties. A range of
stimuli have been employed to control the assembly/disassembly
of pseudorotaxanes of this type including: redox reactions,
3
acid/base reactions,
4 photochemical processes,
5 and alkali
metal complexation.
6 In addition, the tetracationic nature of
CBPQT
4+ allows the solubility and assembly properties
7 to be
tuned by varying the nature of the counter anion.
In this communication, we describe a CBPQT
4+-based
pseudorotaxane assembly that has the propensity to be
controlled in aqueous media by the addition of a surfactant
(Fig. 1).
8 The pseudorotaxane is comprised of an electron rich
1,5-dialkyloxynaphthalene unit incorporating an ammonium
moiety (1) and CBPQT
4+ (2). The ammonium moiety of
compound 1 was introduced to promote micelle formation
with an anionic surfactant molecule such as sodium dodecyl
sulfate (SDS). Previous studies have demonstrated that
cationic alkylammonium derivatives allow the self-assembly
of mixed micelles with SDS, due to attractive electrostatic
interactions.
9
The synthesis of compound 1 is outlined in the ESIw.
10 The
complexation between 1 and 2 was established by comparing
the
1H NMR spectra of 1 and 2 and their equimolar admixture
(Fig. 2). As shown in Fig. 2b, proton resonances belonging to
the CBPQT
4+ and naphthalene units of the complex show
broad signals and display noticeable chemical shift changes that
are characteristic of a pseudorotaxane-based complex.
11 It is
particularly noteworthy that a dramatic chemical shift change
for resonances belonging to protons H4 and H8 (Dd E 5.5 ppm)
of 1 occurred during the formation of pseudorotaxane 12.
Host–guest binding was also investigated by UV-vis
spectroscopy (see ESIw). Addition of aliquots of 2 to a solution
containing 1 immediately resulted in the formation of a purple
coloured solution and the appearance of a broad absorption
band l = B520 nm in the UV-vis spectrum. This colour
change is indicative of complex formation between the
1,5-dialkyloxynaphthalene moiety of 1 and 2.
5 A binding
constant (Ka) of 7.8  10
3 M
1 was determined in water using
Fig. 1 The SDS-mediated complexation between 1 and 2.
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ITC (see ESIw). This value is signiﬁcantly lower than that
obtained for complex 23 (Ka = 1.1  10
6 M
1),
11 and is likely
due to coulombic repulsion between the tetracationic 2 and the
ammonium group of 1.
The ability of 1 to be incorporated into micelles of SDS was
ﬁrst investigated using ﬂuorescence spectroscopy by exploiting
the intrinsic ﬂuorescence properties of the naphthalene unit.
Fig. 3 clearly shows the inﬂuence of increasing SDS concen-
tration on the ﬂuorescence emission of 1. In particular, a
gradual decrease in the relative ﬂuorescence intensity of the
naphthalene moiety
12 with increasing surfactant concentration
was observed until a value of around 4 mM was reached. At
this concentration an abrupt change in the ﬂuorescence
intensity of 1 was observed, suggesting the onset of micelle
formation. It should be noted that this observed CMC is lower
than the CMC of pure SDS (8.2 mM),
13 indicating that 1
promotes the micellization of SDS.
9
The incorporation of 1 into micelles of SDS was also
investigated by
1H NMR spectroscopy (see ESIw). The
addition of SDS to a solution of 1 induced upﬁeld shifts in
the resonances of all protons (for H2/6 see Fig. 4, for others see
ESIw) above the CMC, indicating a change in their environ-
ment. In addition, a plateau was reached at a SDS concentra-
tion of 14 mM, suggesting a complete incorporation of SDS at
this concentration. To demonstrate the importance of both the
ammonium unit of 1 and hydrophobic alkyl chain of SDS in
the micellization process, ﬂuorescence experiments were
undertaken with compounds 1 and 3 upon the addition of
sodium methyl sulfonate (SMS) and SDS, respectively
(see ESIw). In both cases, no signiﬁcant variation in the
relative intensity of ﬂuorescence emission was observed upon
the addition of SMS to 1 and SDS to 3, indicating that no
micellization occurred under the conditions investigated.
With complexation conﬁrmed for 12 and the ability of 1 to
be incorporated into a SDS-based micelle, we next investigated
whether the micellization process could be used as a tool to
control the assembly of pseudorotaxane 12. As shown in
Fig. 5, addition of SDS to a solution of 12 resulted in an
immediate change in turbidity and a complete disappearance
of the characteristic purple colour of the complex, suggesting
the dethreading of the pseudorotaxane. This was conﬁrmed by
removing the white precipitate from the solution by centri-
fugation and by analysing the supernatant by UV-vis and
1H NMR spectroscopies. The UV-vis spectrum of the
supernatant (see ESIw) did not display the typical broad
absorption band at l = B520 nm for the pseudorotaxane.
Furthermore, the
1H NMR spectra of the supernatant indi-
cated that compound 1 was incorporated inside SDS micelles
(see Fig. 5b) and that proton resonances associated with 2
were absent. The
1H NMR spectrum of the precipitate
recorded in DMSO-d6 (see Fig. 5d) showed the characteristic
resonances of the tetracationic cyclophane associated with
four dodecyl sulfate anions (DS
). Inspection of the
integration of the NMR signals indicated that the four Cl

counter-ions of 2 were exchanged by 4DS
, giving the water
insoluble 2 (4DS
).
To obtain further insight on the dethreading process, we
have studied the behaviour of pseudorotaxanes 12 and 23
upon the addition of SMS and SDS, respectively, using
1H
NMR and UV-vis spectroscopies (see ESIw). While the
addition of SMS into a solution 12 showed the persistence
of the absorption band at B520 nm characteristic of pseudo-
rotaxane architecture, the addition of SDS to a solution
containing 23 resulted in the disappearance of colour in the
liquid phase and the formation of a purple precipitate
presumably of the pseudorotaxane 23 (4DS
) (see ESIw).
These results demonstrate that the presence of the ammonium
unit of 1 and the hydrophobic alkyl chain of the surfactant are
needed to disrupt pseudorotaxane 12.
Finally, we have investigated whether it is possible to reform
complex 12 following SDS addition. We reasoned that the
addition of a strong acid, such as HCl,
14 would result in the
conversion of SDS to dodecyl sulfonic acid thereby allowing
reformation of the water soluble form of 2 (4Cl
), and thus
complex 12. To test this hypothesis, the addition of HCl to a
Fig. 2 Partial
1H NMR spectra of (a) 2 (1 mM); (b) 12 (1/1 molar
ratio) and (c) 1. Recorded in D2Oa t2 51C.
Fig. 3 Graph showing the variation in the ﬂuorescence emission
intensity of 1 (3.6 mM) as a function of SDS concentration. lex = 295 nm.
lem = 329 nm. Recorded in H2Oa t2 51C.
Fig. 4 Graph showing the eﬀect of SDS concentration on the
chemical shift of protons H2 and H6 of 1.
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solution of 1, 2 and SDS was monitored by UV-vis spectro-
scopy and clearly showed the reappearance of the character-
istic purple colour of the pseudorotaxane and a corresponding
absorption band centred around l = B520 nm (see ESIw).
Comparison of the absorbance values at 520 nm for solutions
of 12 and 1 + 2 + SDS + HCl, when recorded at equal
concentration, suggests that the acidiﬁcation process results in
a near complete re-assembly of the pseudorotaxane when a pH
value of 1.0 was reached (Fig. 6).
In conclusion, we have shown that compounds 1 and 2 have
the ability to form a pseudorotaxane in aqueous media. Upon
the addition of SDS to the solution containing the pseudo-
rotaxane, complexation is disrupted by the simultaneous
precipitation of 2 by an anion exchange reaction and the
sequestering of 1 by incorporation into SDS based micelles.
Furthermore, we have shown that the complex between 1 and
2 can be reformed by acidifying the media. Further work in
our laboratory will develop analogues of the systems described
here in endeavours to extend this methodology to biological
applications such as drug delivery.
We thank the EPSRC and Agence Nationale de la
Recherche (ANR-09-JCJC-0032-01) for funding. CEM thanks
the University of Glasgow for the award of a Kelvin-Smith
Scholarship.
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Fig. 5 Partial
1H NMR spectra of (a) 12; (b) 12 + SDS
(supernatant); (c) 1 recorded in D2O; (d) precipitate from 12 +S D S
recorded in DMSO-d6 (B10
4 M) at 40 1C.
Fig. 6 UV-vis spectra of 12 (2.7 mM) (black curve) and 12
(2.7 mM) + SDS + HCl conc (red curve). Recorded at 25 1C.
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